Original Article
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
N Engl J Med 1997; 337:1576-1584November 27, 1997
- Abstract
Background
Patients who survive life-threatening ventricular arrhythmias are at risk for recurrent arrhythmias. They can be treated with either an implantable cardioverter–defibrillator or antiarrhythmic drugs, but the relative efficacy of these two treatment strategies is unknown.
Methods
To address this issue, we conducted a randomized comparison of these two treatment strategies in patients who had been resuscitated from near-fatal ventricular fibrillation or who had undergone cardioversion from sustained ventricular tachycardia. Patients with ventricular tachycardia also had either syncope or other serious cardiac symptoms, along with a left ventricular ejection fraction of 0.40 or less. One group of patients was treated with implantation of a cardioverter–defibrillator; the other received class III antiarrhythmic drugs, primarily amiodarone at empirically determined doses. Fifty-six clinical centers screened all patients who presented with ventricular tachycardia or ventricular fibrillation during a period of nearly four years. Of 1016 patients (45 percent of whom had ventricular fibrillation, and 55 percent ventricular tachycardia), 507 were randomly assigned to treatment with implantable cardioverter–defibrillators and 509 to antiarrhythmic-drug therapy. The primary end point was overall mortality.
Results
Follow-up was complete for 1013 patients (99.7 percent). Overall survival was greater with the implantable defibrillator, with unadjusted estimates of 89.3 percent, as compared with 82.3 percent in the antiarrhythmic-drug group at one year, 81.6 percent versus 74.7 percent at two years, and 75.4 percent versus 64.1 percent at three years (P<0.02). The corresponding reductions in mortality (with 95 percent confidence limits) with the implantable defibrillator were 39±20 percent, 27±21 percent, and 31±21 percent.
Conclusions
Among survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms, the implantable cardioverter–defibrillator is superior to antiarrhythmic drugs for increasing overall survival.
Media in This Article
Figure 1
Overall Survival, Unadjusted for Base-Line Characteristics.Figure 4
Hazard Ratios (and 95 Percent Confidence Limits) for Death from Any Cause in the Defibrillator Group as Compared with the Antiarrhythmic-Drug Group in Prespecified Subgroup Analyses in the Univariate Model.Article Activity
- Article
Survivors of ventricular fibrillation or symptomatic, sustained ventricular tachycardia have a high risk of recurrence of arrhythmia, which is often fatal.1,2 Commonly prescribed treatments for the prevention of fatal recurrences are the implantable cardioverter–defibrillator and a variety of antiarrhythmic drugs. Whether the implantable cardioverter–defibrillator or antiarrhythmic-drug therapy is more effective in reducing mortality has not been shown.3-6
The results of the use of most antiarrhythmic drugs in the prevention of life-threatening ventricular tachyarrhythmias have been disappointing — even in the case of drugs that effectively reduce spontaneous ventricular arrhythmias.5-10 The implantable defibrillator effectively terminates sustained ventricular tachyarrhythmias,11,12 but its effectiveness as compared with antiarrhythmic drugs in prolonging survival has been demonstrated only in a small subgroup of patients at high risk for sudden death who had persistently inducible ventricular arrhythmias in the electrophysiology laboratory13 — a feature not required of our patients.
Randomized clinical trials comparing defibrillators with antiarrhythmic drugs in patients resuscitated after near-fatal ventricular fibrillation or sustained ventricular tachycardia are being performed in the United States, Canada, and Europe,14-16 and the study populations in these three trials are virtually identical. Our study, the Antiarrhythmics versus Implantable Defibrillators (AVID) Trial, examined the effect on overall survival of initial therapy with an implantable defibrillator as compared with initial therapy with amiodarone (Cordarone, Wyeth–Ayerst Laboratories, Philadelphia) or sotalol (Betapace, Berlex Laboratories, Wayne, N.J.) in patients resuscitated from near-fatal ventricular fibrillation or those with symptomatic, sustained ventricular tachycardia with hemodynamic compromise.
Methods
Study Design
The AVID Trial was a multicenter, randomized comparison of two treatment strategies for patients who were resuscitated from near-fatal ventricular fibrillation; sustained ventricular tachycardia with syncope; or sustained ventricular tachycardia with an ejection fraction of 0.40 or less and symptoms suggesting severe hemodynamic compromise due to the arrhythmia (near-syncope, congestive heart failure, and angina).14 If patients underwent revascularization, the ejection fraction had to be <0.40 for them to be eligible for the study.
Therapy
The therapies used in the two randomly assigned groups of patients were the best contemporary antiarrhythmic drugs and state-of-the-art implantable cardioverter–defibrillators. Patients had to be eligible for treatment with amiodarone to be enrolled. Consideration of the use of sotalol was left to the judgment of the physician, with common reasons for exclusion being a history of asthma, a low left ventricular ejection fraction, or a history of congestive heart failure. If patients randomly assigned to receive antiarrhythmic drugs were also eligible for treatment with sotalol, a second randomization procedure assigned them to either amiodarone at doses determined empirically or sotalol guided by electrophysiologic testing, Holter monitoring, or both.
Any advanced, state-of-the-art implantable cardioverter–defibrillator that met prespecified criteria14 could be used. Almost all were transvenous systems that could be implanted without thoracotomy and provided tiered therapy, including antitachycardia pacing functions, bradycardia pacing, diagnostic memory, and in many, a capability for pectoral implantation. The defibrillators used were either approved for general use by the Food and Drug Administration or implanted under an Investigational Device Exemption to permit the use of the newest devices before market approval. The devices implanted in this study were manufactured by Guidant/CPI (St. Paul, Minn.), Sulzer Intermedics (Angleton, Tex.), Medtronic (Minneapolis), and Ventritex (Sunnyvale, Calif.).
A registry was maintained of all patients who qualified for the study but did not undergo randomization in order to compare the randomized and nonrandomized patients. In addition, the registry followed patients with ventricular fibrillation or ventricular tachycardia who were not eligible for randomization. Data on long-term mortality among the nonrandomized patients will be obtained from the National Death Index.
Recruitment and Follow-up
The investigational review board of each institution approved the study. All patients gave written informed consent. Recruitment of patients began on June 1, 1993; patients were evaluated every three months and at the time of events. Randomization concluded on April 7, 1997. The primary end point was overall mortality. Secondary end points were cost and quality of life.
Statistical Analysis
We tested the null hypothesis that there was no difference in overall mortality between therapy with an implantable defibrillator and antiarrhythmic-drug therapy.14 Analysis was performed according to the intention-to-treat principle. Significance was based on a two-sided alpha level of 0.05 for comparisons of survival distributions. A sample size of 1200 patients was estimated to be sufficient, assuming an average follow-up of 2.6 years and an event rate of 40 percent in the control group (antiarrhythmic-drug group) at 4 years to detect a 30 percent decrease in mortality.14
At the end of the pilot phase, sequential data monitoring was performed every six months.17 Criteria for termination of the study were based on an O'Brien–Fleming spending function, which requires a substantial difference between treatment groups to stop the study early.18
Early Termination of the Study
The original goal was to enroll 1200 patients by March 1997. At its meeting on October 3, 1996, the Data and Safety Monitoring Board recommended that enrollment be extended to allow this goal to be reached. The board subsequently recommended stopping the AVID Trial on April 7, 1997, when analysis revealed that the difference in the primary outcome variable between the two groups had crossed the statistical boundary for early termination of the study. By that time, 1016 patients had been randomly assigned to treatment groups.
Results
Base-Line Characteristics
Of 6035 patients screened, 4621 entered the registry; 1885 were found to be eligible for randomization. Of these, 1016 were randomly assigned to treatment with an implanted defibrillator or antiarrhythmic drugs. The base-line characteristics of these 1016 patients (Table 1Table 1
History and Characteristics of the Patients Assigned to Receive Implantable Cardioverter–Defibrillators or Antiarrhythmic Drugs.) were similar in the two treatment groups, except for a history of atrial fibrillation or flutter and New York Heart Association class III heart failure. The mean age was 65 years; 79 percent of the patients were male, and 86 percent were white. A total of 455 patients had ventricular fibrillation, and 561 had ventricular tachycardia (216 with syncope, and 345 with other symptoms of serious hemodynamic compromise and with an ejection fraction <0.40).The mean (±SD) left ventricular ejection fraction was 0.32±0.13 in the defibrillator group and 0.31±0.13 in the antiarrhythmic-drug group. The minor difference in ejection fraction was confined to the patients with ventricular fibrillation (0.36±0.15 in the implanted-defibrillator group vs. 0.33±0.15 in the antiarrhythmic-drug group). The left ventricular ejection fraction was virtually identical (0.29±0.10 vs. 0.29±0.11) among the patients with ventricular tachycardia in the two groups.
During hospitalization for the index arrhythmia, 10 percent of the patients in the defibrillator group and 12 percent in the antiarrhythmic-drug group underwent coronary revascularization.
Therapy
The implantable cardioverter–defibrillator was the assigned therapy for 507 patients. A non-thoracotomy lead system was used in 93 percent; 5 percent received an epicardial system; and no device was implanted in 2 percent. Antiarrhythmic-drug treatment was the assigned therapy for 509 patients, of whom 356 immediately began empirical therapy with amiodarone, usually because they were not considered candidates for sotalol because of concern on the part of the investigators about heart failure, a low ejection fraction, or both. Antiarrhythmic-drug therapy was further randomly assigned in the remaining 153 drug patients: 79 to amiodarone and 74 to sotalol. In 53 of the 74 patients assigned to sotalol, electrophysiologic testing or ambulatory monitoring revealed sufficient arrhythmia to guide sotalol therapy. However, only 13 patients given sotalol (2.6 percent of those assigned to antiarrhythmic-drug therapy) had adequate suppression of arrhythmia and were receiving sotalol at discharge. The remaining patients assigned to be evaluated for sotalol therapy received amiodarone (58 patients) or another antiarrhythmic drug (1) or were treated with an implantable cardioverter–defibrillator (2).
The daily maintenance dose of amiodarone was progressively decreased throughout the course of follow-up (mean, 389±112 mg at three months; 331±99 mg at one year; 294±94 mg at two years; and 256±95 mg at three years). Most patients who were receiving amiodarone at discharge continued to take the drug (87 percent at one year and 85 percent at two years). The mean daily maintenance dose of sotalol during follow-up was stable over the course of the study (258±81 mg at three months, 248±88 mg at one year, 280±121 mg at two years, and 240±113 mg at three years).
Table 2Table 2
Therapy at Discharge and during Follow-up. lists the concurrent therapies at hospital discharge and during follow-up. Investigators were encouraged to treat patients with aspirin, beta-blockers, and angiotensin-converting–enzyme inhibitors when clinically appropriate. More patients were taking beta-blockers (P<0.001) and slightly more patients were taking digitalis (P = 0.04) in the defibrillator group than in the antiarrhythmic-drug group.Outcome
Fewer deaths occurred among the patients assigned to receive an implantable defibrillator (80 deaths) than in the antiarrhythmic-drug group (122). Over a mean follow-up of 18.2±12.2 months, the crude death rates (with 95 percent confidence limits) were 15.8±3.2 percent in the defibrillator group and 24.0±3.7 percent in the antiarrhythmic-drug group. Figure 1Figure 1
Overall Survival, Unadjusted for Base-Line Characteristics. shows survival (life-table) distributions (not adjusted for any base-line differences between the groups). Patients treated with defibrillators had better survival throughout the course of the study (Wilcoxon statistic, 3.32; P<0.02, adjusted for sequential monitoring). These survival figures represent a decrease in death rates (with 95 percent confidence limits) of 39±20 percent, 27±21 percent, and 31±21 percent, at one, two, and three years, respectively, though the accuracy of long-term data is limited because few patients had been followed beyond two years at the time the study ended. The average unadjusted length of additional life associated with cardioverter–defibrillator therapy was 2.7 months at 3 years.Automatic pacing or shocks from the implantable cardioverter–defibrillator were more common among patients who entered the study with ventricular tachycardia than among those who had ventricular fibrillation as the index arrhythmia. The cumulative percentage of patients with any activation of the defibrillator, either antitachycardia pacing or shock, was as follows: for the patients with ventricular tachycardia, 36 percent at three months, 68 percent at one year, 81 percent at two years, and 85 percent at three years; for the patients with ventricular fibrillation, 15 percent, 39 percent, 53 percent, and 69 percent, respectively (P<0.001 for patients with ventricular tachycardia vs. those with ventricular fibrillation).
Figure 2Figure 2
Time to Crossover in the Two Groups. illustrates the length of time to crossover in the study groups. Overall, approximately 20 percent of patients had crossed over to or added the other therapy by 24 months. The crossover rate was higher among those initially assigned to therapy with a defibrillator (P<0.001).Figure 3Figure 3
Time to First Rehospitalization. shows the times to first rehospitalization in each group. Patients with an implanted defibrillator were rehospitalized somewhat sooner, on average, than patients treated with drugs, most often for evaluation of recurrent arrhythmias and defibrillator shocks. By one year, 60 percent of the patients in the defibrillator group had been rehospitalized, as had 56 percent in the antiarrhythmic-drug group (P = 0.04).Figure 4Figure 4
Hazard Ratios (and 95 Percent Confidence Limits) for Death from Any Cause in the Defibrillator Group as Compared with the Antiarrhythmic-Drug Group in Prespecified Subgroup Analyses in the Univariate Model. shows the hazard ratios for death from any cause in subgroups defined according to variables prespecified in the study design: age, left ventricular ejection fraction, cardiac diagnosis, and qualifying arrhythmia. The hazard ratios were not significantly different for any of these subgroups, but the early termination of the study diminished its power to detect differences between the subgroups. Multivariate analysis showed that the beneficial effect of the implantation of a defibrillator persisted after adjustment for other factors, such as age, use of beta-blockers during follow-up, presence or absence of congestive heart failure, and ejection fraction at base line. Furthermore, revascularization after the index arrhythmia did not alter survival. Estimates in which the Cox model was used to adjust for base-line differences in the presence or absence of heart failure, the ejection fraction, and history with respect to atrial fibrillation indicated that the reductions in mortality (with 95 percent confidence limits) that were attributable to the implantable defibrillator were 37±22 percent at one year, 24±22 percent at two years, and 29±23 percent at three years. Estimates adjusted for the use of beta-blockers were unchanged from the unadjusted values.Complications of Therapy
Nonfatal torsade-de-pointes ventricular tachycardia was observed only once throughout the course of the study, in a patient given amiodarone. Pulmonary toxicity, though difficult to diagnose,19 was suspected in 3 percent of the patients treated with amiodarone at one year and 5 percent at two years. One patient died from pulmonary toxicity. Thyroid-replacement medication was prescribed for 10 percent of the patients treated with amiodarone by one year and 16 percent by two years, as compared with 1 percent and 1 percent, respectively, for the patients treated with a defibrillator. No other serious complications of amiodarone were noted.
Serious complications of defibrillator therapy were infrequent. Twelve patients in the defibrillator group (2.4 percent) died within 30 days of the initiation of therapy (or by the time of hospital discharge, if discharge occurred later than 30 days after therapy began), as compared with 18 patients (3.5 percent) in the antiarrhythmic-drug group (P = 0.27). Bleeding requiring reoperation or transfusion occurred in 6 patients in the defibrillator group, and serious hematomas in 13. Other complications included infection (in 10 patients), pneumothorax (8), and cardiac perforation (1). Early dislodgment or migration of leads occurred in three patients. The first attempt at implantation of the cardioverter–defibrillator without thoracotomy was unsuccessful in five patients — in four because of an excessively high defibrillation threshold and in one because of cardiac perforation. Three of these five patients subsequently underwent successful implantation procedures.
Discussion
In patients who were resuscitated from ventricular fibrillation or who had sustained ventricular tachycardia causing symptoms and hemodynamic compromise, the implantable cardioverter–defibrillator improved survival in the AVID Trial as compared with antiarrhythmic-drug therapy.
The effectiveness of defibrillator therapy in reducing overall mortality, as compared with the rates with other therapies, has been uncertain since its original clinical application in 1980.20,21 Although contemporary models are quite successful in recognizing serious ventricular arrhythmias and initiating cardioversion or defibrillation,11 the effect of these devices on overall mortality, particularly in comparison with the best available antiarrhythmic-drug therapy, has remained unknown. Many studies of the defibrillator have emphasized only death due to arrhythmia.22,23 However, assigning a cause of death can be difficult, particularly if a patient has congestive heart failure, and assignment may be biased when therapy has not been blinded.24,25 Previous reports comparing treatment with the implantable cardioverter–defibrillator and antiarrhythmic-drug therapy have been complicated by the fact that the groups of patients given these two therapies have not been equivalent.26,27 It is impossible to compare the defibrillator with antiarrhythmic drugs accurately with the use of historical controls, concurrent nonrandomized controls, or matched case–control studies. Furthermore, any comparison of defibrillator with drug therapy reveals only the relative effect of these two therapies, not the difference between treatment and no treatment.
In the AVID Trial, the base-line clinical characteristics of the defibrillator and antiarrhythmic-drug groups were similar. The mean left ventricular ejection fraction was nonsignificantly lower in the antiarrhythmic-drug group; the entire difference occurred in those who had ventricular fibrillation as the index arrhythmia. In addition, the incidence of heart failure was slightly greater in the antiarrhythmic-drug group. However, stratified regression analysis suggests that these minor imbalances in base-line characteristics explained only about 8 percent of the observed difference in survival.
Beta-blockers were used less often in the antiarrhythmic-drug group than in the defibrillator group, as was also the case in the Multicenter Automatic Defibrillator Implantation Trial (MADIT).13 Amiodarone has mild antiadrenergic properties, and sotalol is a more potent beta-blocker. Many physicians may have felt that the addition of a beta-blocker to amiodarone or sotalol was not necessary or might aggravate bradyarrhythmias. Furthermore, beta-blockers are often given to control the ventricular rate in atrial fibrillation, thus preventing inappropriate defibrillator shocks. Finally, beta-blockers may have been used less often in the antiarrhythmic-drug group because of an attempt by physicians to simplify drug regimens. Adjustment for this imbalance in the Cox regression analysis slightly reduced the estimated beneficial effect of defibrillator therapy on survival (unadjusted hazard ratio for the defibrillator group as compared with the antiarrhythmic-drug group, 0.62; adjusted hazard ratio, 0.67).
Amiodarone was administered empirically, whereas the dose of sotalol was based on the results of Holter monitoring or electrophysiologic testing for evidence of suppression of arrhythmias. Many patients did not have findings on these studies that allowed the guided use of sotalol, or they had contraindications to its use. The investigators decided at the beginning of the study that no comparison of mortality would be made between patients given amiodarone and those given sotalol, nor would the various models and manufacturers of the implantable cardioverter–defibrillator be compared.
Most patients randomly assigned to therapy with an implantable cardioverter–defibrillator received transvenous devices whose implantation did not require thoracotomy. The rate of nonfatal complications of implantation (5.7 percent) was lower than that previously reported for epicardial implantation.11,28 Virtually all patients assigned to receive a defibrillator achieved an adequate defibrillation threshold; 30-day mortality in the defibrillator group was 2.4 percent, as compared with 3.5 percent in the antiarrhythmic-drug group.
Rates of crossover from the defibrillator group to drug therapy (25.7 percent) or from drug therapy to defibrillator therapy (18.9 percent) at two years were relatively low and did not compromise the power of the study. Most crossovers occurred because arrhythmia recurred, rather than because of intolerance of the drugs or devices. As expected, the addition of antiarrhythmic drugs to the treatment of patients who were initially assigned to defibrillator therapy was common because of the perceived need to reduce the frequency of shocks.
Data in the AVID registry demonstrate that the clinical characteristics of the patients who underwent randomization were similar to those of nonrandomized patients29; therefore, the population studied in this trial is representative of the general population of patients who are resuscitated from ventricular fibrillation or who have symptomatic, sustained ventricular tachycardia.
Limitations of the Study
The differences in base-line characteristics (notably the proportions with heart failure and atrial fibrillation) and concomitant drug therapy (with respect to beta-blockers) do not explain the differences in survival in our study group. Although many patients had to be screened to identify the 1016 survivors of ventricular fibrillation or sustained ventricular tachycardia who ultimately underwent randomization, the proportion of eligible patients randomly assigned to treatment groups (54 percent) was consistent with the rates in other, similar studies. Most patients who were not enrolled met prespecified criteria for exclusion, such as neurologic impairment, severe coexisting illness, or a decision by the patient or physician not to participate. However, data from the AVID registry confirm that the patients randomly assigned to groups were generally representative of the entire population at risk.29
The dose of amiodarone was determined empirically, not on the basis of electrophysiologic testing. The value of electrophysiologic testing in patients given amiodarone is controversial,30,31 but the empirical use of amiodarone in survivors of ventricular fibrillation is more effective than guided therapy with conventional antiarrhythmic drugs.5 The AVID Trial was purposely a comparison of defibrillator treatment with the antiarrhythmic-drug therapy that could be administered simply by most physicians to a large percentage of the target population.
No control group was included in the study design. We believed it would have been unethical to withhold all treatment from patients with the types of arrhythmias being studied. This study therefore addresses only the relative benefit of two treatments, rather than of a treatment and a control group.
Many different types of implantable cardioverter–defibrillator were used, and there was no standard programming of devices for antitachycardia pacing. However, there is no evidence that one device is better than another in preventing death, and antitachycardia pacing protocols selected by physicians in the AVID Trial were similar among devices and institutions.
Although some might consider our use of overall mortality, rather than mortality due to arrhythmia, as the primary end point to be a limitation of the study, in fact it is a major strength. Particularly in an unblinded study, classification of death according to cause may be subject to bias.24,25,32 Furthermore, we evaluated whether the prevention of death due to cardiac arrhythmia by the implantation of a cardioverter–defibrillator would translate into a benefit in terms of overall survival or would be offset by competing causes of death in this high-risk population.
Conclusions
Although the absolute magnitude of the benefit associated with the implantable-defibrillator therapy remains unknown, the greater efficacy of this device, relative to antiarrhythmic-drug therapy, is strongly supported by this study. The defibrillator was superior to antiarrhythmic-drug therapy in prolonging survival among patients resuscitated after symptomatic, sustained ventricular tachycardia or ventricular fibrillation causing hemodynamic compromise. It should be offered as first-line therapy to such patients.
Supported by a contract (N01-HC-25117) with the National Heart, Lung, and Blood Institute, Bethesda, Md.
The manuscript was prepared by members of the AVID Executive Committee, who accept responsibility for its scientific content: Douglas P. Zipes, M.D. (chairman), Indiana University, Indianapolis; D. George Wyse, M.D., Ph.D., University of Calgary, Calgary, Alta., Canada; Peter L. Friedman, M.D., Ph.D., Brigham and Women's Hospital, Boston; Andrew E. Epstein, M.D., University of Alabama, Birmingham; Alfred P. Hallstrom, Ph.D., and H. Leon Greene, M.D., University of Washington, Seattle; and Eleanor B. Schron, M.S., R.N., and Michael Domanski, M.D., National Heart, Lung, and Blood Institute, Bethesda, Md.
Source Information
From the AVID Clinical Trial Center, University of Washington, Seattle.
Address reprint requests to the AVID Clinical Trial Center, 1107 N.E. 45th St., Rm. 505, Seattle, WA 98105.
The institutions and investigators participating in the trial are listed in the Appendix.
Appendix
The Investigators of the Antiarrhythmics versus Implantable Defibrillators (AVID) Trial (listed in order of number of patients randomized — highest number enrolled listed first):
Oregon Health Sciences University and Collaborating Medical Centers, Portland, OR: J. McAnulty, B. Halperin, J. Kron, G. Larsen, M. Raitt, R. Swenson, R. Florek, C. Marchant, M. Hamlin, G. Heywood; Brigham and Women's Hospital, Boston, MA: P. Friedman, W. Stevenson, M. Swat, L. Ganz, M. Sweeney, J. Shea; St Luke's-Roosevelt Hospital Center and Collaborating Institutions, New York, NY: J. Steinberg, F. Ehlert, S. Zelenkofske, E. Menchavez-Tan, M. De Stefano, G. Brown; University of Utah Medical School, LDS Hospital, Salt Lake City, UT: J. Anderson, L. Karagounis, B. Crandall, J. Osborn, D. Rawling, K. Summers, M. Jacobsen; Sentara Norfolk General Hospital, Norfolk, VA: J. Herre, R. Bernstein, L. Klevan; Good Samaritan Hospital, Los Angeles, CA: D. Cannom, A. Bhandari, R. Lerman, B. Firth; University of Utah/VA Medical Center, Salt Lake City, UT: R. Klein, R. Freedman, M. Marks, M. Delahunty, C. Spratt; Lankenau Hospital and Medical Research Center, Wynnewood, PA: R. Marinchak, S. Rials, P. Kowey, R. Filart, M. Hernandez, D. Scher, L. Zukerman, S. Farrell, D. Kolk, H. Criner, B. Tait; Cleveland Clinic Foundation, Cleveland, OH: B. Wilkoff, S. Pinski, J. Cross, J. Shewchik; University of Alabama at Birmingham, Birmingham, AL: A. Epstein, R. Cooper, S. Dailey, G. Kay, V. Plumb, R. Bubien, S. Knotts-Dolson, P. McKenna, C. Tidwell; Montefiore Medical Center, Bronx, New York, NY: S. Kim, J. Fisher, K. Ferrick, J. Gross, U. Ben-Zur, J. Durkin, A. Ferrick; University of Oklahoma Health Sciences Center, Oklahoma City, OK: K. Beckman, J. McClelland, M. Gonzalez, L. Widman, R. Lane, T. Deaton, J. Foster, G. Straughn, L. Wade; University of California, Irvine Medical Center, Orange, CA: M. Brodsky, B. Allen, S. Ehrlich, L. Wolff, M. Macari-Hinson; Columbia-Presbyterian Medical Center, New York, NY: J. Coromilas, T. Bigger, Jr., F. Livelli, Jr., J. Reiffel, K. Hickey; University of Rochester and Collaborating Hospitals, Rochester, NY: T. Akiyama, J. Daubert, C. Kim, D. Switzer, P. Pande, D. Flynn, M. Keller, C. Ocampo, K. Wahl, J. Vogt; Likoff Cardiovascular Institute, Hahnemann University, Philadelphia, PA: S. Kutalek, S. Hessen, C. Movsowitz, F. Samuels, S. Wilber, C. Baessler, D. Soto, M. Schuster, G. Scott, R. Covelasky-Robinson, S. Fletcher, K. Siegl, L. Finn, C. Saari; Minneapolis Heart Institute, Minneapolis, MN: A. Almquist, P. Baldwin, R. Hauser, S. Milstein, M. Pritzker, V. Schreiber; Loma Linda University Medical Center, Loma Linda, CA: V. Torres, S. Pai, M. Platt, P. Timothy, V. Bishop; Indiana University Medical Center, Indianapolis, IN: D. Zipes, E. Engelstein, W. Miles, L. Foreman; Maine Medical Center, Portland, ME: J. Love, J. Cutler, S. Bosworth-Farrell; Baylor College of Medicine, Houston, TX: C. Rizo-Patron, K. Belco, J. Payne, D. Arnold, W. Zhu, C. Pratt; University of Iowa Hospitals, Iowa City, IA: J. Martins, H. Lee, J. Hopson, R. Hopson; St. Joseph's Hospital and Medical Center, Paterson, NJ: N. Tullo, C. Irmiere, A. Henry; Vanderbilt University Medical Center, Nashville, TN: M. Wathen, D. Echt, D. Roden, J. Lee, K. Murray, J. Rottman, D. Crawford, N. Connors; University of Connecticut Health Center, Farmington, CT: E. Berns, N. Lippman, M. Barry, H. Dalamagas; Baystate Medical Center, Springfield, MA: J. Cook, G. Kabell, J. Kirchhoffer, D. Warwick, B. Burkott, D. Tomaszewski; Temple University School of Medicine, Philadelphia, PA: A. Buxton, H. Hsia, J. Miller, S. Rothman, N. Adelizzi, M. Gastineau, L. Thome, D. Whitley; Arkansas Cardiology Clinic, Little Rock, AR: G. Greer, I. Santoro, J. Swaim, S. Whittle; Tacoma General Hospital, St. Joseph's Hospital, Tacoma, WA: M. Rome, K. Kresge, C. Tregoning, C. Howard; University Hospitals of Cleveland, Cleveland, OH: M. Carlson, D. Rosenbaum, W. Lewis, L. Biblo, J. Mackall, A. Waldo, J. Kandrac; Methodist Hospital of Indiana, Indianapolis, IN: P. Foster, B. Crevey, H. Genovely, J. Schutzman, K. Viater, C. Coyle; Methodist Hospital — Houston, TX: A. Pacifico, N. Nasir, Jr., K. Trainor; Stanford University Medical Center and Collaborating Medical Center, Stanford, CA: R. Sung, B. Liem, C. Young, M. Lauer, J. Peterson, L. Ottoboni, P. Goold; University of Florida, Gainesville, FL: A. Curtis, J. Conti, C. Nelson; University of Virginia Medical Center, Charlottesville, VA: P. Mounsey, S. Nath, D. Haines, S. Ackerman, L. Bowman; Midwest Heart Research Foundation, Lombard, IL: M. Nora, M. O'Toole, R. Collura, E. Enger; Cooper Hospital/University Medical Center, UMDNJ, Camden, NJ: A. Russo, H. Waxman, C. Stubin, J. Morrissey, D. Raspa; North Shore University Hospital, Manhasset, NY: R. Jadonath, B. Goldner, K. Merkatz, L. Chepurko; Eastern Heart Institute, Passaic, NJ: S. Saksena, R. Krol, A. Munsif, C. Lewis; Florida Arrhythmia Consultants, Ft. Lauderdale, FL: R. Luceri, P. Zilo, D. Weiss, A. Jonas, L. Vardeman; Wilson Regional Medical Center, Johnston City, NY: N. Stamato, D. Whiting; Deaconess and Sacred Heart Medical Centers, Spokane, WA: D. Chilson, T. Lessmeier, W. Pochis, J. Baxter; Denver General Hospital/University of Colorado, Denver, CO: K. Nademanee, J. Weinberger, W. Bailey, M. Reiter, M. Blankenship; The University of Texas Southwestern Medical Center, Dallas, TX: R. Page, M. Jessen, R. Canby, R. Horton, P. Welch, D. Kessler, J. Joglar, M. Hamdan, L. Nelson, G. Erwin; Valley Heart Associates, Modesto, CA: W. Chien, R. Stevenot, J. Merillat, M. McPherson; University of Maryland Medical Center, Baltimore, MD: M. Gold, S. Shorofsky, R. Peters, N. Kavesh, D. Froman, H. Scott; University of Texas Medical School-Houston/Baylor College of Medicine, Houston, TX: H.-T. Shih, A. Dougherty, S. Jalal, G. Naccarrelli, D. Wolbrette, D. Wilson; Medical College of Wisconsin, Milwaukee, WI: J. Roth, A. Gadhoke, S. Mauermann; Florida Heart Group, PA, Orlando, FL: K. Schwartz, C. Asbell; University of California, San Francisco, CA: M. Scheinman, S. Eisenberg, L. Epstein, A. Fitzpatrick, G. Griffin, R. Lee, M. Lesh, M. Wong, M. Wong; Mount Sinai Medical Center, Miami Beach, FL: J. Zebede, P. Samet, A. Tolentino, S. Rubin; Boston University Medical Center Hospital, Boston, MA: P. Podrid, T. Fuchs, M. Mazur; The University of Calgary/Calgary Regional Health Authority Hospitals, Calgary, Alberta, Canada: G. Wyse, H. Duff, A. Gillis, B. Mitchell, J. Rothschild, R. Sheldon, P. Cassidy; Presbyterian Hospital and Collaborating Medical Centers, Albuquerque, New Mexico: C. Karaian; St. Michael's Hospital, Toronto, Ontario, Canada: P. Dorian, D. Newman, J. Mitchell, M. Greene; Montreal Heart Institute, Montreal, Quebec, Canada: D. Roy, M. Dubuc, M. Talajic, B. Thibault, D. Morrissette; Other Steering Committee Members: L. Jenkins, University of Maryland, Baltimore, MD; S. Connolly, McMaster Clinic, Hamilton, Ontario; Clinical Trial Center, University of Washington, Seattle, WA: A. Hallstrom, L. Greene, M. Scholz, J. Powell, E. Renfroe, R. Ledingham, M. Morris, S. Lancaster, R. Moore, A. Olarte, Q. Yao, M. Mori Brooks, B. Hofer, S. Sullivan; National Heart, Lung, and Blood Institute, Bethesda, MD: E. Schron, M. Domanski, D. Follmann, Y. Rosenberg, C. Jennings; Events Committee: D. Richardson, Chairman, L. Cobb, C. Pratt; Data and Safety Monitoring Board; S. Furman, Chairman, J. DiMarco, G. Knatterud, R. Levine, H. Strauss, R. Woosley; Planning Committee: D. Zipes, S. Connolly, A. Epstein, L. Jenkins, S. Saksena, B. Singh, J. Mason, J. Griffin, G. Wyse, J. Ruskin, S. Yusuf, S. Furman, E. Schron, M. Domanski, D. Follmann, C. Jennings, J. Watson, D. Dahms, M. Shein, A. Hallstrom, L. Greene.
- References
References
1
Cobb LA ,Baum RS ,Alvarez H III ,Schaffer WA . Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation 1975;52:Suppl III:III-2232
Goldstein S ,Landis JR ,Leighton R , et al. Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease. Circulation 1985;71:873-880
CrossRef | Web of Science | Medline3
Maloney J ,Masterson M ,Khoury D , et al. Clinical performance of the implantable cardioverter defibrillator: electrocardiographic documentation of 101 spontaneous discharges. Pacing Clin Electrophysiol 1991;14:280-285
CrossRef | Web of Science | Medline4
Lehmann MH ,Steinman RT ,Schuger CD ,Jackson K . The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803-805
CrossRef | Web of Science | Medline5
The CASCADE Investigators
CrossRef | Web of Science | Medline6
Mason JW . A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458
Full Text | Web of Science | Medline7
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med 1989;321:406-12.
8
Waldo AL ,Camm AJ ,deRuyter H , et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12[Erratum, Lancet 1996;348:416.]
CrossRef | Web of Science | Medline9
Julian DG ,Camm AJ ,Frangin G , et al. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-674[Erratum, Lancet 1997;349:1180.]
CrossRef | Web of Science | Medline10
Cairns JA ,Connolly SJ ,Roberts R ,Gent M . Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-682
CrossRef | Web of Science | Medline11
Zipes DP ,Roberts D . Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65
Web of Science | Medline12
Winkle RA ,Mead RH ,Ruder MA , et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353-1361
CrossRef | Web of Science | Medline13
Moss AJ ,Hall WJ ,Cannom DS , et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940
Full Text | Web of Science | Medline14
Antiarrhythmics versus Implantable Defibrillators (AVID) -- rationale, design, and methodsAm J Cardiol 1995;75:470-475
CrossRef | Web of Science | Medline15
Connolly SJ ,Gent M ,Roberts RS , et al. Canadian Implantable Defibrillator Study (CIDS): study design and organization. Am J Cardiol 1993;72:103F-108F
CrossRef | Web of Science | Medline16
Siebels J ,Kuck KH . Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994;127:1139-1144
CrossRef | Web of Science | Medline17
Lan KKG ,DeMets DL . Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-663
CrossRef | Web of Science18
O'Brien PC ,Fleming TR . A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556
CrossRef | Web of Science | Medline19
Dusman RE ,Stanton MS ,Miles WM , et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-59
CrossRef | Web of Science | Medline20
Zipes DP . Implantable cardioverter-defibrillator: lifesaver or a device looking for a disease? Circulation 1994;89:2934-2936
Web of Science | Medline21
Josephson ME ,Nisam S . Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question? Am J Cardiol 1996;77:859-863
CrossRef | Web of Science | Medline22
Thomas AC ,Moser SA ,Smutka ML ,Wilson PA . Implantable defibrillation: eight years clinical experience. Pacing Clin Electrophysiol 1988;11:2053-2058
CrossRef | Web of Science | Medline23
Fogoros RN ,Elson JJ ,Bonnet CA . Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1989;12:1465-1473
CrossRef | Web of Science | Medline24
Greene HL ,Richardson DW ,Barker AH , et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989;63:1-6
CrossRef | Web of Science | Medline25
Epstein AE ,Carlson MD ,Fogoros RN ,Higgins SL ,Venditti FJ Jr . Classification of death in antiarrhythmia trials. J Am Coll Cardiol 1996;27:433-442
CrossRef | Web of Science | Medline26
Newman D ,Sauve MJ ,Herre J , et al. Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899-903
CrossRef | Web of Science | Medline27
Powell AC ,Fuchs T ,Finkelstein DM , et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-1092
Web of Science | Medline28
Saksena S . Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems: the PCD Investigators and participating institutions. Pacing Clin Electrophysiol 1993;16:202-207
CrossRef | Web of Science | Medline29
Kim SG ,Hallstrom A ,Love JC , et al. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) Trial and nonrandomized registry patients. Am J Cardiol 1997;80:454-457
CrossRef | Web of Science | Medline30
Kadish AH ,Buxton AE ,Waxman HL ,Flores B ,Josephson ME ,Marchlinski FE . Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy. J Am Coll Cardiol 1987;10:90-96
CrossRef | Web of Science | Medline31
Borggrefe M ,Haverkamp W ,Shenasa M ,Hindricks G ,Breithardt G . How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach. J Cardiovasc Pharmacol 1992;20:Suppl 2:S32-S40
CrossRef | Web of Science | Medline32
Kim SG ,Fogoros RN ,Furman S ,Connolly SJ ,Kuck KH ,Moss AJ . Standardized reporting of ICD patient outcome: the report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993. Pacing Clin Electrophysiol 1993;16:1358-1362
CrossRef | Web of Science | Medline
- Citing Articles (846)
Citing Articles
1
Pasquale Santangeli, Luigi Di Biase, John David Burkhardt, Rong Bai, Prasant Mohanty, Agnes Pump, Andrea Natale. (2012) Examining the safety of amiodarone. Expert Opinion on Drug Safety1-24
CrossRef2
D. G. Katritsis, M. E. Josephson. (2012) Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?. Europace
CrossRef3
B. Brembilla-Perrot, J.M. Sellal, P.Y. Zinzius, J. Schwartz, H. Blangy, N. Sadoul. (2012) Influence of the time on the prevalence of drug-related resuscitated sudden death during these past 20years. International Journal of Cardiology
CrossRef4
Apurva Badheka, Ankit Rathod, Tushar Tuliani, Luis Afonso, Sony Jacob. (2012) Device Therapy in Heart Failure Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 59:5, 542-543
CrossRef5
Nicholas B. Norgard, Mazen S. Abu-Fadel. 2011. Cardiovascular Disease: In-Depth Look. .
CrossRef6
Steven M. Schwartz, Oliver G. Cameron, Melvyn Rubenfire. 2011. Cardiovascular Manifestations of Panic and Anxiety. , 166-175.
CrossRef7
H. Furushima, M. Chinushi, K. Iijima, K. Hasegawa, A. Sato, D. Izumi, H. Watanabe, Y. Aizawa. (2011) Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases?. Europace
CrossRef8
R. E. Knops, K. M. Kooiman, J. N. Sande, J. R. Groot, A. A. M. Wilde. (2011) First experience with the wearable cardioverter defibrillator in the Netherlands. Netherlands Heart Journal
CrossRef9
Mehul B. Patel, Swapnil Hiremath, Tahmeed Contractor, Ranjan K. Thakur. (2011) Implantable Cardioverter-Defibrillators in End-Stage Renal Disease. Cardiac Electrophysiology Clinics 3:4, 641-650
CrossRef10
Mohan Rao, Ilan Goldenberg, Arthur J. Moss, Helmut Klein, David T. Huang, Nicole R. Bianco, Steven J. Szymkiewicz, Wojciech Zareba, Andrew Brenyo, Jonathan Buber, Alon Barsheshet. (2011) Wearable Defibrillator in Congenital Structural Heart Disease and Inherited Arrhythmias. The American Journal of Cardiology 108:11, 1632-1638
CrossRef11
Ashok J. Shah, Shinsuke Miyazaki, Amir S. Jadidi, Daniel Scherr, Stephen B. Wilton, Laurent Roten, Patrizio Pascale, Michala Pedersen, Nicolas Derval, Sebastien Knecht, Frederic Sacher, Pierre Jais, Michel Haissaguerre, Meleze Hocini. (2011) Catheter Ablation of Ventricular Fibrillation Storms: Will this Replace Defibrillators?. Cardiac Electrophysiology Clinics 3:4, 689-695
CrossRef12
Ganesh Venkataraman, S. Adam Strickberger. (2011) Evaluation of Defibrillation Efficacy at Implantation is Unnecessary. Cardiac Electrophysiology Clinics 3:4, 559-563
CrossRef13
Pasquale Santangeli, Luigi Di Biase, Amin Al-Ahmad, Henry Hsia, J. David Burkhardt, Javier Sanchez, Rong Bai, Michela Casella, Antonio Dello Russo, Claudio Tondo, Andrea Natale. (2011) Primary Ablation for Ventricular Tachycardia: When and How?. Cardiac Electrophysiology Clinics 3:4, 675-688
CrossRef14
Girish M. Nair, Jeffrey S. Healey, Syamkumar M. Divakaramenon, Stuart J. Connolly, Carlos A. Morillo. (2011) Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients. Cardiac Electrophysiology Clinics 3:4, 651-661
CrossRef15
Laura Perrotta, Giuseppe Ricciardi, Paolo Pieragnoli, Luigi Padeletti. (2011) Device Recalls: What’s an Electrophysiologist to Do?. Cardiac Electrophysiology Clinics 3:4, 617-622
CrossRef16
Renee M. Sullivan, Brian Olshansky. (2011) Is a Dual-Chamber ICD Always Better in Patients Requiring an ICD?. Cardiac Electrophysiology Clinics 3:4, 577-592
CrossRef17
Krishnakumar Nair, Jack V. Tu, Douglas S. Lee. (2011) Why Are Implantable Cardioverter Defibrillator Outcomes in Practice Different from Clinical Trials?. Cardiac Electrophysiology Clinics 3:4, 511-520
CrossRef18
E. S. Williams, S. H. Shah, J. P. Piccini, A. Y. Sun, J. I. Koontz, S. M. Al-Khatib, P. M. Hranitzky. (2011) Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. Europace 13:12, 1717-1722
CrossRef19
DOMINIC A. M. J. THEUNS, TIM SMITH, TAMAS SZILI-TOROK, AGNES MUSKENS-HEEMSKERK R. N., PETTER JANSE, LUC JORDAENS. (2011) Prognostic Role of High-Sensitivity C-Reactive Protein and B-Type Natriuretic Peptide in Implantable Cardioverter-Defibrillator Patients. Pacing and Clinical Electrophysiologyno-no
CrossRef20
J. Seegers, M. A. Vos, P. Flevari, R. Willems, C. Sohns, D. Vollmann, L. Luthje, D. T. Kremastinos, V. Flore, M. Meine, A. Tuinenburg, R. C. Myles, D. Simon, J. Brockmoller, T. Friede, G. Hasenfuss, S. E. Lehnart, M. Zabel, . (2011) Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace
CrossRef21
M. Licka, L. Jahn, K. Kelemen, F. Voss, K. Trappe, R. Becker, O. Bikou, M. Hauck, M. Koch, H.A. Katus, A. Bauer. (2011) Is the determination of the defibrillation threshold in patients with an implantable cardioverter–defibrillator still required?. Herzschrittmachertherapie + Elektrophysiologie
CrossRef22
R. Bastiaenen, V. Batchvarov, M. M. Gallagher. (2011) Ventricular automaticity as a predictor of sudden death in ischaemic heart disease. Europace
CrossRef23
Luigi Padeletti, Lisa Innocenti, Alessandro Paoletti Perini, Edoardo Gronda. (2011) Arrhythmic complication in cardiorenal syndrome. Heart Failure Reviews 16:6, 569-573
CrossRef24
TREVOR A. VERGA, JEFFREY M. GILLBERG, RICHARD M. GREENBERG, FLORIN T. DEGER. (2011) True Bipolar and Integrated Bipolar Sensing and Detection by Implantable Defibrillators. Pacing and Clinical Electrophysiology 34:11, 1561-1568
CrossRef25
Daniel Jacoby, Oltjan Albajrami, Lavanya Bellumkonda. (2011) Natural History of End-stage LV Dysfunction: Has It Improved from the Classic Franciosa and Cohn Graph?. Cardiology Clinics 29:4, 485-495
CrossRef26
Ana Teresa Timóteo, Mário Martins Oliveira, Manuel Nogueira Silva, Alexandra Toste, Ruben Ramos, Joana Feliciano, Pedro Silva Cunha, Rui Soares, Sofia Santos, Rui Cruz Ferreira. (2011) Incidência de arritmias ventriculares em doentes com disfunção sistólica ventricular esquerda grave: existe benefício após terapêutica de ressincronização cardíaca. Revista Portuguesa de Cardiologia 30:11, 823-828
CrossRef27
A. Lazarus, N. Biondi, J.-F. Thebaut, I. Durand-Zaleski, M. Chauvin. (2011) Implantable cardioverter-defibrillators in France: practices and regional variability. Europace 13:11, 1568-1573
CrossRef28
Joep Thijssen, C. Jan Willem Borleffs, Johannes B. van Rees, SumChe Man, Mihály K. de Bie, Jeroen Venlet, Enno T. van der Velde, Lieselot van Erven, Martin J. Schalij. (2011) Implantable Cardioverter-Defibrillator Longevity under Clinical Circumstances: an Analysis According to Device Type, Generation, and Manufacturer. Heart Rhythm
CrossRef29
M. Guenther, T. Rauwolf, B. Bruggemann, M. Gerlach, N. K. Wassnig, M. Christoph, M. U. Braun, R. H. Strasser, C. Wunderlich. (2011) Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: A measure of safety or out of date? A retrospective analysis of 975 patients. Europace
CrossRef30
Gina Magyar-Russell, Brett D. Thombs, Jennifer X. Cai, Tarun Baveja, Emily A. Kuhl, Preet Paul Singh, Marcela Montenegro Braga Barroso, Erin Arthurs, Michelle Roseman, Nivee Amin, Joseph E. Marine, Roy C. Ziegelstein. (2011) The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. Journal of Psychosomatic Research 71:4, 223-231
CrossRef31
T. Reichlin, M. Kuhne, C. Sticherling, S. Osswald, B. Schaer. (2011) Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation. QJM 104:10, 849-857
CrossRef32
Ian Crozier. (2011) The subcutaneous defibrillator will replace the transvenous defibrillator. Journal of Interventional Cardiac Electrophysiology 32:1, 73-77
CrossRef33
MICHAEL R. GOLD, DOMINIC A. THEUNS, BRADLEY P. KNIGHT, J. LACY STURDIVANT, RICK SANGHERA, KENNETH A. ELLENBOGEN, MARK A. WOOD, MARTIN C. BURKE. (2011) Head-To-Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study. Journal of Cardiovascular Electrophysiologyno-no
CrossRef34
Olivera Gojkovic, Etienne M. Aliot, Alessandro Capucci, Stuart J. Connolly, Harry Crijns, Stefan H. Hohnloser, Piotr Kulakowski, Denis Roy, David Radzik, Bramah N. Singh, Peter R. Kowey. (2011) Celivarone in patients with an implantable cardioverter-defibrillator: Adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions. Heart Rhythm
CrossRef35
Michael R. Gold, Saleem Ahmad, Kevin Browne, Kellie Chase Berg, Lisa Thackeray, Ronald D. Berger. (2011) Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm
CrossRef36
Samir Saba, Haider Mehdi, Hemal Shah, Zahid Islam, Elie Aoun, Sammy Termanini, Reem Mahjoub, Ryan Aleong, Charles F. McTiernan, Barry London. (2011) Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction. Heart Rhythm
CrossRef37
Z. Syed, C. M. Stultz, B. M. Scirica, J. V. Guttag. (2011) Computationally Generated Cardiac Biomarkers for Risk Stratification After Acute Coronary Syndrome. Science Translational Medicine 3:102, 102ra95-102ra95
CrossRef38
M. T. Hoogwegt, N. Kupper, D. A. M. J. Theuns, L. Jordaens, S. S. Pedersen. (2011) Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator. Europace
CrossRef39
Marwan Refaat, Samir Saba. (2011) Total Subcutaneous Defibrillators: The Current Status and Future Prospect of a New Technology. Cardiac Electrophysiology Clinics 3:3, 403-408
CrossRef40
GISELLE A. BAQUERO, JAVIER E. BANCHS, SONDRA DEPALMA, SALLIE K. YOUNG, ERICA D. PENNY-PETERSON, SORAYA M. SAMII, DEBORAH L. WOLBRETTE, GERALD V. NACCARELLI, MARIO D. GONZALEZ. (2011) Dofetilide Reduces the Frequency of Ventricular Arrhythmias and Implantable Cardioverter Defibrillator Therapies. Journal of Cardiovascular Electrophysiologyno-no
CrossRef41
Joseph J. Gard, Paul A. Friedman. (2011) Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators. Cardiac Electrophysiology Clinics 3:3, 373-387
CrossRef42
David M. Charytan, Amanda R. Patrick, Jun Liu, Soko Setoguchi, Charles A. Herzog, M. Alan Brookhart, Wolfgang C. Winkelmayer. (2011) Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States. American Journal of Kidney Diseases 58:3, 409-417
CrossRef43
DARÍO DI TORO, CLAUDIO MURATORE, LUIS AGUINAGA, LUIZ BATISTA, ANTONIO MALAN, OSWALDO GRECO, CHAMIA BENCHETRIT, MAURICIO DUQUE, ADRIAN BARANCHUK, JENNIFER MALONEY. (2011) Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas’ Cardiomyopathy. Pacing and Clinical Electrophysiology 34:9, 1063-1069
CrossRef44
S. N. Burgess, S. A. Harding, I. C. Melton, N. A. Lever, A. H. Swain, B. Shi, P. D. Larsen. (2011) An unmet need for implantable cardioverter-defibrillators in New Zealand. Europace 13:9, 1299-1303
CrossRef45
Jayanthi N. Koneru, Karoly Kaszala, Jose F. Huizar, Kenneth A. Ellenbogen. (2011) Lead Fracture: Incidence, Diagnosis and Preventing Inappropriate ICD Therapy. Cardiac Electrophysiology Clinics 3:3, 409-420
CrossRef46
Norman C. Wang, Jonathan P. Piccini, Mihai Gheorghiade. (2011) Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. Heart Failure Reviews 16:5, 477-480
CrossRef47
John A. Schoenhard, Paul C. Zei. (2011) Reducing ICD Shocks for Ventricular Arrhythmias. Cardiac Electrophysiology Clinics 3:3, 493-502
CrossRef48
Thomas A. Dewland, Jeffrey E. Olgin, Byron K. Lee. (2011) Indications for a Wearable Cardioverter-Defibrillator. Cardiac Electrophysiology Clinics 3:3, 339-347
CrossRef49
Fadi G. Hage, Wael AlJaroudi, Himanshu Aggarwal, Vikas Bhatia, John Miller, Harish Doppalapudi, Oussama Wazni, Ami E. Iskandrian. (2011) Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: Primary versus secondary prevention. International Journal of Cardiology
CrossRef50
Allison C. Hill, Anne M. Dubin. (2011) Implantable Cardioverter–Defibrillator Therapy in Pediatric Patients and Congenital Heart Disease. Cardiac Electrophysiology Clinics 3:3, 349-357
CrossRef51
James V. Freeman, Aditya Ullal, Mintu P. Turakhia. (2011) Cost-effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Cardiac Electrophysiology Clinics 3:3, 421-440
CrossRef52
CLAIRE E. RAPHAEL, MICHAEL KOA-WING, NOLAN STAIN, IAN WRIGHT, DARREL P. FRANCIS, PRAPA KANAGARATNAM. (2011) Implantable Cardioverter-Defibrillator Recipient Attitudes towards Device Deactivation: How Much do Patients Want to Know?. Pacing and Clinical Electrophysiologyno-no
CrossRef53
Y. Wang, P. S. Cuculich, J. Zhang, K. A. Desouza, R. Vijayakumar, J. Chen, M. N. Faddis, B. D. Lindsay, T. W. Smith, Y. Rudy. (2011) Noninvasive Electroanatomic Mapping of Human Ventricular Arrhythmias with Electrocardiographic Imaging. Science Translational Medicine 3:98, 98ra84-98ra84
CrossRef54
Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher, Sumeet S. Chugh. (2011) HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. Heart Rhythm 8:8, 1340-1356
CrossRef55
Thomas A. Dewland, Cara N. Pellegrini, Yongfei Wang, Gregory M. Marcus, Edmund Keung, Paul D. Varosy. (2011) Dual-Chamber Implantable Cardioverter-Defibrillator Selection Is Associated With Increased Complication Rates and Mortality Among Patients Enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry. Journal of the American College of Cardiology 58:10, 1007-1013
CrossRef56
Charles F. Jackson, Nanette K. Wenger. (2011) Enfermedad cardiovascular en el anciano. Revista Española de Cardiología 64:8, 697-712
CrossRef57
LAURA PERROTTA, PAOLO PIERAGNOLI, GIUSEPPE RICCIARDI, STEFANIA SACCHI, GIUSEPPE MASCIA, MARGHERITA PADELETTI, MARIA GRAZIA BONGIORNI, ANTONIO CURNIS, FULVIO BELLOCCI, ANTONIO MICHELUCCI, MARIA CRISTINA PORCIANI, LUIGI PADELETTI. (2011) Multicenter Experience with Implantable Defibrillators Subject to Recall. Pacing and Clinical Electrophysiology 34:8, 998-1002
CrossRef58
Johannes B. van Rees, Mihály K. de Bie, Joep Thijssen, C. Jan Willem Borleffs, Martin J. Schalij, Lieselot van Erven. (2011) Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices. Journal of the American College of Cardiology 58:10, 995-1000
CrossRef59
Leon A. Cannizzaro, Jonathan P. Piccini, Uptal D. Patel, Adrian F. Hernandez. (2011) Device Therapy in Heart Failure Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 58:9, 889-896
CrossRef60
Deepak Bhakta, Lynne D. Foreman. (2011) Implantable cardioverter-defibrillator shock reduction: The new paradigm. Heart Rhythm
CrossRef61
Gail K. Larsen, John Evans, William E. Lambert, Yiyi Chen, Merritt Raitt. (2011) Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm
CrossRef62
Mauro Biffi, Matteo Ziacchi, Matteo Bertini, Beatrice Gardini, Andrea Mazzotti, Giulia Massaro, Cristian Martignani, Igor Diemberger, Giuseppe Boriani, Daniela Corsini. (2011) How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost?. International Journal of Technology Assessment in Health Care 27:03, 201-206
CrossRef63
Thomas B. Morrison, Paul A. Friedman, Linda M. Kallinen, David O. Hodge, Daniel Crusan, Kapil Kumar, David L. Hayes, Robert F. Rea, Robert G. Hauser. (2011) Impact of Implanted Recalled Sprint Fidelis Lead on Patient Mortality. Journal of the American College of Cardiology 58:3, 278-283
CrossRef64
SEK Y. CHAIR, CHUI K. LEE, KAI C. CHOI, SAMUEL F. SEARS. (2011) Quality of Life Outcomes in Chinese Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 34:7, 858-867
CrossRef65
Paul Marshall, Alison Ketchell, Joan Maclean. (2011) Comparison of male and female psychological outcomes related to implantable cardioverter defibrillators (COMFORTID). European Journal of Cardiovascular Nursing
CrossRef66
GUIDO H. VAN WELSENES, JOHANNES B. VAN REES, JOEP THIJSSEN, SERGE A. TRINES, LIESELOT VAN ERVEN, MARTIN J. SCHALIJ, C.J.W. BORLEFFS. (2011) Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back-Up After an Event-Free First Battery Service-Life. Journal of Cardiovascular Electrophysiologyno-no
CrossRef67
Jeffrey Hsing, Henry Hsia. 2011. Ventricular Tachycardia. , 194-203.
CrossRef68
N. A. Mark Estes, Munther Homoud, Jonathan Weinstock, Caroline Foote, Ania Garlitski, Mark Link, Afshin Ehsan. (2011) Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes. Journal of Interventional Cardiac Electrophysiology 31:1, 91-99
CrossRef69
Kurt C. Roberts-Thomson, Dennis H. Lau, Prashanthan Sanders. (2011) The diagnosis and management of ventricular arrhythmias. Nature Reviews Cardiology 8:6, 311-321
CrossRef70
Nicolas Girerd, Emilie Nonin, Julien Pinot, Elodie Morel, Carine Flys, Alina Scridon, Philippe Chevalier. (2011) Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Archives of Cardiovascular Diseases 104:6-7, 388-395
CrossRef71
K. Joshi, I. Alam, E. Ruden, I. Gradus-Pizlo, J. Mahenthiran, M. Kamalesh, H. Feigenbaum, S. Sawada. (2011) Effect of improvement in left ventricular ejection fraction on long-term survival in revascularized patients with ischaemic left ventricular systolic dysfunction. European Journal of Echocardiography 12:6, 454-460
CrossRef72
Domenico Corrado, Maria Silvano, Federico Migliore, Alessio Marinelli, Loira Leoni, Gaetano Thiene, Sabino Iliceto, Gianfranco Buja. (2011) Implantable Cardioverter Defibrillator in Arrhythmogenic Cardiomyopathy. Cardiac Electrophysiology Clinics 3:2, 311-321
CrossRef73
F. Leyva, I. Fernandez Lozano, J. Morgan. (2011) Cardioverter-defibrillators: a cost or an investment?. Europace 13:Supplement 2, ii25-ii31
CrossRef74
M.-P. Douchet, B. Bakouboula, F. Bronner, M. Chauvin. (2011) Fibrillateur automatique implantable. Annales de Cardiologie et d'Angéiologie
CrossRef75
F. Streitner, J. Kuschyk, C. Veltmann, E. Mahl, C. Dietrich, R. Schimpf, C. Doesch, I. Streitner, C. Wolpert, M. Borggrefe. (2011) Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Europace 13:5, 668-674
CrossRef76
Ming-da WANG, Zhi-gang ZHANG. (2011) Successful management of electrical storm after acute myocardial infarction: a case report. Academic Journal of Second Military Medical University 31:1, 111-112
CrossRef77
Ayesha Hasan, Benjamin Sun. (2011) Defibrillators and Cardiac Resynchronization Therapy as a Bridge to Cardiac Transplantation. Heart Failure Clinics 7:2, 227-239
CrossRef78
John A Dodson, Mathew S Maurer. (2011) Changing nature of cardiac interventions in older adults. Aging Health 7:2, 283-295
CrossRef79
Samir Saba. (2011) Sudden Cardiac Death Risk Stratification and Assessment: Primary Prevention Based on Ejection Fraction Criteria. Heart Failure Clinics 7:2, 175-183
CrossRef80
M. Santini, C. Pignalberi. (2011) Timing of defibrillator implant after acute myocardial infarction: what's new?. Europace 13:4, 455-457
CrossRef81
H. Voller, W. Kamke, H. U. Klein, M. Block, R. Reibis, S. Treusch, K. Contzen, K. Wegscheider, . (2011) Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II Registry. Europace 13:4, 499-508
CrossRef82
Younghoon Kwon, Tom P. Aufderheide. (2011) Optimizing Community Resources to Address Sudden Cardiac Death. Heart Failure Clinics 7:2, 277-286
CrossRef83
D.M. Ginzburg, M. Tavenaux, J. Sperzel, C. Hamm, J. Jordan. (2011) Psychische Störungen nach ICD-Mehrfachschocks und deren psychotherapeutische Behandlung. Der Kardiologe 5:2, 114-121
CrossRef84
Marco Merlo, Stylianos A. Pyxaras, Bruno Pinamonti, Giulia Barbati, Andrea Di Lenarda, Gianfranco Sinagra. (2011) Prevalence and Prognostic Significance of Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy Receiving Tailored Medical Treatment. Journal of the American College of Cardiology 57:13, 1468-1476
CrossRef85
Saurabh Malhotra, Mithilesh K Das. (2011) Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death. Future Cardiology 7:2, 203-217
CrossRef86
G. H. van Welsenes, J. B. van Rees, C. J. W. Borleffs, S. C. Cannegieter, J. J. Bax, L. van Erven, M. J. Schalij. (2011) Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 13:3, 389-394
CrossRef87
Raymond Cutro, Michael W. Rich, Paul J. Hauptman. (2011) Device therapy in patients with heart failure and advanced age: Too much too late?. International Journal of Cardiology
CrossRef88
Melissa H. Kong, Gregg C. Fonarow, Eric D. Peterson, Anne B. Curtis, Adrian F. Hernandez, Gillian D. Sanders, Kevin L. Thomas, David L. Hayes, Sana M. Al-Khatib. (2011) Systematic Review of the Incidence of Sudden Cardiac Death in the United States. Journal of the American College of Cardiology 57:7, 794-801
CrossRef89
D. A. M. J. Theuns, B. A. Schaer, O. I. I. Soliman, D. Altmann, C. Sticherling, M. L. Geleijnse, S. Osswald, L. Jordaens. (2011) The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 13:1, 62-69
CrossRef90
J. Dizon, K. Chen, S. Dizon, A. Biviano, W. Whang, F. Ehlert, J. Vazquez, T. Nazif, H. Garan. (2011) A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS. Europace 13:1, 77-81
CrossRef91
Ahmed El-Damaty, John L Sapp. (2011) The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease. Current Opinion in Cardiology 26:1, 30-39
CrossRef92
P. Santangeli, A. Dello Russo, M. Casella, G. Pelargonio, L. Di Biase, A. Natale. (2011) Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?. Internal Medicine Journal 41:1a, 55-60
CrossRef93
Akihiko Shimizu. (2011) Indication of Implantable Devices for the Prevention of Sudden Cardiac Death. Journal of Arrhythmia 27:1, 87-90
CrossRef94
Charles J. Lick, Tom P. Aufderheide, Robert A. Niskanen, Janet E. Steinkamp, Scott P. Davis, Susan D. Nygaard, Kim K. Bemenderfer, Louis Gonzales, Jeffrey A. Kalla, Sarah K. Wald, Debbie L. Gillquist, Michael R. Sayre, Susie Y. Oski Holm, Dana A. Oakes, Terry A. Provo, Ed M. Racht, John D. Olsen, Demetris Yannopoulos, Keith G. Lurie. (2011) Take Heart America: A comprehensive, community-wide, systems-based approach to the treatment of cardiac arrest*. Critical Care Medicine 39:1, 26-33
CrossRef95
Daniel B. Kramer, William H. Maisel. 2011. Guidelines for Managing Pacemaker and Implantable Defibrillator Advisories. , 1028-1039.
CrossRef96
Sanghoon Park, Hyerim Park, Hye Jin Hwang, Jaemin Shim, Jung-Hoon Sung, Jong-Youn Kim, Hui-Nam Pak, Moon-Hyoung Lee, Boyoung Joung. (2011) Heart Rate Acceleration of a Subsidiary Pacemaker by β-Adrenergic Stimulation. Korean Circulation Journal 41:11, 658
CrossRef97
I. Battipaglia, L. Barone, L. Mariani, F. Infusino, R. Remoli, G. Careri, G. Pinnacchio, P. Tarzia, G. A. Lanza, F. Crea. (2010) Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace 12:12, 1725-1731
CrossRef98
Anthony P. Redhead, Douglas Turkington, Sanjay Rao, Margaret M. Tynan, John P. Bourke. (2010) Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. Journal of Psychosomatic Research 69:6, 555-563
CrossRef99
Wilbert S Aronow. (2010) Implantable Cardioverter-Defibrillators. American Journal of Therapeutics 17:6, e208-e220
CrossRef100
Larisa G. Tereshchenko, Lichy Han, Alan Cheng, Joseph E. Marine, David D. Spragg, Sunil Sinha, Darshan Dalal, Hugh Calkins, Gordon F. Tomaselli, Ronald D. Berger. (2010) Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients. Heart Rhythm 7:11, 1606-1613
CrossRef101
Wilbert S Aronow. (2010) Use of implantable cardioverter-defibrillators. Future Cardiology 6:6, 859-870
CrossRef102
D. A. M. J. Theuns, T. Smith, M. G. M. Hunink, G. H. Bardy, L. Jordaens. (2010) Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace 12:11, 1564-1570
CrossRef103
Arthur E. Fass. (2010) Chronic Coronary Disease in the Post-COURAGE Era. Cardiology in Review 18:6, 292-297
CrossRef104
Sanjiv M. Narayan. 2010. Preventing Sudden Cardiac Arrest in the Heart Failure Patient. , 177-195.
CrossRef105
Keld Kjeldsen, Dan Atar, Jonas Hallén, Panos Vardas, Faiez Zannad, Stig Haunsø. (2010) Editorial: Sudden cardiac death - the challenge to cardiology. Fundamental & Clinical Pharmacology 24:5, 535-537
CrossRef106
Kei Nishiyama, Satoshi Shizuta, Takahiro Doi, Takeshi Morimoto, Takeshi Kimura. (2010) Sudden cardiac death after PCI and CABG in the bare-metal stent era: Incidence, prevalence, and predictors. International Journal of Cardiology 144:2, 263-266
CrossRef107
Rajdeep S. Gaitonde, Roopa Subbarao, Mark A. Michael, Gopi Dandamudi, Deepak Bhakta, Jo Mahenthiran, Mithilesh K. Das. (2010) Segmental wall-motion abnormalities of the left ventricle predict arrhythmic events in patients with nonischemic cardiomyopathy. Heart Rhythm 7:10, 1390-1395
CrossRef108
Charles D. Deakin, Laurie J. Morrison, Peter T. Morley, Clifton W. Callaway, Richard E. Kerber, Steven L. Kronick, Eric J. Lavonas, Mark S. Link, Robert W. Neumar, Charles W. Otto, Michael Parr, Michael Shuster, Kjetil Sunde, Mary Ann Peberdy, Wanchun Tang, Terry L. Vanden Hoek, Bernd W. Böttiger, Saul Drajer, Swee Han Lim, Jerry P. Nolan. (2010) Part 8: Advanced life support. Resuscitation 81:1, e93-e174
CrossRef109
Giuseppe Boriani, Igor Diemberger, Cinzia Valzania, Mauro Biffi, Cristian Martignani, Emanuel Raschi, Valentina Mantovani, Matteo Ziacchi, Matteo Bertini, Fabrizio De Ponti, Angelo Branzi. (2010) Role of drugs and devices in patients at risk of sudden cardiac death. Fundamental & Clinical Pharmacology 24:5, 575-594
CrossRef110
Jason T. Jacobson, Justin B. Weiner. (2010) REVIEW: Management of Ventricular Tachycardia in Patients with Structural Heart Disease. Cardiovascular Therapeutics 28:5, 255-263
CrossRef111
Matthew J. O'Connor, David N. Rosenthal, Robert E. Shaddy. (2010) Outpatient Management of Pediatric Heart Failure. Heart Failure Clinics 6:4, 515-529
CrossRef112
J. Jimenez-Candil, J. Hernandez, A. Martin, M. Ruiz-Olgado, J. Herrero, C. Ledesma, J. Morinigo, C. Martin-Luengo. (2010) Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect. Europace 12:9, 1231-1238
CrossRef113
Louis L. Nguyen, Neal R. Barshes. (2010) Analysis of large databases in vascular surgery. Journal of Vascular Surgery 52:3, 768-774
CrossRef114
Anoop K Shetty, Miles WH Behan, Julian Bostock, C Aldo Rinaldi. (2010) Device therapy for the management of cardiac tachyarrhythmias. Expert Review of Cardiovascular Therapy 8:9, 1257-1266
CrossRef115
Daniel E Hilleman, Aryan N Mooss. (2010) Role of Dronedarone in Atrial Fibrillation: More Questions Than Answers. Pharmacotherapy 30:9, 867-871
CrossRef116
Cara N. Pellegrini, Melvin M. Scheinman. (2010) Clinical Management of Ventricular Tachycardia. Current Problems in Cardiology 35:9, 453-504
CrossRef117
LAUREN D. VAZQUEZ, JAMIE B. CONTI, SAMUEL F. SEARS. (2010) Female-Specific Education, Management, and Lifestyle Enhancement for Implantable Cardioverter Defibrillator Patients: The FEMALE-ICD Study. Pacing and Clinical Electrophysiology 33:9, 1131-1140
CrossRef118
Ann Marie P. Mauro. (2010) Long-term follow-up study of uncertainty and psychosocial adjustment among implantable cardioverter defibrillator recipients. International Journal of Nursing Studies 47:9, 1080-1088
CrossRef119
Gillian D. Sanders, Melissa H. Kong, Sana M. Al-Khatib, Eric D. Peterson. (2010) Cost-effectiveness of implantable cardioverter defibrillators in patients ≥65 years of age. American Heart Journal 160:1, 122-131
CrossRef120
Mina K. Chung, Steven J. Szymkiewicz, Mingyuan Shao, Edwin Zishiri, Mark J. Niebauer, Bruce D. Lindsay, Patrick J. Tchou. (2010) Aggregate National Experience With the Wearable Cardioverter-Defibrillator. Journal of the American College of Cardiology 56:3, 194-203
CrossRef121
Wilbert S. Aronow. (2010) Office Management after Myocardial Infarction. The American Journal of Medicine 123:7, 593-595
CrossRef122
Badri Chandrasekaran, Peter J Cowburn. (2010) Heart failure: the challenge of selecting patients for implantable cardioverter defibrillator therapy. Expert Review of Medical Devices 7:4, 461-467
CrossRef123
Sandra L. Carroll, Heather M. Arthur. (2010) A comparative study of uncertainty, optimism and anxiety in patients receiving their first implantable defibrillator for primary or secondary prevention of sudden cardiac death. International Journal of Nursing Studies 47:7, 836-845
CrossRef124
Bardy, Gust H., Smith, Warren M., Hood, Margaret A., Crozier, Ian G., Melton, Iain C., Jordaens, Luc, Theuns, Dominic, Park, Robert E., Wright, David J., Connelly, Derek T., Fynn, Simon P., Murgatroyd, Francis D., Sperzel, Johannes, Neuzner, Jörg, Spitzer, Stefan G., Ardashev, Andrey V., Oduro, Amo, Boersma, Lucas, Maass, Alexander H., Van Gelder, Isabelle C., Wilde, Arthur A., van Dessel, Pascal F., Knops, Reinoud E., Barr, Craig S., Lupo, Pierpaolo, Cappato, Riccardo, Grace, Andrew A., . (2010) An Entirely Subcutaneous Implantable Cardioverter–Defibrillator. New England Journal of Medicine 363:1, 36-44
Full Text125
BRETT D. ATWATER, JAMES P. DAUBERT. (2010) Can We Improve the Identification of Ventricular Scar to Guide Substrate-Based Ventricular Tachycardia Ablation?. Journal of Cardiovascular Electrophysiology 21:6, 685-687
CrossRef126
D. Bänsch, G. Grönefeld. (2010) Der Patient mit chronischer Herzinsuffizienz. Herzschrittmachertherapie + Elektrophysiologie 21:2, 112-116
CrossRef127
Robert Guidoin, Yvan Douville, Marie-Annick Clavel, Ze Zhang, Mark Nutley, Philippe Pîbarot, Guy Dionne. (2010) The marvel of percutaneous cardiovascular devices in the elderly. Annals of the New York Academy of Sciences 1197:1, 188-199
CrossRef128
T. Sellmann, M. Winterhalter, U. Herold, P. Kienbaum. (2010) Implantation von Kardioverter-Defibrillatoren. Der Anaesthesist 59:6, 507-518
CrossRef129
K. Seidl, M. Strauss, T. Kleemann. (2010) ICD-Therapie zur Sekundärprävention. Herzschrittmachertherapie + Elektrophysiologie 21:2, 96-101
CrossRef130
STEVEN M. KURTZ, JORGE A. OCHOA, EDMUND LAU, YAKOV SHKOLNIKOV, BEHZAD B. PAVRI, DANIEL FRISCH, ARNOLD J. GREENSPON. (2010) Implantation Trends and Patient Profiles for Pacemakers and Implantable Cardioverter Defibrillators in the United States: 1993-2006. Pacing and Clinical Electrophysiology 33:6, 705-711
CrossRef131
Brian J. Barnes, James M. Hollands. (2010) Drug-induced arrhythmias. Critical Care Medicine 38, S188-S197
CrossRef132
T. BEN MORRISON, ROBERT F. REA, DAVID O. HODGE, DANIEL CRUSAN, CELESTE KOESTLER, SAMUEL J. ASIRVATHAM, DAVID BRADLEY, WIN K. SHEN, THOMAS M. MUNGER, STEPHEN C. HAMMILL, PAUL A. FRIEDMAN. (2010) Risk Factors for Implantable Defibrillator Lead Fracture in a Recalled and a Nonrecalled Lead. Journal of Cardiovascular Electrophysiology 21:6, 671-677
CrossRef133
Sanjeev P. Bhavnani, Jeffrey Kluger, Craig I. Coleman, C. Michael White, Danette Guertin, Nabil A. Shafi, Ravi K. Yarlagadda, Christopher A. Clyne. (2010) The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm 7:6, 755-760
CrossRef134
Scott M. Berry, K. Jack Ishak, Bryan R. Luce, Donald A. Berry. (2010) Bayesian Meta-Analyses for Comparative Effectiveness and Informing Coverage Decisions. Medical Care 48, S137-S144
CrossRef135
JAVIER JIMÉNEZ-CANDIL, MARÍA RUIZ, JESÚS HERRERO, VÍCTOR LEÓN, ANA MARTÍN, JOSÉ MORIÑIGO, CLAUDIO LEDESMA, CÁNDIDO MARTÍN-LUENGO. (2010) Relationship between the Duration of the Basal QRS Complex and Electrical Therapies for Ventricular Tachycardias among ICD Patients. Pacing and Clinical Electrophysiology 33:5, 596-604
CrossRef136
Darren Green, Paul R. Roberts. (2010) VENTRICULAR ARRHYTHMIAS AND SUDDEN DEATH IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of Renal Care 36, 54-60
CrossRef137
DAISUKE IZUMI, MASAOMI CHINUSHI, KENICHI IIJIMA, SHIZUE AHARA, SATORU KOMURA, HIROSHI FURUSHIMA, YUKIO HOSAKA, AKIKO SANADA, NOBUE YAGIHARA, YOSHIFUSA AIZAWA. (2010) Effects of Bepridil Versus E-4031 on Transmural Ventricular Repolarization and Inducibility of Ventricular Tachyarrhythmias in the Dog. Pacing and Clinical Electrophysiologyno-no
CrossRef138
David A. Philips, Terry D. Bauch. (2010) Rapid Correction of Hypokalemia in a Patient with an Implantable Cardioverter-Defibrillator and Recurrent Ventricular Tachycardia. The Journal of Emergency Medicine 38:3, 308-316
CrossRef139
DAVID D. SPRAGG, JOSEPH E. MARINE. (2010) Inappropriate Biventricular Implantable Cardioverter Defibrillator Firing Due to Cryptogenic Double Counting. Pacing and Clinical Electrophysiology 33:4, 486-490
CrossRef140
Jenny Tagney. (2010) A literature review comparing the experiences and emergent needs of adult patients with permanent pacemakers (PPMs) and implantable cardioverter defibrillators (ICDs). Journal of Clinical Nursingno-no
CrossRef141
Eloi Marijon, Ludovic Trinquart, Akli Otmani, Christophe Leclercq, Laurent Fauchier, Philippe Chevalier, Didier Klug, Pascal Defaye, Nicolas Lellouche, Jacques Mansourati, Jean-Claude Deharo, Nicolas Sadoul, Frédéric Anselme, Philippe Maury, Jean-Marc Davy, Fabrice Extramiana, Françoise Hidden-Lucet, Vincent Probst, Pierre Bordachar, Hassan Mansour, Michel Chauvin, Xavier Jouven, Thomas Lavergne, Gilles Chatellier, Jean-Yves Le Heuzey. (2010) Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator—the EVADEF study. American Heart Journal 159:4, 659-664.e1
CrossRef142
J. Malcolm O. Arnold, Lorne J. Gula. (2010) The Art and Science of Heart Failure. Journal of the American College of Cardiology 55:17, 1811-1813
CrossRef143
Chi-Wen Kao, Erika Friedmann, Sue A. Thomas. (2010) Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Quality of Life Research 19:3, 307-315
CrossRef144
C. JAN WILLEM BORLEFFS, JOEP THIJSSEN, MIHÁLY K. De BIE, JOHANNES B. Van REES, GUIDO H. Van WELSENES, LIESELOT Van ERVEN, JEROEN J. BAX, SUZANNE C. CANNEGIETER, MARTIN J. SCHALIJ. (2010) Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications. Pacing and Clinical Electrophysiologyno-no
CrossRef145
Beena B Johnson, Johnson Francis, Beena B Johnson. 2010. Cognitive behavourial therapy for patients with implantable cardioverter-defibrillators. .
CrossRef146
C. J. W. Borleffs, G. H. van Welsenes, R. J. van Bommel, E. T. van der Velde, J. J. Bax, L. van Erven, H. Putter, J. G. van der Bom, F. R. Rosendaal, M. J. Schalij. (2010) Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease. European Heart Journal 31:6, 712-718
CrossRef147
JAMES D. DANIELS, JUSTIN SAUNDERS, SUNTHOSH PARVATHANENI, AMANDA BYRD, JOSE A. JOGLAR, OWEN OBEL. (2010) Electrocardiographic Findings, Device Therapies, and Comorbidities in Octogenarian Implantable Defibrillator Recipients. Journal of Cardiovascular Electrophysiology 21:3, 236-241
CrossRef148
D. A. Iacobas, S. Iacobas, N. Thomas, D. C. Spray. (2010) Sex-dependent gene regulatory networks of the heart rhythm. Functional & Integrative Genomics 10:1, 73-86
CrossRef149
STEVEN M. MARKOWITZ. (2010) Defibrillator Implantation in the Elderly: Patients Are Older, But Are Physicians Wiser?. Journal of Cardiovascular Electrophysiology 21:3, 242-244
CrossRef150
Christopher H. Jackson, Linda D. Sharples, Simon G. Thompson. (2010) Structural and parameter uncertainty in Bayesian cost-effectiveness models. Journal of the Royal Statistical Society: Series C (Applied Statistics) 59:2, 233-253
CrossRef151
Jason Bradfield, Noel G. Boyle. (2010) The paradox of ICD shocks: Sudden cardiac death prevention—Heart failure death acceleration. Heart Rhythm 7:3, 361-362
CrossRef152
ATUL VERMA, BRADLEY SARAK, ALEXANDER J. KAPLAN, RICHARD OOSTHUIZEN, MARIANNE BEARDSALL, ZAEV WULFFHART, JANET HIGENBOTTAM, YAARIV KHAYKIN. (2010) Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic Cardiomyopathy. Pacing and Clinical Electrophysiology 33:3, 320-329
CrossRef153
HELMUT U. KLEIN, ULF MELTENDORF, SVEN REEK, JAN SMID, SEBASTIAN KUSS, IWONA CYGANKIEWICZ, CHRISTIAN JONS, STEVEN SZYMKIEWICZ, FRANK BUHTZ, ANKE WOLLBRUECK, WOJCIECH ZAREBA, ARTHUR J. MOSS. (2010) Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD). Pacing and Clinical Electrophysiology 33:3, 353-367
CrossRef154
CLAIRE N. HALLAS, JULIE L. BURKE, DAVID G. WHITE, DEREK T. CONNELLY. (2010) Pre-ICD Illness Beliefs Affect Postimplant Perceptions of Control and Patient Quality of Life. Pacing and Clinical Electrophysiology 33:3, 256-265
CrossRef155
HANS J. MOORE, MATTHEW N. PETERS, MICHAEL R. FRANZ, PAMELA E. KARASIK, STEVEN N. SINGH, ROSS D. FLETCHER. (2010) Intrathoracic Impedance Preceding Ventricular Tachyarrhythmia Episodes. Pacing and Clinical Electrophysiology
CrossRef156
OSMAN FAHEEM, ARUN PADALA, JEFFREY KLUGER, STEVEN ZWEIBEL, CHRISTOPHER A. CLYNE. (2010) Coronary Sinus Shocking Lead As Salvage In Patients with Advanced CHF and High Defibrillation Thresholds. Pacing and Clinical Electrophysiology
CrossRef157
ANDREA NATALE, ANTONIO RAVIELE, AMIN AL-AHMAD, OTTAVIO ALFIERI, ETIENNE ALIOT, JESUS ALMENDRAL, GÜNTER BREITHARDT, JOSEP BRUGADA, HUGH CALKINS, DAVID CALLANS, RICCARDO CAPPATO, JOHN A. CAMM, PAOLO DELLA BELLA, GERARD M. GUIRAUDON, MICHEL HAÏSSAGUERRE, GERHARD HINDRICKS, SIEW YEN HO, KARL H. KUCK, FRANCIS MARCHLINSKI, DOUGLAS L. PACKER, ERIC N. PRYSTOWSKY, VIVEK Y. REDDY, JEREMY N. RUSKIN, MAURICIO SCANAVACCA, KALYANAM SHIVKUMAR, KYOKO SOEJIMA, WILLIAM J. STEVENSON, SAKIS THEMISTOCLAKIS, ATUL VERMA, DAVID WILBER, . (2010) Venice Chart International Consensus Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation. Journal of Cardiovascular Electrophysiology 21:3, 339-379
CrossRef158
MAYURKUMAR BHAKTA, CHEDOZIE C. OBIOHA, DAN SORAJJA, KOMADOOR SRIVATHSAN, FRANCISCO A. ARABIA, PATRICK A. DEVALERIA, DAWN E. JAROSZEWSKI, LUIS R. SCOTT, GREGORY T. ALTEMOSE. (2010) Nontraditional Implantable Cardioverter Defibrillator Placement in Adult Patients with Limited Venous Access: A Case Series. Pacing and Clinical Electrophysiology 33:2, 217-225
CrossRef159
KARIN KRAAIER, PASCAL F.H.M. VAN DESSEL, JOB VAN DER PALEN, ARTHUR A.M. WILDE, MARCOEN F. SCHOLTEN. (2010) ECG Quantification of Myocardial Scar Does Not Differ between Primary and Secondary Prevention ICD Recipients with Ischemic Heart Disease. Pacing and Clinical Electrophysiology 33:2, 192-197
CrossRef160
Dirk Prochnau, Ralf Surber, Helmut Kuehnert, Matthias Heinke, Helmut U. Klein, Hans R. Figulla. (2010) Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction. Clinical Research in Cardiology 99:2, 129-131
CrossRef161
Ingvild Margreta Morken, Elisabeth Severinsson, Bjørg Karlsen. (2010) Reconstructing unpredictability: experiences of living with an implantable cardioverter defibrillator over time. Journal of Clinical Nursing 19:3-4, 537-546
CrossRef162
Mithilesh K Das, Douglas P Zipes. (2010) Antiarrhythmic and Nonantiarrhythmic Drugs for Sudden Cardiac Death Prevention. Journal of Cardiovascular Pharmacology1
CrossRef163
Douglas S. Lee, Andrew D. Krahn, Jeffrey S. Healey, David Birnie, Eugene Crystal, Paul Dorian, Christopher S. Simpson, Yaariv Khaykin, Douglas Cameron, Amir Janmohamed, Raymond Yee, Peter C. Austin, Zhongliang Chen, Judy Hardy, Jack V. Tu. (2010) Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation. Journal of the American College of Cardiology 55:8, 774-782
CrossRef164
Alfred E Buxton, Kristin E Ellison, Peem Lorvidhaya, Ohad Ziv. (2010) Left Ventricular Ejection Fraction for Sudden Death Risk Stratification and Guiding ICD Implantation. Journal of Cardiovascular Pharmacology1
CrossRef165
Garrick C. Stewart, Joanne R. Weintraub, Parakash P. Pratibhu, Marc J. Semigran, Janice M. Camuso, Kimberly Brooks, Sui W. Tsang, Mary Susan Anello, Viviane T. Nguyen, Eldrin F. Lewis, Anju Nohria, Akshay S. Desai, Michael M. Givertz, Lynne W. Stevenson. (2010) Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure. Journal of Cardiac Failure 16:2, 106-113
CrossRef166
Naomichi Matsumoto, Koichiro Kumagai, Masahiro Ogawa, Kunihiro Matsuo, Tomoo Yasuda, Hideo Takashima, Chiharu Mitsutake, Soichi Muraoka, Akira Matsunaga, Shin-ichiro Miura, Keijiro Saku. (2010) Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator. Journal of Arrhythmia 26:2, 103-110
CrossRef167
Robert E. Shaddy, Daniel J. Penny. 2010. Chronic Cardiac Failure. , 257-268.
CrossRef168
Karl-Heinz Kuck, Anselm Schaumann, Lars Eckardt, Stephan Willems, Rodolfo Ventura, Etienne Delacrétaz, Heinz-Friedrich Pitschner, Josef Kautzner, Burghard Schumacher, Peter S Hansen. (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. The Lancet 375:9708, 31-40
CrossRef169
Nam-Ho Kim, Kyeong Ho Yun, Seok Kyu Oh. (2010) Sudden Cardiac Death. Journal of the Korean Medical Association 53:3, 214
CrossRef170
Elizabeth A. Stephenson, Andrew M. Davis. 2010. Electrophysiology, Pacing, and Devices. , 379-413.
CrossRef171
Mithilesh Kumar Das, Waddah Maskoun, Changyu Shen, Mark A. Michael, Hussam Suradi, Mona Desai, Roopa Subbarao, Deepak Bhakta. (2010) Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 7:1, 74-80
CrossRef172
Valeria Calvi, Daniela Dugo, Davide Capodanno, Rocco Arancio, Angelo Di Grazia, Claudio Liotta, Euglena Puzzangara, Antonio Ragusa, Alberto Arestia, Corrado Tamburino. (2010) Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it?. American Heart Journal 159:1, 98-102
CrossRef173
Kumral Ergun Cagli, Umit Guray, İbrahim Akpınar, Nihat Sen, Dursun Aras, Serkan Topaloglu. (2010) Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report. Journal of Electrocardiology 43:1, 68-70
CrossRef174
Aamir Cheema, Tejwant Singh, Manreet Kanwar, Karuna Chilukuri, Viqar Maria, Fareena Saleem, Katrina Johnson, John Frank, Luis Pires, Sohail Hassan. (2010) Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients. Cardiology Research and Practice 2010, 1-6
CrossRef175
William H. Sauer, Erica Zado, Edward P. Gerstenfeld, Francis E. Marchlinski, David J. Callans. (2010) Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator. Heart Rhythm 7:1, 9-14
CrossRef176
Abel Rivero, Anne B Curtis. (2010) Sex differences in arrhythmias. Current Opinion in Cardiology 25:1, 8-15
CrossRef177
ARNOLD PINTER, IQWAL MANGAT, VICTORIA KORLEY, STUART CONNOLLY, SEAN CONNORS, MARTIN GARDNER, FRANCOIS PHILIPPON, LARRY STERNS, BERNARD THIBAULT, PAUL DORIAN. (2009) Assessment of Resynchronization Therapy on Functional Status and Quality of Life in Patients Requiring an Implantable Defibrillator. Pacing and Clinical Electrophysiology 32:12, 1509-1519
CrossRef178
Atul Aggarwal, Yongfei Wang, John S. Rumsfeld, Jeptha P. Curtis, Paul A. Heidenreich. (2009) Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 6:11, 1565-1571
CrossRef179
JORGE E. SCHLIAMSER, MOEEN A. SALEEM, JEFFREY J. GOLDBERGER. (2009) Use of a Custom-Designed Adapter to Manage ICD Lead Fracture. Journal of Cardiovascular Electrophysiology 20:11, 1284-1286
CrossRef180
Joseph D. Mishkin, Sherry J. Saxonhouse, Gregory W. Woo, Thomas A. Burkart, William M. Miles, Jamie B. Conti, Richard S. Schofield, Samuel F. Sears, Juan M. Aranda. (2009) Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge. Journal of the American College of Cardiology 54:22, 1993-2000
CrossRef181
SAMIR SABA, LAKSHMI PRASAD RAVIPATI, ANDREW VOIGT. (2009) Recent Trends in Utilization of Implantable Cardioverter-Defibrillators in Survivors of Cardiac Arrest in the United States. Pacing and Clinical Electrophysiology 32:11, 1444-1449
CrossRef182
Mary Bond, Stuart Mealing, Rob Anderson, John Dean, Ken Stein, Rod S. Taylor. (2009) Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction?. International Journal of Cardiology 137:3, 206-215
CrossRef183
E. M. Kanoupakis, E. G. Manios, P. E. Vardas. (2009) Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers. Europace 11:11, 1434-1439
CrossRef184
Steinbeck, Gerhard, Andresen, Dietrich, Seidl, Karlheinz, Brachmann, Johannes, Hoffmann, Ellen, Wojciechowski, Dariusz, Kornacewicz-Jach, Zdzisława, Sredniawa, Beata, Lupkovics, Géza, Hofgärtner, Franz, Lubinski, Andrzej, Rosenqvist, Mårten, Habets, Alphonsus, Wegscheider, Karl, Senges, Jochen, . (2009) Defibrillator Implantation Early after Myocardial Infarction. New England Journal of Medicine 361:15, 1427-1436
Full Text185
Juan Carlos Claro, Roberto Candia, Gabriel Rada, Francisco Larrondo, Fernando Baraona, Luz M Letelier, Juan Carlos Claro. 2009. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death. .
CrossRef186
PAUL KNOPS, DOMINIC A. M. J. THEUNS, JAN C. J. RES, LUC JORDAENS. (2009) Analysis of Implantable Defibrillator Longevity Under Clinical Circumstances: Implications for Device Selection. Pacing and Clinical Electrophysiology 32:10, 1276-1285
CrossRef187
K. Kraaier, P. M.J. Verhorst, J. van der Palen, P. F.H.M. van Dessel, A. A.M. Wilde, M. F. Scholten. (2009) Microvolt T-wave alternans during exercise and pacing are not comparable. Europace 11:10, 1375-1380
CrossRef188
EMILY C. SIMONS, DAVID Y. FEIGENBLUM, DMITRY NEMIROVSKY, GRANT R. SIMONS. (2009) Alert Tones Are Frequently Inaudible among Patients with Implantable Cardioverter-Defibrillators. Pacing and Clinical Electrophysiology 32:10, 1272-1275
CrossRef189
H.-J. Trappe. (2009) 25 Jahre Defibrillatortherapie in Deutschland. Der Kardiologe 3:5, 413-424
CrossRef190
B. McHale, S. A. Harding, N. A. Lever, P. D. Larsen. (2009) A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators. Europace 11:10, 1313-1316
CrossRef191
YEN-HUNG LIN, LIAN-YU LIN, YING-SHREN CHEN, HUI-CHUN HUANG, JEN-KUANG LEE, YI-LWUN HO, LIN-CHU LIAO, WEN-JONE CHEN. (2009) The Association between T-Wave Morphology and Life-Threatening Ventricular Tachyarrhythmias in Patients with Congestive Heart Failure. Pacing and Clinical Electrophysiology 32:9, 1173-1177
CrossRef192
Adam T. Hirsh, Samuel F. Sears, Jamie B. Conti. (2009) Cognitive and Behavioral Treatments for Anxiety and Depression in a Patient with an Implantable Cardioverter Defibrillator (ICD): A Case Report and Clinical Discussion. Journal of Clinical Psychology in Medical Settings 16:3, 270-279
CrossRef193
Derek R. MacFadden, Jack V. Tu, Alice Chong, Peter C. Austin, Douglas S. Lee. (2009) Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: Role of cardiac conditions and noncardiac comorbidities. Heart Rhythm 6:9, 1289-1296
CrossRef194
WENJIE XU, HANS J. MOORE, PAMELA E. KARASIK, MICHAEL R. FRANZ, STEVE N. SINGH, ROSS D. FLETCHER. (2009) Management Strategies When Implanted Cardioverter Defibrillator Leads Fail: Survey Findings. Pacing and Clinical Electrophysiology 32:9, 1130-1141
CrossRef195
Krista C. van den Broek, Ivan Nyklíĉek, Johan Denollet. (2009) Anxiety Predicts Poor Perceived Health in Patients With an Implantable Defibrillator. Psychosomatics 50:5, 483-492
CrossRef196
JUAN MARTÍNEZ-SÁNCHEZ, ARCADI GARCÍA-ALBEROLA, JUAN JOSÉ SÁNCHEZ-MUÑOZ, PABLO PEÑAFIEL-VERDÚ, JOSÉ ANTONIO GINER-CARO, MARIANO VALDÉS-CHÁVARRI. (2009) ICD Proarrhythmia as a Consequence of an Interaction with an Algorithm to Prevent Atrial Arrhythmias. Pacing and Clinical Electrophysiology 32:8, 1096-1098
CrossRef197
, J. Vijgen, G. Botto, J. Camm, C.-J. Hoijer, W. Jung, J.-Y. Le Heuzey, A. Lubinski, T. M. Norekval, M. Santomauro, M. Schalij, J.-P. Schmid, P. Vardas. (2009) Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 11:8, 1097-1107
CrossRef198
Robert J. Myerburg, Vivek Reddy, Agustin Castellanos. (2009) Indications for Implantable Cardioverter-Defibrillators Based on Evidence and Judgment. Journal of the American College of Cardiology 54:9, 747-763
CrossRef199
Akli Otmani, Ludovic Trinquart, Eloi Marijon, Thomas Lavergne, Xavier Waintraub, Antoine Lepillier, Gilles Chatellier, Jean-Yves Le Heuzey. (2009) Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study. American Heart Journal 158:2, 230-237.e1
CrossRef200
Tetsuo Sasano, Kamilla Kelemen, Ian D. Greener, J. Kevin Donahue. (2009) Ventricular tachycardia from the healed myocardial infarction scar: Validation of an animal model and utility of gene therapy. Heart Rhythm 6:8, S91-S97
CrossRef201
CHARLES I. BERUL. (2009) Implantable Cardioverter Defibrillator Criteria for Primary and Secondary Prevention of Pediatric Sudden Cardiac Death. Pacing and Clinical Electrophysiology 32, S67-S70
CrossRef202
G. C. Digby, M. E. Daubney, J. Baggs, D. Campbell, C. S. Simpson, D. P. Redfearn, F. J. Brennan, H. Abdollah, A. Baranchuk. (2009) Physiotherapy and cardiac rhythm devices: a review of the current scope of practice. Europace 11:7, 850-859
CrossRef203
M. Stockburger, O. Celebi, A. Krebs, T. Knaus, A. Nitardy, D. Habedank, R. Dietz. (2009) Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing. Europace 11:7, 924-930
CrossRef204
C. J. W. Borleffs, L. van Erven, M. Schotman, E. Boersma, P. Kies, A. E. B. van der Burg, K. Zeppenfeld, M. Bootsma, E. E. van der Wall, J. J. Bax, M. J. Schalij. (2009) Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). European Heart Journal 30:13, 1621-1626
CrossRef205
Komandoor Srivathsan, Daniel WC Ng, Farouk Mookadam. (2009) Ventricular tachycardia and ventricular fibrillation. Expert Review of Cardiovascular Therapy 7:7, 801-809
CrossRef206
L. Mont, E. Guasch, A. Berruezo. (2009) An implantable defibrillator and what else?. European Heart Journal 30:13, 1551-1553
CrossRef207
Wenwen Li, Crystal M. Ripplinger, Qing Lou, Igor R. Efimov. (2009) Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction. Heart Rhythm 6:7, 1020-1027
CrossRef208
MAULLY J. SHAH. (2009) Implantable Cardioverter Defibrillator-Related Complications in the Pediatric Population. Pacing and Clinical Electrophysiology 32, S71-S74
CrossRef209
Massimo Santini, Riccardo Cappato, Dietrich Andresen, Johannes Brachmann, D. Wyn Davies, John Cleland, Alessandro Filippi, Edoardo Gronda, Richard Hauer, Gerhard Steinbeck, David Steinhaus. (2009) Current state of knowledge and experts’ perspective on the subcutaneous implantable cardioverter-defibrillator. Journal of Interventional Cardiac Electrophysiology 25:1, 83-88
CrossRef210
JOERG O. SCHWAB, MAURIZIO GASPARINI, MAURIZIO LUNATI, ALESSANDRO PROCLEMER, BERND KAUP, ELISABETTA SANTI, GUISEPPE LIGORIO, CATHERINE KLERSY, JOÃO DE SOUSA, ANDRZEJ OKREGLICKI, ANGEL ARENAL, MAURITS WIJFFELS, BERND LEMKE. (2009) Avoid Delivering Therapies for Nonsustained Fast Ventricular Tachyarrhythmia in Patients with Implantable Cardioverter/Defibrillator: The ADVANCE III Trial. Journal of Cardiovascular Electrophysiology 20:6, 663-666
CrossRef211
K. M. Stein, S. Mittal, F. R. Gilliam, D. M. Gilligan, Q. Zhong, S. M. Kraus, T. E. Meyer. (2009) Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace 11:6, 734-740
CrossRef212
BRETT GIDNEY, DAVID S. CANNOM. (2009) The Role of Electrophysiologic Studies in Dilated Cardiomyopathy: Definitive Results from the DEFINITE Trial. Pacing and Clinical Electrophysiology 32:6, 753-754
CrossRef213
William H. Maisel, Robert G. Hauser, Stephen C. Hammill, Robert G. Hauser, Kenneth A. Ellenbogen, Andrew E. Epstein, David L. Hayes, Joseph S. Alpert, Ronald D. Berger, Anne B. Curtis, Anne M. Dubin, N.A. Mark Estes, Melanie T. Gura, Andrew D. Krahn, Rachel Lampert, Bruce D. Lindsay, Bruce L. Wilkoff. (2009) Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines. Heart Rhythm 6:6, 869-885
CrossRef214
MOHAMAD A. ALAITI, ANJLI MAROO, THOMAS B. EDEL. (2009) Troponin Levels after Cardiac Electrophysiology Procedures: Review of the Literature. Pacing and Clinical Electrophysiology 32:6, 800-810
CrossRef215
Fanny Jacq, Gael Foulldrin, Arnaud Savouré, Frédéric Anselme, Audrey Baguelin-Pinaud, Alain Cribier, Florence Thibaut. (2009) A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. General Hospital Psychiatry 31:3, 266-273
CrossRef216
R. P. Ricci, A. Quesada, J. Almendral, F. Arribas, C. Wolpert, P. Adragao, M. Zoni-Berisso, X. Navarro, T. DeSanto, A. Grammatico, M. Santini, . (2009) Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Europace 11:5, 587-593
CrossRef217
Wilbert S. Aronow. (2009) Treatment of Ventricular Arrhythmias in the Elderly. Cardiology in Review 17:3, 136-146
CrossRef218
D. R. Tomlinson, Y. Bashir, T. R. Betts, K. Rajappan. (2009) Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 11:5, 638-642
CrossRef219
KARIN KRAAIER, PATRICK M.J. VERHORST, MARCOEN F. SCHOLTEN. (2009) A Shock Lead Intentionally Placed in the Left Ventricle. Pacing and Clinical Electrophysiology 32:5, 675-676
CrossRef220
ALESSANDRO PROCLEMER, MARCO GHIDINA, DOMENICO FACCHIN, LUCA REBELLATO, DOMENICO CORRADO, MAURIZIO GASPARINI, DARIO GREGORI. (2009) Use of Implantable Cardioverter-Defibrillator in Inherited Arrhythmogenic Diseases: Data from Italian ICD Registry for the Years 2001-6. Pacing and Clinical Electrophysiology 32:4, 434-445
CrossRef221
Kristian B. Filion, Xuanqian Xie, Charlotte J. van der Avoort, Nandini Dendukuri, James M. Brophy. (2009) Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: A cost-effectiveness study. International Journal of Technology Assessment in Health Care 25:02, 151
CrossRef222
Paul S. Chan, John D. Birkmeyer, Harlan M. Krumholz, John A. Spertus, Brahmajee K. Nallamothu. (2009) Racial and Gender Trends in the Use of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries Between 1997 and 2003. Congestive Heart Failure 15:2, 51-57
CrossRef223
DAVID LAWRENCE, NICHOLAS VON BERGEN, IAN H. LAW, DAVID J. BRADLEY, MACDONALD DICK II, PATRICIO A. FRIAS, MARGARET J. STREIPER, PETER S. FISCHBACH. (2009) Inappropriate ICD Discharges in Single-Chamber Versus Dual-Chamber Devices in the Pediatric and Young Adult Population. Journal of Cardiovascular Electrophysiology 20:3, 287-290
CrossRef224
Sami Viskin, Arthur A.M. Wilde, Hanno L. Tan, Charles Antzelevitch, Wataru Shimizu, Bernard Belhassen. (2009) Empiric quinidine therapy for asymptomatic Brugada syndrome: Time for a prospective registry. Heart Rhythm 6:3, 401-404
CrossRef225
Rahul Sakhuja, Mary Keebler, Tai-Shuan Lai, Cara McLaughlin Gavin, Ranjan Thakur, Deepak L. Bhatt. (2009) Meta-Analysis of Mortality in Dialysis Patients With an Implantable Cardioverter Defibrillator. The American Journal of Cardiology 103:5, 735-741
CrossRef226
Michael J. Mirro. (2009) Strategies for reducing sudden cardiac death: Application of microvolt T-wave alternans testing in clinical practice. Heart Rhythm 6:3, S45-S48
CrossRef227
Eyal Herzog, Emad F. Aziz, Marrick Kukin, Jonathan S. Steinberg, Suneet Mittal. (2009) Novel Pathway for Sudden Cardiac Death Prevention. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 8:1, 1-6
CrossRef228
MARTIN STOCKBURGER, ALICE KREBS, AISCHA NITARDY, DIRK HABEDANK, ÖZLEM CELEBI, THOMAS KNAUS, RAINER DIETZ. (2009) Survival and Appropriate Device Interventions in Recipients of Cardioverter Defibrillators Implanted for the Primary Versus Secondary Prevention of Sudden Cardiac Death. Pacing and Clinical Electrophysiology 32, S16-S20
CrossRef229
B. A. Koplan, W. G. Stevenson. (2009) Ventricular Tachycardia and Sudden Cardiac Death. Mayo Clinic Proceedings 84:3, 289-297
CrossRef230
Jaydutt B. Patel, Bruce A. Koplan. (2009) ICD implantation in patients with ischemic left ventricular dysfunction. Current Treatment Options in Cardiovascular Medicine 11:1, 3-9
CrossRef231
Mithilesh Das. (2009) Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Expert Review of Cardiovascular Therapy 7:2, 181-195
CrossRef232
Jon W. Schrock, Charles L. Emerman. (2009) Observation Unit Management of Acute Decompensated Heart Failure. Heart Failure Clinics 5:1, 85-100
CrossRef233
Crystal M. Ripplinger, Qing Lou, Wenwen Li, Jennifer Hadley, Igor R. Efimov. (2009) Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: Implications for low-voltage cardioversion. Heart Rhythm 6:1, 87-97
CrossRef234
Fabian J. Arnaldo, Nikolaos Anatoliotakis, Carlos Palacio, David R. Nabert, Steve S. Hsu. (2009) Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies. Heart & Lung: The Journal of Acute and Critical Care 38:1, 10-16
CrossRef235
A. Proclemer, M. Ghidina, D. Gregori, D. Facchin, L. Rebellato, P. Fioretti, M. Brignole. (2008) Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 11:4, 465-475
CrossRef236
A. Verma. (2008) Alternatives to amiodarone: search for the Holy Grail. Europace 11:4, 402-404
CrossRef237
Ori Galante, Guy Amit, Doron Zahger, Abraham Wagshal, Reuben Ilia, Amos Katz. (2008) B-type Natruiretic Peptide Levels Stratify the Risk for Arrhythmia Among Implantable Cardioverter Defibrillator Patients. Clinical Cardiology 31:12, 586-589
CrossRef238
Jerry P. Nolan, Robert W. Neumar, Christophe Adrie, Mayuki Aibiki, Robert A. Berg, Bernd W. Böttiger, Clifton Callaway, Robert S.B. Clark, Romergryko G. Geocadin, Edward C. Jauch, Karl B. Kern, Ivan Laurent, W.T. Longstreth, Raina M. Merchant, Peter Morley, Laurie J. Morrison, Vinay Nadkarni, Mary Ann Peberdy, Emanuel P. Rivers, Antonio Rodriguez-Nunez, Frank W. Sellke, Christian Spaulding, Kjetil Sunde, Terry Vanden Hoek. (2008) Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. Resuscitation 79:3, 350-379
CrossRef239
Alfred P. Hallstrom, D. George Wyse, John McAnulty, . (2008) Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis. Journal of Interventional Cardiac Electrophysiology 23:3, 159-166
CrossRef240
Martin Stockburger. (2008) Ein- und Zweikammer-ICD: Sind die Unterschiede zum Schrittmacher in Implantation und Nachsorge heutzutage noch bedeutsam?. Herzschrittmachertherapie + Elektrophysiologie 19:S1, 6-13
CrossRef241
RONG BAI, LUIGI DI BIASE, CLAUDE ELAYI, CHI KEONG CHING, CONOR BARRETT, KAREN PHILIPPS, PASCAL LIM, DIMPI PATEL, TOM CALLAHAN, DAVID O. MARTIN, MAURICIO ARRUDA, ROBERT A. SCHWEIKERT, WALID I. SALIBA, BRUCE WILKOFF, ANDREA NATALE. (2008) Mortality of Heart Failure Patients After Cardiac Resynchronization Therapy: Identification of Predictors. Journal of Cardiovascular Electrophysiology 19:12, 1259-1265
CrossRef242
Antonio Curnis, Giosue Mascioli, Luca Bontempi, Manuel Cerini, Tommaso Bignotti, Gabriele Bonetti, Livio Dei Cas. (2008) Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience. Journal of Cardiovascular Medicine 9:12, 1241-1245
CrossRef243
Michael J. Root. (2008) Implantable Cardiac Rhythm Device Batteries. Journal of Cardiovascular Translational Research 1:4, 254-257
CrossRef244
Myerburg, Robert J., . (2008) Implantable Cardioverter–Defibrillators after Myocardial Infarction. New England Journal of Medicine 359:21, 2245-2253
Full Text245
C. A. Muratore, L. A. Batista Sa, P. A. Chiale, R. Eloy, M. C. Tentori, J. Escudero, A. M. C. Lima, L. E. Medina, R. Garillo, J. Maloney. (2008) Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 11:2, 164-168
CrossRef246
David J. Whellan, Christopher M. O'Connor, Kevin T. Ousdigian, Te-Hsin Lung. (2008) Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF). American Heart Journal 156:5, 833-839.e2
CrossRef247
Maurizio Gasparini, Maurizio Lunati, Maurizio Landolina, Massimo Santini, Luigi Padeletti, Gianni Perego, Antonio Vincenti, Antonio Curnis, Angelo Carboni, Alessandra Denaro, Alessia Spotti, Andrea Grammatico, François Regoli, Giuseppe Boriani. (2008) Electrical storm in patients with biventricular implantable cardioverter defibrillator: Incidence, predictors, and prognostic implications. American Heart Journal 156:5, 847-854
CrossRef248
DAVID SCHWARTZMAN. (2008) Getting the Most Out of Life. Journal of Cardiovascular Electrophysiology 19:11, 1167-1168
CrossRef249
John P. Boehmer, Mark D. Carlson, Teresa Marco, Brian E. Jaski, Steven L. Higgins, Charles Kennergren, Andrew E. Epstein. (2008) Adjudication of mortality events in a heart failure–arrhythmia trial by a multiparameter descriptive method: Comparison with methods used in heart failure trials and methods used in arrhythmia trials. Journal of Interventional Cardiac Electrophysiology 23:2, 101-110
CrossRef250
MICHAEL O SWEENEY, ANNE S HELLKAMP, KENNETH A ELLENBOGEN, GERVASIO A LAMAS. (2008) Reduced Ejection Fraction, Sudden Cardiac Death, and Heart Failure Death in the Mode Selection Trial (MOST): Implications for Device Selection in Elderly Patients with Sinus Node Disease. Journal of Cardiovascular Electrophysiology 19:11, 1160-1166
CrossRef251
Yaariv Khaykin, Allan Skanes, Bonnie Whaley, Carol Hill, Marianne Beardsall, Catherine Seabrook, Zaev Wulffhart, Richard Oosthuizen, Lorne Gula, Atul Verma. (2008) Real-time integration of 2D intracardiac echocardiography and 3D electroanatomical mapping to guide ventricular tachycardia ablation. Heart Rhythm 5:10, 1396-1402
CrossRef252
J. Tebbenjohanns, S. Willems, M. Antz, D. Pfeiffer, K.-H. Seidl, T. Lewalter. (2008) Kommentar zu den „ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary“. Der Kardiologe 2:5, 363-388
CrossRef253
Sana M. Al-Khatib, Gillian D. Sanders, Mark Carlson, Aida Cicic, Anne Curtis, Gregg C. Fonarow, Peter W. Groeneveld, David Hayes, Paul Heidenreich, Daniel Mark, Eric Peterson, Eric N. Prystowsky, Philip Sager, Marcel E. Salive, Kevin Thomas, Clyde W. Yancy, Wojciech Zareba, Douglas Zipes. (2008) Preventing tomorrow's sudden cardiac death today. American Heart Journal 156:4, 613-622
CrossRef254
Sanjeev Saksena, Rangadham Nagarakanti. (2008) The future of implantable defibrillator and cardiac resynchronization therapy trials. Journal of Interventional Cardiac Electrophysiology 23:1, 29-39
CrossRef255
DAVID S. CANNOM, JOHN FISHER. (2008) The Fidelis Recall: How Much Pressure Can the ICD World Bear?. Pacing and Clinical Electrophysiology 31:10, 1233-1235
CrossRef256
P. Peter Borek, Bruce L. Wilkoff. (2008) Pacemaker and ICD leads: Strategies for long-term management. Journal of Interventional Cardiac Electrophysiology 23:1, 59-72
CrossRef257
Fei Yang, Robert Patterson. (2008) Optimal Transvenous Coil Position on Active-can Single-coil ICD Defibrillation Efficacy: A Simulation Study. Annals of Biomedical Engineering 36:10, 1659-1667
CrossRef258
, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori, K. Swedberg, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , M. Tendera, A. Auricchio, J. Bax, M. Bohm, U. Corra, P. della Bella, P. M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.-L. Vachiery, F. W. A. Verheugt, J. L. Zamorano, F. Zannad. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 29:19, 2388-2442
CrossRef259
Naoki Serizawa, Dai Yumino, Katsuya Kajimoto, Yoshimi Tagawa, Atsushi Takagi, Morio Shoda, Hiroshi Kasanuki, Nobuhisa Hagiwara. (2008) Impact of Sleep-Disordered Breathing on Life-Threatening Ventricular Arrhythmia in Heart Failure Patients With Implantable Cardioverter-Defibrillator. The American Journal of Cardiology 102:8, 1064-1068
CrossRef260
BARRY J. MARON, PAOLO SPIRITO. (2008) Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 19:10, 1118-1126
CrossRef261
Mark, Daniel B., Anstrom, Kevin J., Sun, Jie L., Clapp-Channing, Nancy E., Tsiatis, Anastasios A., Davidson-Ray, Linda, Lee, Kerry L., Bardy, Gust H., . (2008) Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure. New England Journal of Medicine 359:10, 999-1008
Full Text262
Roderick Tung, Peter Zimetbaum, Mark E. Josephson. (2008) A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 52:14, 1111-1121
CrossRef263
Andrew E. Epstein. (2008) Benefits of the Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 52:14, 1122-1127
CrossRef264
C. N. Pellegrini, K. Lee, J. E. Olgin, M. P. Turakhia, Z. H. Tseng, R. Lee, N. Badhwar, B. Lee, P. D. Varosy. (2008) Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 10:11, 1296-1301
CrossRef265
S. Tzeis, G. Andrikopoulos, C. Kolb, P. E. Vardas. (2008) Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 10:11, 1256-1265
CrossRef266
M. Biffi, M. Ziacchi, M. Bertini, D. Sangiorgi, D. Corsini, C. Martignani, I. Diemberger, G. Boriani. (2008) Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10:11, 1288-1295
CrossRef267
D. A.M.J. Theuns, M. Rivero-Ayerza, D. M. Goedhart, M. Miltenburg, L. J. Jordaens. (2008) Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10:9, 1060-1066
CrossRef268
L. Ding, W. Hua, H. Niu, K. Chen, S. Zhang. (2008) Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Europace 10:9, 1034-1041
CrossRef269
Deepak Bhakta, Lynne D. Foreman. (2008) Cosmic radiation: Not science fiction, but clinical reality. Heart Rhythm 5:8, 1204-1205
CrossRef270
Charles A. Herzog, J. Michael Mangrum, Rod Passman. (2008) NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients. Seminars in Dialysis 21:4, 300-307
CrossRef271
Grace Lin, Ryan A. Meverden, David O. Hodge, Daniel Z. Uslan, David L. Hayes, Peter A. Brady. (2008) Age and gender trends in implantable cardioverter defibrillator utilization: A population based study. Journal of Interventional Cardiac Electrophysiology 22:1, 65-70
CrossRef272
Martin C. Burke. (2008) Poor survival of the fittest: A call for resources, research and public awareness. Heart Rhythm 5:6, 800-801
CrossRef273
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N. A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Heart Rhythm 5:6, e1-e62
CrossRef274
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Heart Rhythm 5:6, 934-955
CrossRef275
Tetsuo Sasano, M. Roselle Abraham, Kuan-Cheng Chang, Hiroshi Ashikaga, Kevin J. Mills, Daniel P. Holt, John Hilton, Stephan G. Nekolla, Jun Dong, Albert C. Lardo, Henry Halperin, Robert F. Dannals, Eduardo Marbán, Frank M. Bengel. (2008) Abnormal Sympathetic Innervation of Viable Myocardium and the Substrate of Ventricular Tachycardia After Myocardial Infarction. Journal of the American College of Cardiology 51:23, 2266-2275
CrossRef276
Ronni Levy, Andrea DellaValle, A. Serdar Atav, Afazal ur Rehman, Allan H. Sklar, Nicolas J. Stamato. (2008) The Relationship Between Glomerular Filtration Rate and Survival in Patients Treated with an Implantable Cardioverter Defibrillator. Clinical Cardiology 31:6, 265-269
CrossRef277
J. Philip Saul, Andrew E. Epstein, Michael J. Silka, Charles I. Berul, MacDonald Dick, John P. DiMarco, Richard A. Friedman, Eric Rosenthal, Elizabeth A. Stephenson, Victoria L. Vetter. (2008) Heart Rhythm Society/Pediatric and Congenital Electrophysiology Society Clinical Competency Statement: Training pathways for implantation of cardioverter-defibrillators and cardiac resynchronization therapy devices in pediatric and congenital heart patients. Heart Rhythm 5:6, 926-933
CrossRef278
S. P. Bhavnani, C. I. Coleman, C. M. White, C. A. Clyne, R. Yarlagadda, D. Guertin, J. Kluger. (2008) Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy. Europace 10:7, 854-859
CrossRef279
Harvinder Singh Arora, Pranav Loyalka, Biswajit Kar, Reynolds Delgado. (2008) Devices for Heart Failure: The Future Is Now. Congestive Heart Failure 14:3, 141-148
CrossRef280
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Journal of the American College of Cardiology 51:21, e1-e62
CrossRef281
Ilan Goldenberg, Arthur J. Moss. (2008) Implantable Device Therapy. Progress in Cardiovascular Diseases 50:6, 449-474
CrossRef282
Ganesh S. Kamath, Suneet Mittal. (2008) The Role of Antiarrhythmic Drug Therapy for the Prevention of Sudden Cardiac Death. Progress in Cardiovascular Diseases 50:6, 439-448
CrossRef283
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Journal of the American College of Cardiology 51:21, 2085-2105
CrossRef284
Wolfram Grimm. (2008) Outcomes of elderly heart failure recipients of ICD and CRT. International Journal of Cardiology 125:2, 154-160
CrossRef285
Dominic A.M.J. Theuns, Maximo Rivero-Ayerza, Erik Boersma, Luc Jordaens. (2008) Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. International Journal of Cardiology 125:3, 352-357
CrossRef286
James P. Daubert, Wojciech Zareba, David S. Cannom, Scott McNitt, Spencer Z. Rosero, Paul Wang, Claudio Schuger, Jonathan S. Steinberg, Steven L. Higgins, David J. Wilber, Helmut Klein, Mark L. Andrews, W. Jackson Hall, Arthur J. Moss. (2008) Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II. Journal of the American College of Cardiology 51:14, 1357-1365
CrossRef287
Michael T. Koller, Theo Stijnen, Ewout W. Steyerberg, Jacobus Lubsen. (2008) Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios. Journal of Clinical Epidemiology 61:4, 365-372
CrossRef288
LORNE J. GULA, DAVID MASSEL, ANDREW D. KRAHN, RAYMOND YEE, ALLAN C. SKANES, GEORGE J. KLEIN. (2008) Is Defibrillation Testing Still Necessary? A Decision Analysis and Markov Model. Journal of Cardiovascular Electrophysiology 19:4, 400-405
CrossRef289
KATJA ZEPPENFELD, WILLIAM G. STEVENSON. (2008) Ablation of Ventricular Tachycardia in Patients with Structural Heart Disease. Pacing and Clinical Electrophysiology 31:3, 358-374
CrossRef290
Jonathan S. Steinberg, Sandeep Joshi, Eleanor B. Schron, Judy Powell, Alfred Hallstrom, MaryAnn McBurnie. (2008) Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm 5:3, 361-365
CrossRef291
Sunil K. Sinha. (2008) AVID revisited: Quality of life is important too. Heart Rhythm 5:3, 366
CrossRef292
Björn C. Knollmann, Dan M. Roden. (2008) A genetic framework for improving arrhythmia therapy. Nature 451:7181, 929-936
CrossRef293
Wilbert S. Aronow, Carmine Sorbera. 2008. Ventricular Arrhythmias in the Elderly. , 605-626.
CrossRef294
Wilbert S. Aronow. 2008. Management of the Older Patient After Myocardial Infarction. , 327-350.
CrossRef295
Karen M. Stugensky, Gerald W. Neuberg, Mathew S. Maurer. 2008. Evaluation of Syncope in the Elderly Patient. , 673-704.
CrossRef296
ANDREAS W. SCHOENENBERGER, PAUL ERNE, STEPHAN AMMANN, GERHARD GILLMANN, RICHARD KOBZA, ANDREAS E. STUCK. (2008) Prediction of Arrhythmic Events after Myocardial Infarction Based on Signal-Averaged Electrocardiogram and Ejection Fraction. Pacing and Clinical Electrophysiology 31:2, 221-228
CrossRef297
Kai Wang, Kazunobu Yamauchi, Ping Li, Hiroki Kato, Makoto Kobayashi, Ken Kato, Yoshiyuki Shimizu. (2008) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Brugada Syndrome Treatment. Journal of Medical Systems 32:1, 51-57
CrossRef298
Arnt V. Kristen, Thomas J. Dengler, Ute Hegenbart, Stefan O. Schonland, Hartmut Goldschmidt, Falk-Udo Sack, Frederik Voss, Rüdiger Becker, Hugo A. Katus, Alexander Bauer. (2008) Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm 5:2, 235-240
CrossRef299
Christopher H George, Steven R Barberini-Jammaers, Carsten T Muller. (2008) Refocussing therapeutic strategies for cardiac arrhythmias: defining viable molecular targets to restore cardiac ion flux. Expert Opinion on Therapeutic Patents 18:1, 1-19
CrossRef300
Shinichi Niwano, Hidehira Fukaya, Masaru Yuge, Ryuta Imaki, Shouji Hirasawa, Takeshi Sasaki, Yoshihiro Yumoto, Takayuki Inomata, Tohru Izumi. (2008) Role of Electrophysiologic Study (EPS)-Guided Preventive Therapy for the Management of Ventricular Tachyarrhythmias in Patients With Heart Failure. Circulation Journal 72:2, 268-273
CrossRef301
Anna Legreid Dopp, John M Miller, James E Tisdale. (2008) Effect of Drugs on Defibrillation Capacity. Drugs 68:5, 607-630
CrossRef302
Carsten W Israel. (2008) How to avoid inappropriate therapy. Current Opinion in Cardiology 23:1, 65-71
CrossRef303
SUSANNE S PEDERSEN, DOMINIC AMJ THEUNS, RUUD AM ERDMAN, LUC JORDAENS. (2008) Clustering of Device-Related Concerns and Type D Personality Predicts Increased Distress in ICD Patients Independent of Shocks1. Pacing and Clinical Electrophysiology 31:1, 20-27
CrossRef304
Akihiko Shimizu, Takashi Nitta, Takashi Kurita, Katsuhiko Imai, Takeshi Kimura, Yoshinori Kobayashi, Kyoko Soejima, Shinichi Niwano, Shigeyuki Watanabe, Haruhiko Abe. (2008) Current status of implantable defibrillator devices in patients with left ventricular dysfunction-The first report from the online registry database. Journal of Arrhythmia 24:3, 133-140
CrossRef305
Benoît Allenet, Étienne Brudieu, Jean-Philippe Baguet, François Gimenez†, Claude Cassat. 2008. Traitement de l'insuffisance cardiaque. , 101-125.
CrossRef306
Reddy, Vivek Y., Reynolds, Matthew R., Neuzil, Petr, Richardson, Allison W., Taborsky, Milos, Jongnarangsin, Krit, Kralovec, StepanSediva, Lucie, Ruskin, Jeremy N., Josephson, Mark E., . (2007) Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy. New England Journal of Medicine 357:26, 2657-2665
Full Text307
H.-J. Trappe. (2007) Plötzlicher Herztod. Der Kardiologe 1:4, 261-271
CrossRef308
J. Michael Bostwick, Christopher L. Sola. (2007) An Updated Review of Implantable Cardioverter/Defibrillators, Induced Anxiety, and Quality of Life. Psychiatric Clinics of North America 30:4, 677-688
CrossRef309
Rachel Lampert. (2007) Implantable Cardioverter-Defibrillator Use and Benefit in Women. Cardiology in Review 15:6, 298-303
CrossRef310
Mikhael F. El-Chami, Ibrahim R. Hanna, Heather Bush, Jonathan J. Langberg. (2007) Impact of race and gender on cardiac device implantations. Heart Rhythm 4:11, 1420-1426
CrossRef311
Kurt Fritzsche, Florian Forster, Axel Schweickhardt, Hartmut Kanwischer, Arno Drinkmann, Sven Rabung, Günter Bergmann, Annette Geibel, Christoph Herrmann-Lingen. (2007) Depressive coping is a predictor for emotional distress and poor quality of life in a German–Austrian sample of cardioverter-defibrillator implant recipients at 3 months and 1 year after implantation. General Hospital Psychiatry 29:6, 526-536
CrossRef312
Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Heart Failure Clinics 3:4, 519-528
CrossRef313
VENKU JAYANTI, MENEKHEM M. ZVIMAN, SAMAN NAZARIAN, HENRY R. HALPERIN, RONALD D. BERGER. (2007) Novel Electrode Design for Potentially Painless Internal Defibrillation Also Allows for Successful External Defibrillation. Journal of Cardiovascular Electrophysiology 18:10, 1095-1100
CrossRef314
Wilbert S. Aronow. (2007) Treatment After Myocardial Infarction. Comprehensive Therapy 33:1, 39-47
CrossRef315
Eric J Kessler, Bradley P Knight. (2007) Catheter ablation for ventricular tachycardia: indications and techniques. Expert Review of Cardiovascular Therapy 5:5, 977-988
CrossRef316
SCOTT L. GREENBERG, J. MAURICIO SNCHEZ, JONAS A. COOPER, MICHAEL E. CAIN, JANE CHEN, MARYE J. GLEVA, BRUCE D. LINDSAY, TIMOTHY W. SMITH, MITCHELL N. FADDIS. (2007) Sustained Polymorphic Arrhythmias Induced by Programmed Ventricular Stimulation have Prognostic Value in Patients Receiving Defibrillators. Pacing and Clinical Electrophysiology 30:9, 1067-1075
CrossRef317
Mintu Turakhia, Zian H. Tseng. (2007) Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapy. Current Problems in Cardiology 32:9, 501-546
CrossRef318
HAITHAM HREYBE, EATHAR RAZAK, SAMIR SABA. (2007) Effect of End-Stage Renal Failure and Hemodialysis on Mortality Rates in Implantable Cardioverter-Defibrillator Recipients. Pacing and Clinical Electrophysiology 30:9, 1091-1095
CrossRef319
HIROSHI FURUSHIMA, MASAOMI CHINUSHI, KAZUKI OKAMURA, SATORU KOMURA, YASUTAKA TANABE, AKINORI SATO, DAISUKE IZUMI, YOSHIFUSA AIZAWA. (2007) Effect of Dl-Sotalol on Mortality and Recurrence of Ventricular Tachyarrhythmias:Ischemic Compared to Nonischemic Cardiomyopathy. Pacing and Clinical Electrophysiology 30:9, 1136-1141
CrossRef320
Alessandro Biffi. (2007) How to Manage Athletes with Ventricular Arrhythmias. Cardiology Clinics 25:3, 449-455
CrossRef321
M. Roser, S. Götze. (2007) ICD-Therapie. Der Kardiologe 1:2, 149-164
CrossRef322
Mark S. Link, N.A. Mark Estes. (2007) How to Manage Athletes with Syncope. Cardiology Clinics 25:3, 457-466
CrossRef323
DAVID T. HUANG, HENRY W. SESSELBERG, SCOTT McNITT, KATIA NOYES, MARK L. ANDREWS, W. JACKSON HALL, ANDREW DICK, JAMES P. DAUBERT, WOJCIECH ZAREBA, ARTHUR J. MOSS, . (2007) Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT-II Substudy. Journal of Cardiovascular Electrophysiology 18:8, 833-838
CrossRef324
Jacob A. Udell, David N. Juurlink, Alexander Kopp, Douglas S. Lee, Jack V. Tu, Muhammad M. Mamdani. (2007) Inequitable distribution of implantable cardioverter defibrillators in Ontario. International Journal of Technology Assessment in Health Care 23:03,
CrossRef325
J.O. Schwab, B. Lüderitz. (2007) Indikationen für den implantierbaren Cardioverter/Defibrillator (ICD). Der Internist 48:7, 715-726
CrossRef326
Michael R. Gold, Hue-Teh Shih, John Herre, David Breiter, Yunlong Zhang, Mark Schwartz. (2007) Comparison of Defibrillation Efficacy and Survival Associated With Right Versus Left Pectoral Placement for Implantable Defibrillators. The American Journal of Cardiology 100:2, 243-246
CrossRef327
Salvatore Rosanio, Ernst R. Schwarz, Antonio Vitarelli, Ignatius Gerardo E. Zarraga, Sanjay Kunapuli, David L. Ware, Yochai Birnbaum, Enrique Tuero, Barry F. Uretsky. (2007) Sudden death prophylaxis in heart failure. International Journal of Cardiology 119:3, 291-296
CrossRef328
SAMUEL F. SEARS, LAUREN D. VAZQUEZ SOWELL, EMILY A. KUHL, ADRIENNE H. KOVACS, EVA R. SERBER, EILEEN HANDBERG, SHAWN M. KNEIPP, ISSAM ZINEH, JAMIE B. CONTI. (2007) The ICD Shock and Stress Management Program: A Randomized Trial of Psychosocial Treatment to Optimize Quality of Life in ICD Patients. Pacing and Clinical Electrophysiology 30:7, 858-864
CrossRef329
JAY CHEN, R. HARIS NASEEM, OWEN OBEL, JOSE A. JOGLAR. (2007) Habitual Cocaine Use Is Associated with High Defibrillation Threshold During ICD Implantation. Journal of Cardiovascular Electrophysiology 18:7, 722-725
CrossRef330
Sumeet S. Chugh, Kyndaron Reinier, Eric C. Stecker. (2007) Learning From a Real-World Analysis of Implantable Cardioverter-Defibrillator Recipients. Journal of the American College of Cardiology 49:25, 2416-2418
CrossRef331
NEIL K SANGHVI, CYNTHIA M TRACY. (2007) Sustained Ventricular Tachycardia in Apical Hypertrophic Cardiomyopathy, Midcavitary Obstruction, and Apical Aneurysm. Pacing and Clinical Electrophysiology 30:6, 799-803
CrossRef332
Douglas S. Lee, Jack V. Tu, Peter C. Austin, Paul Dorian, Raymond Yee, Alice Chong, David A. Alter, Andreas Laupacis. (2007) Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation. Journal of the American College of Cardiology 49:25, 2408-2415
CrossRef333
SURAJ KAPA, LINDA HYBERGER, ROBERT F. REA, DAVID L. HAYES. (2007) Complication Risk with Pulse Generator Change: Implications When Reacting to a Device Advisory or Recall. Pacing and Clinical Electrophysiology 30:6, 730-733
CrossRef334
Arijit Dasgupta, Jessica Montalvo, Sara Medendorp, Donald M. Lloyd-Jones, Cybele Ghossein, Jeffrey Goldberger, Rod Passman. (2007) Increased Complication Rates of Cardiac Rhythm Management Devices in ESRD Patients. American Journal of Kidney Diseases 49:5, 656-663
CrossRef335
Amir Abdelwahab, John L Sapp. (2007) NaviStar ® ThermoCool ® catheter for ventricular tachycardia. Expert Review of Medical Devices 4:3, 307-314
CrossRef336
Charles P. Davis. (2007) Electrical Storm and Implanted Defibrillators. Southern Medical Journal 100:5, 547-548
CrossRef337
CHARLES D. SWERDLOW, ANDREA M. RUSSO, PAUL J. DEGROOT. (2007) The Dilemma of ICD Implant Testing. Pacing and Clinical Electrophysiology 30:5, 675-700
CrossRef338
Alessandro Proclemer, Marco Ghidina. (2007) Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of Cardiovascular Medicine 8:5, 320-323
CrossRef339
Anne B. Curtis. (2007) Are women worldwide under-treated with regard to cardiac resynchronization and sudden death prevention?. Journal of Interventional Cardiac Electrophysiology 17:3, 169-175
CrossRef340
Timothy W. Smith, Michael E. Cain. (2007) Sudden cardiac death: Epidemiologic and financial worldwide perspective. Journal of Interventional Cardiac Electrophysiology 17:3, 199-203
CrossRef341
Michael E. Field, Michael O. Sweeney. (2007) Socio-economic analysis of cardiac resynchronization therapy. Journal of Interventional Cardiac Electrophysiology 17:3, 225-236
CrossRef342
A. Selcuk Adabag, Barry J. Maron. (2007) Implications of Arrhythmias and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Annals of Noninvasive Electrocardiology 12:2, 171-180
CrossRef343
Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, W. Jackson Hall, Mark L. Andrews. (2007) Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. Journal of the American College of Cardiology 49:13, 1427-1433
CrossRef344
Mitesh S. Amin, Kenneth A. Ellenbogen. (2007) Critical Pathway for Management of Pacemaker and Implantable Cardioverter-Defibrillator Advisories. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 6:1, 1-4
CrossRef345
Andrew E. Epstein, Christina A. Baessler, Anne B. Curtis, N.A. Mark Estes, Bernard J. Gersh, Blair Grubb, L. Brent Mitchell. (2007) Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”. Heart Rhythm 4:3, 386-393
CrossRef346
K M Giacomini, C M Brett, R B Altman, N L Benowitz, M E Dolan, D A Flockhart, J A Johnson, D F Hayes, T Klein, R M Krauss, D L Kroetz, H L McLeod, A T Nguyen, M J Ratain, M V Relling, V Reus, D M Roden, C A Schaefer, A R Shuldiner, T Skaar, K Tantisira, R F Tyndale, L Wang, R M Weinshilboum, S T Weiss, I Zineh. (2007) The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response. Clinical Pharmacology & Therapeutics 81:3, 328-345
CrossRef347
HAITHAM HREYBE, SAMIR SABA. (2007) A Clinical Risk Score to Predict the Time to First Appropriate Device Therapy in Recipients of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 30:3, 385-389
CrossRef348
Alexander Crössmann, Paul Pauli, Wilhelm Dengler, Volker Kühlkamp, Georg Wiedemann. (2007) Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: A longitudinal two-year follow-up. Heart & Lung: The Journal of Acute and Critical Care 36:2, 87-95
CrossRef349
Lorne J. Gula, David Massel, Andrew D. Krahn, Allan C. Skanes, Raymond Yee, George J. Klein. (2007) Survival rates as a guide to implanted cardioverter-defibrillator replacement strategies for device recalls—Adding statistical insight to clinical intuition. American Heart Journal 153:2, 253-259
CrossRef350
Kavitha M. Chinnaiyan, Justin Trivax, Barry A. Franklin, Brian Williamson, Joel K. Kahn. (2007) Stress Testing in Patients With Implantable Cardioverter-Defibrillators: A Preliminary Report. Preventive Cardiology 10:2, 92-95
CrossRef351
OLIVER R. SEGAL, ANTHONY W.C. CHOW, TOM WONG, NICOLA TREVISI, MARTIN D. LOWE, D. WYN DAVIES, PAOLO DELLA BELLA, DOUGLAS L. PACKER, NICHOLAS S. PETERS. (2007) A Novel Algorithm for Determining Endocardial VT Exit Site from 12-Lead Surface ECG Characteristics in Human, Infarct-Related Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology 18:2, 161-168
CrossRef352
Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Clinics in Geriatric Medicine 23:1, 205-219
CrossRef353
Rishi Sukhija, Vimal Mehta, Marino Leonardi, Jawahar L. Mehta. (2007) Implantable cardioverter defibrillators for prevention of sudden cardiac Death. Clinical Cardiology 30:1, 3-8
CrossRef354
Warren Smith, Margaret Hood. 2007. Arrhythmias. , 316-341.
CrossRef355
Anil-Martin Sinha, Rainer Schimpf, Jörg Otto Schwab, Frank Birkenhauer, Ole A. Breithardt, Johannes Brachmann, Volker Schibgilla, Peter Hanrath, Christoph Stellbrink. (2007) A new method to investigate the response to the morphology discrimination algorithm in patients with ICD. International Journal of Cardiology 114:3, 323-331
CrossRef356
Serkan Topaloglu, Dursun Aras, Onur Sahin, Kumral Ergun, Bulent Deveci, Ozcan Ozdemir, Ozcan Ozeke, Ali Yildiz, Omer Alyan, Ahmet Duran Demir, Mustafa Soylu, Halil Lutfi Kisacik, Sule Korkmaz. (2007) QT Dispersion Significantly Increases after Implantable Cardioverter-Defibrillator Shocks. Annals of Noninvasive Electrocardiology 12:1, 44-49
CrossRef357
Jackie Bryant, Hakan Brodin, Emma Loveman, Andrew Clegg. (2007) Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: A systematic review and economic evaluation. International Journal of Technology Assessment in Health Care 23:01,
CrossRef358
Andrea M. Russo, Francis E. Marchlinski. (2007) Should Microvolt T-Wave Alternans Be Utilized Routinely in Selecting Patients for Prophylactic Implantable Cardioverter-Defibrillator Insertion in the Setting of Ischemic Heart Disease?. Journal of the American College of Cardiology 49:1, 59-61
CrossRef359
Daisuke Izumi, Masaomi Chinushi, Hiroshi Watanabe, Takashi Washizuka, Kazuki Okamura, Satoru Komura, Yasutaka Tanabe, Hiroshi Furushima, Yoshifusa Aizawa. (2007) Bepridil for Drug-Refractory Ventricular Tachyarrhythmias. Internal Medicine 46:3, 119-124
CrossRef360
Masaomi Chinushi, Yoshifusa Aizawa. (2007) Non-Pharmacological Management of Ventricular Tachycardia. Circulation Journal 71:SupplementA, A97-A105
CrossRef361
Sae Sasaki, Shinichi Niwano, Hidehira Fukaya, Masaru Yuge, Ryuta Imaki, Takayuki Inomata, Tohru Izumi. (2007) Clinical Usefulness of Electrophysiologic Study (EPS)-Guided Risk Stratification for Life-Threatening Arrhythmia in Patients With Heart Failure. International Heart Journal 48:2, 155-163
CrossRef362
Akira Ueno, Yoshinori Kobayashi, Kenji Yodogawa, Yasushi Miyauchi, Toshimi Yajima, Takashi Nitta, Takao Kato, Teruo Takano. (2007) A Prospective Study on the Risk-Stratification for Patients With Non-Sustained Ventricular Tachycardia Using a Novel Algorithm. Circulation Journal 71:7, 1107-1114
CrossRef363
J. ALBERTO LOPEZ, MICHAEL MIHALICK. (2006) Successful Use of a Transvenous Dual-Chamber Automatic Implantable Cardiac Defibrillator After a Classic Fontan Operation for Tricuspid Atresia. Pacing and Clinical Electrophysiology 29:12, 1449-1451
CrossRef364
GIOVANNI LUCA BOTTO, MARIO LUZI, FRANCO RUFFA, GIOVANNI RUSSO, GIOVANNI FERRARI. (2006) Atrial Tachyarrhythmias in Primary and Secondary Prevention ICD Recipients: Clinical and Prognostic Data. Pacing and Clinical Electrophysiology 29:s2, S48-S53
CrossRef365
MICHAEL O. SWEENEY, KENNETH A. ELLENBOGEN, ELAINE HOGAN MILLER, LOU SHERFESEE, TODD SHELDON, DAVID WHELLAN. (2006) The Managed Ventricular Pacing? Versus VVI 40 Pacing (MVP) Trial: Clinical Background, Rationale, Design, and Implementation. Journal of Cardiovascular Electrophysiology 17:12, 1295-1298
CrossRef366
Werner Jung, Dietrich Andresen, Michael Block, Dirk Böcker, Stefan H. Hohnloser, Karl-Heinz Kuck, Johannes Sperzel. (2006) Leitlinien zur Implantation von Defibrillatoren. Clinical Research in Cardiology 95:12, 696-708
CrossRef367
MAURIZIO LUNATI, MAURIZIO GASPARINI, MARIO BOCCHIARDO, ANTONIO CURNIS, MAURIZIO LANDOLINA, ANGELO CARBONI, GIANNI LUZZI, GABRIELE ZANOTTO, PIERANTONIO RAVAZZI, GIOVANNI MAGENTA, ALESSANDRA DENARO, PAOLA DISTEFANO, ANDREA GRAMMATICO, . (2006) Clustering of Ventricular Tachyarrhythmias in Heart Failure Patients Implanted with a Biventricular Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 17:12, 1299-1306
CrossRef368
PAOLO DELLA BELLA, STEFANIA RIVA. (2006) Hybrid Therapies for Ventricular Arrhythmias. Pacing and Clinical Electrophysiology 29:s2, S40-S47
CrossRef369
Adnan Siddiqui, Peter R Kowey. (2006) Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Current Opinion in Internal Medicine 5:6, 544-552
CrossRef370
STEFAN ASBACH, INGO WEISS, BEATE WENZEL, CHRISTOPH BODE, MANFRED ZEHENDER. (2006) Intrathoracic Far-Field Electrocardiogram Allows Continuous Monitoring of Ischemia After Total Coronary Occlusion. Pacing and Clinical Electrophysiology 29:12, 1334-1340
CrossRef371
DAVID N. KENIGSBERG, KENNETH A. ELLENBOGEN. (2006) ICD Arrhythmia Detection and Discrimination: Are We There Yet?. Journal of Cardiovascular Electrophysiology 17:12, 1320-1322
CrossRef372
ALESSANDRO PROCLEMER, MARCO GHIDINA, GLORIA CICUTTINI, DARIO GREGORI, PAOLO MARIA FIORETTI. (2006) Impact of the Main Implantable Cardioverter-Defibrillator Trials for Primary and Secondary Prevention in Italy: A Survey of the National Activity During the Years 2001?2004. Pacing and Clinical Electrophysiology 29:s2, S20-S28
CrossRef373
(2006) Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita.Versión resumida. Revista Española de Cardiología 59:12, 1328.e1-1328.e51
CrossRef374
Michael J. Yarnoz, Anne B. Curtis. (2006) Sex-Based Differences in Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapies. Cardiology in Review 14:6, 292-298
CrossRef375
Michael A. Weber, Nanette K. Wenger, Stephen Scheidt. (2006) Who Should Be Treated With Implantable Cardioverter-Defibrillators?. The American Journal of Geriatric Cardiology 15:6, 336-337
CrossRef376
Michael J. Yarnoz, Anne B. Curtis. (2006) Why Cardioverter-Defibrillator Implantation Might Not Be the Best Idea for Your Elderly Patient. The American Journal of Geriatric Cardiology 15:6, 367-371
CrossRef377
N. N. HENYAN, C. M. WHITE, E. L. GILLESPIE, K. SMITH, C. I. COLEMAN, J. KLUGER. (2006) The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. Journal of Internal Medicine 260:5, 467-473
CrossRef378
Alfred E. Boxton. (2006) Implantable Cardioverter-Defibrillators Should Be Used Routinely in the Elderly. The American Journal of Geriatric Cardiology 15:6, 361-364
CrossRef379
Liza A. Prudente, Juanita Reigle, Cheryl Bourguignon, David E. Haines, John P. DiMarco. (2006) Psychological indices and phantom shocks in patients with ICD. Journal of Interventional Cardiac Electrophysiology 15:3, 185-190
CrossRef380
H. U. Klein. (2006) Prävention des plötzlichen Herztodes. Der Internist 47:10, 1040-1050
CrossRef381
D. Steven, B. Lutomsky, T. Rostock, S. Willems. (2006) Moderne Pharmakotherapie bei supraventrikulären und ventrikulären Herzrhythmusstörungen. Der Internist 47:10, 1013-1023
CrossRef382
Michael G. McLaughlin, Peter J. Zimetbaum. (2006) Electrocardiographic Predictors of Arrhythmic Death. Annals of Noninvasive Electrocardiology 11:4, 327-337
CrossRef383
Andrew Ho, Ramin Assadi, Sudha M. Pai, Ramdas G. Pai. (2006) Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?. Current Cardiology Reports 8:5, 365-369
CrossRef384
David R. Holmes, Douglas L. Wood. (2006) Medical Devices and Pharmaceuticals: Differences in Public Acceptance. The American Heart Hospital Journal 4:4, 269-272
CrossRef385
CHRISTOF KOLB, ISABEL DEISENHOFER, SEBASTIAN SCHMIEDER, PETRA BARTHEL, BERNHARD ZRENNER, MARTIN R. KARCH, CLAUS SCHMITT. (2006) Long-Term Follow-Up of Patients Supplied with Single-Chamber or Dual-Chamber Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 29:9, 946-952
CrossRef386
Jeanne E. Poole. (2006) New indications for implantable defibrillator therapy. Current Cardiology Reports 8:5, 330-335
CrossRef387
Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 48:5, e247-e346
CrossRef388
Apiradee Thammanomai, Michael O. Sweeney, Solomon R. Eisenberg. (2006) A comparison of the output characteristics of several implantable cardioverter-defibrillators. Heart Rhythm 3:9, 1053-1059
CrossRef389
Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary. Journal of the American College of Cardiology 48:5, 1064-1108
CrossRef390
Lauren Vazquez Sowell, Emily A. Kuhl, Samuel F. Sears, Charles T. Klodell, Jamie B. Conti. (2006) Device Implant Technique and Consideration of Body Image: Specific Procedures for Implantable Cardioverter Defibrillators in Female Patients. Journal of Women's Health 15:7, 830-835
CrossRef391
Mitesh S. Amin, Kenneth A. Ellenbogen. (2006) Focus on management of pacemaker and ICD advisories, recalls, and alerts. Current Treatment Options in Cardiovascular Medicine 8:5, 347-352
CrossRef392
Claudia Ypenburg, Lieselot van Erven, Gabe B. Bleeker, Jeroen J. Bax, Marianne Bootsma, Maurits C. Wijffels, Ernst E. van der Wall, Martin J. Schalij. (2006) Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias. Journal of the American College of Cardiology 48:3, 464-470
CrossRef393
N. A. MARK ESTES. (2006) Discrimination When Dual-Chamber Termination Fails: A New Paradigm for ICDs?. Journal of Cardiovascular Electrophysiology 17:7, 702-704
CrossRef394
SAMIR SABA, LINDA BAKER, LEONARD GANZ, WILLIAM BARRINGTON, SANDEEP JAIN, OGUNDU NGWU, JILL CHRISTENSEN, MARK BROWN. (2006) Simultaneous Atrial and Ventricular Anti-Tachycardia Pacing as a Novel Method of Rhythm Discrimination. Journal of Cardiovascular Electrophysiology 17:7, 695-701
CrossRef395
Eric J. Rashba, Stephen R. Shorofsky, Avram Scheiner, Robert W. Peters, Carol Ma, Michael R. Gold. (2006) Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm 3:6, 647-652
CrossRef396
Robert G. Hauser, David L. Hayes, Andrew E. Epstein, David S. Cannom, Stephen C. Vlay, Susan L. Song, G. Frank O. Tyers. (2006) Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm 3:6, 640-644
CrossRef397
Jack Zwanziger, W. Jackson Hall, Andrew W. Dick, Hongwei Zhao, Alvin I. Mushlin, Rebecca Marron Hahn, Hongkun Wang, Mark L. Andrews, Cathleen Mooney, Hongyue Wang, Arthur J. Moss. (2006) The Cost Effectiveness of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:11, 2310-2318
CrossRef398
P. Gil, M. L. Fernandez Guerrero, J. F. Bayona, J. M. Rubio, M. de Gorgolas, J. J. Granizo, J. Farre. (2006) Infections of implantable cardioverter-defibrillators: frequency, predisposing factors and clinical significance. Clinical Microbiology and Infection 12:6, 533-537
CrossRef399
Oscar Bernal, Concepción Moro. (2006) Arritmias cardiacas en la mujer. Revista Española de Cardiología 59:6, 609-618
CrossRef400
Adrienne H. Kovacs, Suzannef Eigofsky, J. Sean Goff, Arwa S. Saidi, Anne B. Curtis, Jamie B. Conti, Samuel F. Sears. (2006) Implantable cardioverter defibrillator implant-explant-implant case study: Addressing the psychological adjustment to multiple shocks. Clinical Cardiology 29:6, 274-276
CrossRef401
Fred Kusumoto, Nora Goldschlager. (2006) Implantable cardiac arrhythmia devices-Part II: Implantable cardioverter defibrillators and implantable loop recorders. Clinical Cardiology 29:6, 237-242
CrossRef402
Sheharyar Ali, Eduardo S. Antezano. (2006) Sudden Cardiac Death. Southern Medical Journal 99:5, 502-510
CrossRef403
E. M. L. Wong, E. B. Wu, W. W. M. Chan, C. M. Yu. (2006) A review of the management of patients after percutaneous coronary intervention. International Journal of Clinical Practice 60:5, 582-589
CrossRef404
MICHAEL H. LEHMANN, KEITH D. AARONSON. (2006) CRT-D Therapy in Heart Failure: How Much Do NYHA Class IV Patients Benefit?. Journal of Cardiovascular Electrophysiology 17:5, 491-494
CrossRef405
Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, W. Jackson Hall, Mark L. Andrews, David J. Wilber, Helmut U. Klein. (2006) Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology 47:9, 1811-1817
CrossRef406
Bradley J. Roth. 2006. Defibrillators. .
CrossRef407
Kevin J. Makati, Airley E. Fish, Hannah H. England, Hocine Tighiouart, N.A. Mark Estes, Mark S. Link. (2006) Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more. Heart Rhythm 3:4, 397-403
CrossRef408
H.-J. Trappe. (2006) New perspectices in arrhythmia and heart failure monitoring. Clinical Research in Cardiology 95:S3, iii1-iii2
CrossRef409
Stephen Hammill, Steve Phurrough, Ralph Brindis. (2006) The National ICD Registry: Now and into the future. Heart Rhythm 3:4, 470-473
CrossRef410
Gastone Sabbadini, Marco Metra, Andrea Di Lenarda, Savina Nodari, Gianfranco Sinagra, Livio Dei Cas. (2006) Managing heart failure in the very old. Aging Health 2:2, 253-275
CrossRef411
David A. Cesario, G. William Dec. (2006) Implantable Cardioverter- Defibrillator Therapy in Clinical Practice. Journal of the American College of Cardiology 47:8, 1507-1517
CrossRef412
J. Herlitz, M. Castren, H. Friberg, J. Nolan, M. Skrifvars, K. Sunde, P.-A. Steen. (2006) Post resuscitation care. Resuscitation 69:1, 15-22
CrossRef413
Lars Eckardt, Günter Breithardt. (2006) Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?. Heart Rhythm 3:4, 484-487
CrossRef414
C. Perings, T. Korte, H.-J. Trappe, . (2006) IEGM-online based evaluation of implantable cardioverter defibrillator therapy appropriateness. Clinical Research in Cardiology 95:S3, iii22-iii28
CrossRef415
James D. Allred, Andrew E. Epstein, Raymond E. Ideker. (2006) The Sign of Four and the SDNN of one of three. Heart Rhythm 3:3, 287-289
CrossRef416
Michael O. Sweeney. 2006. Cardiac Resynchronization Therapy. , 259-300.
CrossRef417
Genevieve Smith, Sandra B. Dunbar, Amy L. Valderrama, Bindu Viswanathan. (2006) Gender Differences in Implantable Cardioverter-Defibrillator Patients at the Time of Insertion. Progress in Cardiovascular Nursing 21:2, 76-82
CrossRef418
Eric C. Stecker, Catherine Vickers, Justin Waltz, Carmen Socoteanu, Benjamin T. John, Ronald Mariani, John H. McAnulty, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2006) Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction. Journal of the American College of Cardiology 47:6, 1161-1166
CrossRef419
Darren Traub, Leonard Ganz. (2006) Implantable Cardioverter-Defibrillators for Secondary Prevention: Is It Worth It in the Elderly?. The American Journal of Geriatric Cardiology 15:2, 93-101
CrossRef420
Usha B. Tedrow, William G. Stevenson. 2006. Management of Ventricular Arrhythmias in Heart Failure. , 183-202.
CrossRef421
Per Otto Schueller, Marcus Guenter Hennersdorf, Bodo Eckehard Strauer. (2006) Sudden death is associated with a widened paced QRS complex in noncoronary cardiac disease. Journal of Interventional Cardiac Electrophysiology 15:2, 125-130
CrossRef422
F. T. Wegener, G. C. Grönefeld, G. Duray, J. R. Ehrlich, S. H. Hohnloser. (2006) Pharmakotherapie der ventrikulären Rhythmusstörungen. Der Internist 47:3, 297-307
CrossRef423
Claudia Martinez, Assaf Tzur, Hakop Hrachian, Joseph Zebede, Gervasio A. Lamas. (2006) Pacemakers and Defibrillators: Recent and Ongoing Studies That Impact the Elderly. The American Journal of Geriatric Cardiology 15:2, 82-87
CrossRef424
Robert D Winslow, Sean Pinney, Valentin Fuster. (2006) Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure. Nature Clinical Practice Cardiovascular Medicine 3:2, 86-93
CrossRef425
Bruce D. Gunderson, Jeffrey M. Gillberg, Mark A. Wood, Pugazhendhi Vijayaraman, Richard K. Shepard, Kenneth A. Ellenbogen. (2006) Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Heart Rhythm 3:2, 155-162
CrossRef426
Luis A. Pires. (2006) Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy. Current Opinion in Anaesthesiology 19:1, 69-74
CrossRef427
WOJCIECH ZAREBA, ARTHUR J. MOSS, W. JACKSON HALL, DAVID J. WILBER, JEREMY N. RUSKIN, SCOTT MCNITT, MARY BROWN, HONGYUE WANG, . (2006) Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular Dysfunction. Journal of Cardiovascular Electrophysiology 0:0, 060118052427054
CrossRef428
Margaret C. Herbst, William E. Sanders. 2006. Marcapasos y desfibriladores cardíacos. , 248-255.
CrossRef429
Hiroshi Watanabe, Masaomi Chinushi, Daisuke Izumi, Akinori Sato, Shinsuke Okada, Kazuki Okamura, Satoru Komura, Yukio Hosaka, Hiroshi Furushima, Takashi Washizuka, Yoshifusa Aizawa. (2006) Decrease in Amplitude of Intracardiac Ventricular Electrogram and Inappropriate Therapy in Patients With an Implantable Cardioverter Defibrillator. International Heart Journal 47:3, 363-370
CrossRef430
Hiroshi Watanabe, Masaomi Chinushi, Takashi Washizuka, Hirotaka Sugiura, Takashi Hirono, Yoshiyasu Aizawa, Satoru Komura, Yukio Hosaka, Yasutaka Tanabe, Hiroshi Furushima, Yoshifusa Aizawa. (2006) Comparison of Efficacy of Sotalol and Nifekalant for Ventricular Tachyarrhythmias. Circulation Journal 70:5, 583-587
CrossRef431
Ivan C.K. Ho, Jonathan J. Passeri, Mary L. Guy, Jeremy N. Ruskin, Patrick T. Ellinor. (2006) Impact of the Multicenter Automatic Defibrillator Implantation Trial on Clinical Practice. Annals of Noninvasive Electrocardiology 11:1, 20-27
CrossRef432
CHARLES D. SWERDLOW, PAUL A. FRIEDMAN. (2006) Advanced ICD Troubleshooting: Part II. Pacing and Clinical Electrophysiology 29:1, 70-96
CrossRef433
Daniel M. Bloomfield, J. Thomas Bigger, Richard C. Steinman, Pearila B. Namerow, Michael K. Parides, Anne B. Curtis, Elizabeth S. Kaufman, Jorge M. Davidenko, Timothy S. Shinn, John M. Fontaine. (2006) Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 47:2, 456-463
CrossRef434
HIROSHI KASANUKI. (2006) Present status and prospect of non-pharmacotherapy of arrhythmia.. Nihon Naika Gakkai Zasshi 95:9, 1912-1921
CrossRef435
Stephen Minor, Toshio Akiyama. (2006) Ventricular Arrhythmias in the Elderly. Journal of Arrhythmia 22:1, 19-30
CrossRef436
Masaru Yuge, Shinichi Niwano, Masahiko Moriguchi, Takeshi Sasaki, Shoji Hirasawa, Ryuta Imaki, Daisuke Sato, Tohru Izumi. (2006) Clinical Significance of the Electrophysiologic Study (EPS)-Guided Therapy for the Secondary Prevention of Ventricular Tachycardia. Circulation Journal 70:3, 268-272
CrossRef437
Kathryn A. Glatter, J. Nilas Young, Matthew D. McElvany. (2006) Implantable Cardioverter?Defibrillators: A New Preventive Medical Option. Preventive Cardiology 9:1, 49-55
CrossRef438
J. Malcolm O. Arnold, Peter Liu, Catherine Demers, Paul Dorian, Nadia Giannetti, Haissam Haddad, George A. Heckman, Jonathan G. Howlett, Andrew Ignaszewski, David E. Johnstone, Philip Jong, Robert S. McKelvie, Gordon W. Moe, John D. Parker, Vivek Rao, Heather J. Ross, Errol J. Sequeira, Anna M. Svendsen, Koon Teo, Ross T. Tsuyuki, Michel White. (2006) Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology 22:1, 23-45
CrossRef439
Satoko Kitamura, Kazuhiro Satomi, Takashi Kurita, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Kazuo Niwaya, Junjiro Kobayashi, Shiro Kamakura. (2006) Long-Term Follow-up of Transvenous Defibrillation Leads. Circulation Journal 70:3, 273-277
CrossRef440
Germanas Marinskis, Audrius Aidietis. (2006) Advances in nonpharmacologic therapies for ventricular arrhythmias. Therapy 3:1, 125-138
CrossRef441
Richard G. Sheahan. 2006. Taquicardia ventricular. , 196-204.
CrossRef442
Remzi Karaoguz, Sevgül Maydanozcu, Timuçin Altun, Muharrem Güldal, Ömer Akyürek, Çetin Erol. (2006) Appropriate ICD Therapy in Patients With Idiopathic Dilated Cardiomyopathy. International Heart Journal 47:5, 763-773
CrossRef443
WOJCIECH ZAREBA, ARTHUR J. MOSS, W. JACKSON HALL, DAVID J. WILBER, JEREMY N. RUSKIN, SCOTT MCNITT, MARY BROWN, HONGYUE WANG, . (2005) Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular Dysfunction. Journal of Cardiovascular Electrophysiology 16:12, 1265-1270
CrossRef444
Angel R. León, William T. Abraham, Anne B. Curtis, James P. Daubert, Westby G. Fisher, John Gurley, David L. Hayes, Randy Lieberman, Susan Petersen-Stejskal, Kevin Wheelan. (2005) Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 46:12, 2348-2356
CrossRef445
Gabor Duray, Sergio Richter, Johannes Manegold, Carsten W. Israel, Gerian Grönefeld, Stefan H. Hohnloser. (2005) Efficacy and Safety of ICD Therapy in a Population of Elderly Patients Treated with Optimal Background Medication. Journal of Interventional Cardiac Electrophysiology 14:3, 169-173
CrossRef446
Rafael Peinado, Ángel Arenal, Fernando Arribas, Esteban Torrecilla, Miguel Álvarez, José M. Ormaetxe, Nicasio Pérez-Castellano. (2005) Registro Español de Desfibrilador Automático Implantable. Primer Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (años 2002-2004). Revista Española de Cardiología 58:12, 1435-1449
CrossRef447
Gerald V. Naccarelli. (2005) Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices. Clinical Cardiology 28:S1, 51-57
CrossRef448
NICHOLAS S. PETERS. (2005) Arrhythmias After Cell Transplantation for Myocardial Regeneration: Natural History or Result of the Intervention?. Journal of Cardiovascular Electrophysiology 16:11, 1255-1257
CrossRef449
Eric N. Prystowsky. (2005) Prevention of sudden cardiac death. Clinical Cardiology 28:S1, 12-18
CrossRef450
JAMES S. KALUS, C. MICHAEL WHITE, MICHAEL F. CARON, DANETTE GUERTIN, BRIAN F. MCBRIDE, JEFFREY KLUGER. (2005) The Impact of Catecholamines on Defibrillation Threshold in Patients with Implanted Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 28:11, 1147-1156
CrossRef451
Sanders, Gillian D., Hlatky, Mark A., Owens, Douglas K., . (2005) Cost-Effectiveness of Implantable Cardioverter–Defibrillators. New England Journal of Medicine 353:14, 1471-1480
Full Text452
R. Matía Francés, V. Suberviola Sánchez-Caballero, I. Sánchez Pérez, C. Sáenz de la Calzada Campos. (2005) Tratamiento de las complicaciones del infarto de miocardio. Medicine - Programa de Formación Médica Continuada Acreditado 9:40, 2671-2681
CrossRef453
Juan Fernández-Yáñez, Jesús Palomo, Esteban G. Torrecilla, David Pascual, Gregorio Garrido, José J. Gómez de Diego, Marta Domínguez, Jesús Almendral. (2005) Pronóstico de una población inicialmente candidata a trasplante cardíaco controlada con tratamiento médico. Revista Española de Cardiología 58:10, 1162-1170
CrossRef454
Sergio Dubner, Elina Valero, Ricardo Pesce, Jorge Gonzalez Zuelgaray, Jose C. Pachon Mateos, Silas Galvao Filho, Walter Reyes, Raul Garillo, . (2005) A Latin American Registry of Implantable Cardioverter Defibrillators: The ICD-LABOR Study. Annals of Noninvasive Electrocardiology 10:4, 420-428
CrossRef455
Vinod Jayam, Menekhem Zviman, Venku Jayanti, Ariel Roguin, Henry Halperin, Ronald D. Berger. (2005) Internal defibrillation with minimal skeletal muscle activation: A new paradigm toward painless defibrillation. Heart Rhythm 2:10, 1108-1113
CrossRef456
PHILIPPINE KIES, ERIC BOERSMA, JEROEN J. BAX, ALIDA E. BORGER van der BURG, MARIANNE BOOTSMA, LIESELOT van ERVEN, ERNST E. van der WALL, MARTIN J. SCHALIJ. (2005) Determinants of Recurrent Ventricular Arrhythmia or Death in 300 Consecutive Patients with Ischemic Heart Disease Who Experienced Aborted Sudden Death: Data from the Leiden Out-of-Hospital Cardiac Arrest Study. Journal of Cardiovascular Electrophysiology 16:10, 1049-1056
CrossRef457
Sana M. Al-Khatib, F. Lee Lucas, James G. Jollis, David J. Malenka, David E. Wennberg. (2005) The Relation Between Patients’ Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries. Journal of the American College of Cardiology 46:8, 1536-1540
CrossRef458
Loren D. Berenbom, Brian C. Weiford, James L. Vacek, Martin P. Emert, W. Jackson Hall, Mark L. Andrews, Scott McNitt, Wojciech Zareba, Arthur J. Moss, . (2005) Differences in Outcomes Between Patients Treated with Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: A Substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Annals of Noninvasive Electrocardiology 10:4, 429-435
CrossRef459
Jennifer S. Davids, Craig A. McPherson, Christine Earley, William P. Batsford, Rachel Lampert. (2005) Benefits of Cardiac Rehabilitation in Patients With Implantable Cardioverter-Defibrillators: A Patient Survey. Archives of Physical Medicine and Rehabilitation 86:10, 1924-1928
CrossRef460
Ilan Goldenberg, Arthur J. Moss, Barry J. Maron, Andrew W. Dick, Wojciech Zareba. (2005) Cost-Effectiveness of Implanted Defibrillators in Young People with Inherited Cardiac Arrhythmias. Annals of Noninvasive Electrocardiology 10:s4, 67-83
CrossRef461
R. Gradaus, L. Eckardt, H. Wedekind, A. Löher, D. Böcker. (2005) Transvenous ICD implantation after artificial tricuspid valve replacement. Zeitschrift für Kardiologie 94:9, 588-591
CrossRef462
GEORGE J. KLEIN, ANDREW D. KRAHN, ALLAN C. SKANES, RAYMOND YEE, LORNE J. GULA. (2005) Primary Prophylaxis of Sudden Death in Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, and Dilated Cardiomyopathy. Journal of Cardiovascular Electrophysiology 16:s1, S28-S34
CrossRef463
Zachary Goldberger, Brian Elbel, Craig A. McPherson, A. David Paltiel, Rachel Lampert. (2005) Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation. Journal of the American College of Cardiology 46:5, 850-857
CrossRef464
Anand Soni, Paul LeLorier. (2005) Sudden death in nondilated cardiomyopathies: Pathophysiology and prevention. Current Heart Failure Reports 2:3, 118-123
CrossRef465
CRAIG J. McCOTTER, J. FRITZ ANGLE, LIZA A. PRUDENTE, J. PAUL MOUNSEY, JOHN D. FERGUSON, JOHN P. DiMARCO, JAMES P. HUMMEL, J. MICHAEL MANGRUM. (2005) Placement of Transvenous Pacemaker and ICD Leads Across Total Chronic Occlusions. Pacing and Clinical Electrophysiology 28:9, 921-925
CrossRef466
JONATHAN A. DREZNER, KENNETH J. ROGERS, ROSS R. ZIMMER, BRIAN J. SENNETT. (2005) Use of Automated External Defibrillators at NCAA Division I Universities. Medicine & Science in Sports & Exercise 37:9, 1487-1492
CrossRef467
Matthew W. Ebinger, Subramaniam Krishnan, Claudio D. Schuger. (2005) Mechanisms of ventricular arrhythmias in heart failure. Current Heart Failure Reports 2:3, 111-117
CrossRef468
Prash Jayaraj, Kevin M. Monahan. (2005) Sudden cardiac death and the role of device therapy in dilated cardiomyopathy. Current Heart Failure Reports 2:3, 124-127
CrossRef469
(2005) Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005). Revista Española de Cardiología 58:9, 1062-1092
CrossRef470
DAVID S. CANNOM. (2005) Prevention of Sudden Cardiac Death. Journal of Cardiovascular Electrophysiology 16:s1, S21-S24
CrossRef471
PETER ALTER, STEFAN WALDHANS, EVELINE PLACHTA, RAINER MOOSDORF, WOLFRAM GRIMM. (2005) Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients. Pacing and Clinical Electrophysiology 28:9, 926-932
CrossRef472
Wataru Shimizu, Kazuhiro Satomi. (2005) Implications and problems of the Sudden Cardiac Death in Heart Failure Trial. Future Cardiology 1:5, 599-603
CrossRef473
Jonathan A. Leighton, Komandoor Srivathsan, Elizabeth J. Carey, Virender K. Sharma, Russell I. Heigh, Janice K. Post, Paula J. Erickson, Sarah R. Robinson, Jane L. Bazzell, David E. Fleischer. (2005) Safety of Wireless Capsule Endoscopy in Patients with Implantable Cardiac Defibrillators. The American Journal of Gastroenterology 100:8, 1728-1731
CrossRef474
U. C. Hoppe, M. Böhm, R. Dietz, P. Hanrath, H. K. Kroemer, A. Osterspey, A. A. Schmaltz, E. Erdmann. (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Zeitschrift für Kardiologie 94:8, 488-509
CrossRef475
Arjun D. Sharma, Carlos Rizo-Patron, Alfred P. Hallstrom, Gearoid P. O’Neill, Stephen Rothbart, James B. Martins, Marc Roelke, Jonathan S. Steinberg, H. Leon Greene. (2005) Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2:8, 830-834
CrossRef476
CHARLES A HERZOG, SHULING LI, ERIC D WEINHANDL, JEREMY W STRIEF, ALLAN J COLLINS, DAVID T GILBERTSON. (2005) Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney International 68:2, 818-825
CrossRef477
Daniel J. Garry, Sean C. Goetsch, Amanda J. McGrath, Pradeep P.A. Mammen. (2005) Alternative Therapies for Orthotopic Heart Transplantation. The American Journal of the Medical Sciences 330:2, 88-101
CrossRef478
ANDREW T. HO, SUDHA M. PAI, PAM TIMOTHY, RAMDAS G. PAI. (2005) Effect of Concomitant Antiarrhythmic Therapy on Survival in Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 28:7, 647-653
CrossRef479
Joseph J. Schwerha. (2005) Occupational Medicine Forum. Journal of Occupational and Environmental Medicine 47:7, 752-755
CrossRef480
C. Richard Conti. (2005) Ventricular arrhythmias: A general cardiologist's assessment of therapies in 2005. Clinical Cardiology 28:7, 314-316
CrossRef481
Robert D Winslow, Davendra Mehta, Valentin Fuster. (2005) Sudden cardiac death: mechanisms, therapies and challenges. Nature Clinical Practice Cardiovascular Medicine 2:7, 352-360
CrossRef482
Alfred E. Buxton, Michael O. Sweeney, Mark S. Wathen, Mark E. Josephson, Mary F. Otterness, Elaine Hogan-Miller, Alice J. Stark, Paul J. DeGroot. (2005) QRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators. Journal of the American College of Cardiology 46:2, 310-316
CrossRef483
M.C. Viana Llamas, A. Hernández Madrid, C. Moro Serrano. (2005) Tratamiento de las taquiarritmias por métodos no farmacológicos. Técnicas de ablación. Desfibriladores. Medicine - Programa de Formación Médica Continuada Acreditado 9:36, 2391-2399
CrossRef484
J.Á. Rodríguez Fernández, I.P. Garrido Bravo, L.F. Hermida Álvarez, A. Castro Beiras. (2005) Insuficiencia cardíaca crónica. Etiología, manifestaciones clínicas y criterios diagnósticos. Medicine - Programa de Formación Médica Continuada Acreditado 9:35, 2300-2307
CrossRef485
Robert G. Hauser. (2005) The Growing Mismatch Between Patient Longevity and the Service Life of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 45:12, 2022-2025
CrossRef486
I.P. Garrido Bravo, J.Á. Rodríguez Fernández, J. García de Lara, A. Castro Beiras. (2005) Tratamiento de la insuficiencia cardíaca crónica. Medicine - Programa de Formación Médica Continuada Acreditado 9:35, 2318-2326
CrossRef487
T. Jared Bunch, Stephen C. Hammill, Roger D. White. (2005) Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival. Mayo Clinic Proceedings 80:6, 774-782
CrossRef488
Mahi Lakshmi Ashwath, Felix O. Sogade. (2005) Ejection Fraction and QRS Width as Predictors of Event Rates in Patients with Implantable Cardioverter Defibrillators. Southern Medical Journal 98:5, 513-517
CrossRef489
Domenic A. Sica, Mark Wood, Michael Hess. (2005) Gender and Its Effect in Cardiovascular Pharmacotherapeutics: Recent Considerations. Congestive Heart Failure 11:3, 163-166
CrossRef490
Aslan T. Turer, Sunil V. Rao. (2005) Device Therapy in the Management of Congestive Heart Failure. Cardiology in Review 13:3, 130-138
CrossRef491
Paul S. Chan, Rodney A. Hayward. (2005) Mortality Reduction by Implantable Cardioverter-Defibrillators in High-Risk Patients With Heart Failure, Ischemic Heart Disease, and New-Onset Ventricular Arrhythmia. Journal of the American College of Cardiology 45:9, 1474-1481
CrossRef492
MICHAEL O. SWEENEY. (2005) The Nature of the Game. Journal of Cardiovascular Electrophysiology 16:5, 483-485
CrossRef493
Eric M. Crespo, Jane Kim, Kimberly A. Selzman. (2005) The Use of Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: A Review of the Evidence and Implications. The American Journal of the Medical Sciences 329:5, 238-246
CrossRef494
Oliver R. Segal, Anthony W.C. Chow, Vias Markides, Richard J. Schilling, Nicholas S. Peters, D. Wyn Davies. (2005) Long-term results after ablation of infarct-related ventricular tachycardia. Heart Rhythm 2:5, 474-482
CrossRef495
ULRICH BACKENKOHLER, ALI ERDOGAN, MARY-KAY STEEN-MUELLER, CHRISTOPH KUHLMANN, ASTRID MOST, CHRISTIAN SCHAEFER, WILHELM STERTMANN, WOLFGANG WAAS, HARALD TILLMANNS, BERND WALDECKER. (2005) Long-Term Incidence of Malignant Ventricular Arrhythmia and Shock Therapy in Patients with Primary Defibrillator Implantation Does Not Differ from Event Rates in Patients Treated for Survived Cardiac Arrest. Journal of Cardiovascular Electrophysiology 16:5, 478-482
CrossRef496
R. Sukhija, W. S. Aronow, C. Sorbera, K. Yalamanchili, M. Cohen. (2005) Patients, Mean Age 70 Years, With Automatic Implantable Cardioverter-Defibrillators Treated With Dual-Chamber Rate Responsive Pacing (DDDR-70) Have a Higher Mortality Than Patients With Backup Ventricular Pacing (VVI-40) at 3.7-Year Follow-Up. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:5, 603-604
CrossRef497
Andrea M. Russo, William Sauer, Edward P. Gerstenfeld, Henry H. Hsia, David Lin, Joshua M. Cooper, Sanjay Dixit, Ralph J. Verdino, Hemal M. Nayak, David J. Callans, Vickas Patel, Francis E. Marchlinski. (2005) Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm 2:5, 456-461
CrossRef498
Anne B Curtis. (2005) Do implantable cardioverter-defibrillators benefit patients immediately after acute myocardial infarction?. Nature Clinical Practice Cardiovascular Medicine 2:4, 192-193
CrossRef499
(2005) K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. American Journal of Kidney Diseases 45, 16-153
CrossRef500
HIROSHI WATANABE, MASAOMI CHINUSHI, TAKASHI WASHIZUKA, HIROTAKA SUGIURA, TAKASHI HIRONO, SATORU KOMURA, YUKIO HOSAKA, YASUTAKA TANABE, HIROSHI FURUSHIMA, SATOSHI FUJITA, KIMINORI KATO, YOSHIFUSA AIZAWA. (2005) Electrophysiologic Study-Guided Therapy with Sotalol for Life-Threatening Ventricular Tachyarrhythmias. Pacing and Clinical Electrophysiology 28:4, 285-290
CrossRef501
Peter Cram, Sandeep Vijan, David Katz, A. Mark Fendrick. (2005) Cost-effectiveness of In-home Automated External Defibrillators for Individuals at Increased Risk of Sudden Cardiac Death. There's No Place Like Home?. Journal of General Internal Medicine 20:3, 251-258
CrossRef502
William H Maisel. (2005) Cardiovascular Device Development: Lessons Learned from Pacemaker and Implantable Cardioverter-Defibrillator Therapy. American Journal of Therapeutics 12:2, 183-185
CrossRef503
MICHAEL O. SWEENEY, MARK H. SCHOENFELD, DAVID S. CANNOM. (2005) Rules of Evidence:. CMS and Primary Prevention of Sudden Cardiac Death in Systolic Heart Failure. Pacing and Clinical Electrophysiology 28:2, 81-88
CrossRef504
Kathy A. Hodgkinson, Patrick S. Parfrey, Anne S. Bassett, Christine Kupprion, Jörg Drenckhahn, Mark W. Norman, Ludwig Thierfelder, Susan N. Stuckless, Elizabeth L. Dicks, William J. McKenna, Sean P. Connors. (2005) The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). Journal of the American College of Cardiology 45:3, 400-408
CrossRef505
M.J. Reed, C.E. Robertson, P.S. Addison. (2005) Heart rate variability measurements and the prediction of ventricular arrhythmias. QJM 98:2, 87-95
CrossRef506
Beena B Johnson, Johnson Francis, Beena B Johnson. 2005. Cognitive behavourial therapy for patients with implantable cardioverter-defibrillators. .
CrossRef507
Bardy, Gust H., Lee, Kerry L., Mark, Daniel B., Poole, Jeanne E., Packer, Douglas L., Boineau, Robin, Domanski, Michael, Troutman, Charles, Anderson, Jill, Johnson, George, McNulty, Steven E., Clapp-Channing, Nancy, Davidson-Ray, Linda D., Fraulo, Elizabeth S., Fishbein, Daniel P., Luceri, Richard M., Ip, John H., . (2005) Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure. New England Journal of Medicine 352:3, 225-237
Full Text508
Takashi Washizuka, Masaomi Chinushi, Hiroshi Watanabe, Yukio Hosaka, Satoru Komura, Hirotaka Sugiura, Takashi Hirono, Hiroshi Furushima, Yasutaka Tanabe, Yoshifusa Aizawa. (2005) Nifekalant Hydrochloride Suppresses Severe Electrical Storm in Patients With Malignant Ventricular Tachyarrhythmias. Circulation Journal 69:12, 1508-1513
CrossRef509
Antoni Martínez-Rubio, Gabriel Gusi, Eva Guillaumet, Montse Cazorla, Sonia Galán, Rosa Bagà, Elena Guilera, Manel Bonastre, Joan Raimón Gumà, Ignaci Anguera, Sonia Ibars, Ana Ochagavia, Jaume Mestre, Juli Font, Pilar Saura, Martí Dalmases, Lluís Blanch, Antoni Artigas. (2005) The fully automatic external cardioverter defibrillator: reality of a new meaningful scenario for in-hospital cardiac arrests. Expert Review of Medical Devices 2:1, 33-39
CrossRef510
C. Leclercq. (2005) La resynchronisation cardiaque : quel type d’appareil utiliser ?. Annales de Cardiologie et d'Angéiologie 54:1, 12-16
CrossRef511
Sanjeev Saksena. (2005) Federal Guidelines for Prophylactic ICD Therapy in High Risk Populations for Sudden Cardiac Death: Is this a Necessary Course Correction?. Journal of Interventional Cardiac Electrophysiology 12:1, 5-7
CrossRef512
Takashi Washizuka, Masaomi Chinushi, Ryu Kazama, Takashi Hirono, Hiroshi Watanabe, Satoru Komura, Hirotaka Sugiura, Yasutaka Tanabe, Hiroshi Furushima, Satoru Fujita, Yuji Okura, Yoshifusa Aizawa. (2005) Inappropriate Discharges of Intravenous Implantable Cardioverter Defibrillators Owing to Lead Failure. International Heart Journal 46:5, 909-913
CrossRef513
Eric J. Rashba, Stephen R. Shorofsky, Traci Brown, Robert W. Peters, Michael R. Gold. (2005) Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm 2:1, 49-54
CrossRef514
Kärstin Bolse, Glenys Hamilton, Jane Flanagan, Diane L. Caroll, Bengt Fridlund. (2005) Ways of Experiencing the Life Situation Among United States Patients With an Implantable Cardioverter-Defibrillator: A Qualitative Study. Progress in Cardiovascular Nursing 20:1, 4-10
CrossRef515
Peter W. Groeneveld, Paul A. Heidenreich, Alan M. Garber. (2005) Trends in implantable cardioverter-defibrillator racial disparity. Journal of the American College of Cardiology 45:1, 72-78
CrossRef516
Kevin J. Ferrick. (2005) Antiarrhythmic Therapy in Elderly Persons: A Device-Based Approach. The American Journal of Geriatric Cardiology 14:1, 10-15
CrossRef517
Dominic A.M.J. Theuns, A. Peter J. Klootwijk, Dick M. Goedhart, Luc J.L.M. Jordaens. (2004) Prevention of inappropriate therapy in implantable cardioverter-defibrillators. Journal of the American College of Cardiology 44:12, 2362-2367
CrossRef518
David Rosenthal, Maryanne R.K. Chrisant, Erik Edens, Lynn Mahony, Charles Canter, Steven Colan, Anne Dubin, Jacque Lamour, Robert Ross, Robert Shaddy, Linda Addonizio, Lee Beerman, Stuart Berger, Daniel Bernstein, Elizabeth Blume, Mark Boucek, Paul Checchia, Anne Dipchand, Jonathan Drummond-Webb, Jay Fricker, Richard Friedman, Sara Hallowell, Robert Jaquiss, Seema Mital, Elfriede Pahl, Bennett Pearce, Larry Rhodes, Kathy Rotondo, Paolo Rusconi, Janet Scheel, Tajinder Pal Singh, Jeffrey Towbin. (2004) International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. The Journal of Heart and Lung Transplantation 23:12, 1313-1333
CrossRef519
Wojciech Zareba. (2004) Implantable cardioverter defibrillator therapy in postinfarction patients. Current Opinion in Cardiology 19:6, 619-624
CrossRef520
Helen CM Kamphuis, Nicole WJM Verhoeven, Rob Leeuw, Richard Derksen, Richard NW Hauer, Jacques AM Winnubst. (2004) ICD: a qualitative study of patient experience the first year after implantation. Journal of Clinical Nursing 13:8, 1008-1016
CrossRef521
Hanne Elming, Bente Brendorp, Steen Pehrson, Ole Dyg Pedersen, Lars Køber, Christian Torp-Petersen. (2004) A benefit–risk assessment of class III antiarrhythmic agents. Expert Opinion on Drug Safety 3:6, 559-577
CrossRef522
Peter A McCullough. (2004) Cardiovascular disease in chronic kidney disease from a cardiologistʼs perspective. Current Opinion in Nephrology and Hypertension 13:6, 591-600
CrossRef523
Bruce D. Gunderson, Amisha S. Patel, Chad A. Bounds, Richard K. Shepard, Mark A. Wood, Kenneth A. Ellenbogen. (2004) An algorithm to predict implantable cardioverter-defibrillator lead failure. Journal of the American College of Cardiology 44:9, 1898-1902
CrossRef524
D.George Wyse, April Slee, Andrew E. Epstein, Bernard J. Gersh, Thomas Rocco, Humberto Vidaillet, Annabelle Volgman, Robert Weiss, Lynn Shemanski, H.Leon Greene. (2004) Alternative endpoints for mortality in studies of patients with atrial fibrillation: The AFFIRM study experience. Heart Rhythm 1:5, 531-537
CrossRef525
W. S. Aronow. (2004) Management of the Elderly Person After Myocardial Infarction. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:11, 1173-1185
CrossRef526
Paul Dorian, François Philippon, Bernard Thibault, Shane Kimber, Larry Sterns, Mary Greene, David Newman, Robert Gelaznikas, Aiala Barr. (2004) Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 1:5, 540-547
CrossRef527
KLAUS KETTERING, CHRISTIAN MEWIS, VOLKER DORNBERGER, REINHARD VONTHEIN, RALPH F. BOSCH, LUDGER SEIPEL, VOLKER KUHLKAMP. (2004) Long-Term Experience with Subcutaneous ICD Leads:. A Comparison Among Three Different Types of Subcutaneous Leads. Pacing and Clinical Electrophysiology 27:10, 1355-1361
CrossRef528
Richard L. Page, Douglas P. Zipes, Judy L. Powell, Richard M. Luceri, Michael R. Gold, Robert Peters, Andrea M. Russo, J.Thomas Bigger, Ruey J. Sung, Mary Ann McBurnie. (2004) Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry. Heart Rhythm 1:4, 435-440
CrossRef529
MANINDER S. BEDI, LISA A. POSTAVA, SRINIVAS MURALI, GUY A. MACGOWAN, MICHAEL MATHIER, DENNIS M. MCNAMARA, BARRY LONDON. (2004) Interaction of Implantable Defibrillator Therapy with Angiotensin-Converting Enzyme Deletion/Insertion Polymorphism. Journal of Cardiovascular Electrophysiology 15:10, 1162-1166
CrossRef530
Robert G. Hauser, Linda Kallinen. (2004) Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm 1:4, 399-405
CrossRef531
Hein J.J. Wellens. (2004) Cardiac arrhythmias: The quest for a cure. Journal of the American College of Cardiology 44:6, 1155-1163
CrossRef532
Marvin Bacaner, James Brietenbucher, John LaBree. (2004) Prevention of Ventricular Fibrillation, Acute Myocardial Infarction (Myocardial Necrosis), Heart Failure, and Mortality by Bretylium. American Journal of Therapeutics 11:5, 366-411
CrossRef533
Samuel F. Sears, Eva R. Serber, Tara Saia Lewis, Robyn L. Walker, Nancy Conners, John T. Lee, Anne B. Curtis, Jamie B. Conti. (2004) Do Positive Health Expectations and Optimism Relate to Quality-of-Life Outcomes for the Patient With an Implantable Cardioverter Defibrillator?. Journal of Cardiopulmonary Rehabilitation 24:5, 324-331
CrossRef534
Anne B. Curtis, Kenneth A. Ellenbogen, Stephen C. Hammill, David L. Hayes, Dwight W. Reynolds, David J. Wilber, Michael E. Cain. (2004) Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm 1:3, 371-375
CrossRef535
BRUCE L. WILKOFF, MIKE HESS, JAMES YOUNG, WILLIAM T. ABRAHAM. (2004) Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients. Journal of Cardiovascular Electrophysiology 15:9, 1002-1009
CrossRef536
T.Jared Bunch, Roger D. White, Paul A. Friedman, Thomas E. Kottke, Lambert A. Wu, Douglas L. Packer. (2004) Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: A 17-year population-based study. Heart Rhythm 1:3, 255-259
CrossRef537
ANNE B. CURTIS. (2004) Prevention of Sudden Cardiac Death:. When Is a Woman Just Like a Man?. Journal of Cardiovascular Electrophysiology 15:9, 999-1001
CrossRef538
Lydia A. Conlay. (2004) Special Concerns in the Cardiac Catheterization Lab. International Anesthesiology Clinics 41:2, 63-67
CrossRef539
Sri Sundaram, Jeffrey J. Goldberger. (2004) Risk stratification and epidemiology of sudden death. Current Cardiology Reports 6:5, 333-338
CrossRef540
BRIAN F. MCBRIDE, DANETTE GUERTIN, C. MICHAEL WHITE, JEFFREY KLUGER. (2004) Inappropriate Implantable Cardioverter Defibrillator Discharge Following Consumption of a Dietary Weight Loss Supplement. Pacing and Clinical Electrophysiology 27:9, 1317-1320
CrossRef541
Abrar H. Shah, David T. Huang, Spencer Z. Rosero, James P. Daubert. (2004) Update on implantable cardioverter defibrillator trials. Current Cardiology Reports 6:5, 327-332
CrossRef542
HONG GONG, WEIDONG WANG, TAE-HWAN KWON, THOMAS JONASSEN, CHUNLING LI, TROELS RING, JØRGEN FRØKIÆR, SØREN NIELSEN. (2004) EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney International 66:2, 683-695
CrossRef543
Andrew Voigt, Rana Ezzeddine, William Barrington, Ogundu Obiaha-Ngwu, Leonard I. Ganz, Barry London, Samir Saba. (2004) Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. Journal of the American College of Cardiology 44:4, 855-858
CrossRef544
JOHN R. PAISEY, ARTHUR M. YUE, FREDERICK BESSOULE, STUART ALLEN, PAUL R. ROBERTS, JOHN M. MORGAN. (2004) Examination of a Middle Cardiac Vein Defibrillation Coil as Stand-Alone Anode, Auxiliary Anode, and Bystander Electrode in a Transvenous Defibrillation Circuit. Pacing and Clinical Electrophysiology 27:8, 1089-1093
CrossRef545
ANDREW E. EPSTEIN. (2004) Jumping in Before the Water Is Hot:. Journal of Cardiovascular Electrophysiology 15:8, 867-869
CrossRef546
A.P. Hallstrom, P.K. Stein, R. Schneider, M. Hodges, G. Schmidt, K. Ulm. (2004) Structural Relationships Between Measures Based on Heart Beat Intervals: Potential for Improved Risk Assessment. IEEE Transactions on Biomedical Engineering 51:8, 1414-1420
CrossRef547
K BURNEY. (2004) Cardiac pacing systems and implantable cardiac defibrillators (ICDs): a radiological perspective of equipment, anatomy and complications. Clinical Radiology 59:8, 699-708
CrossRef548
THOMAS KORTE, HARALD KODITZ, MICHAEL NIEHAUS, THOMAS PAUL, JURGEN TEBBENJOHANNS. (2004) High Incidence of Appropriate and Inappropriate ICD Therapies in Children and Adolescents with Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:7, 924-932
CrossRef549
Terrence U.H. Chun, Michael R. Epstein, Macdonald Dick, Gregor Andelfinger, Leomar Ballester, Carlos G. Vanoye, Alfred L. George, D.Woodrow Benson. (2004) Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm 1:2, 235-241
CrossRef550
Terrence UH Chun, Kathryn K Collins, Anne M Dubin. (2004) Implantable cardioverter defibrillators in children. Expert Review of Cardiovascular Therapy 2:4, 561-571
CrossRef551
Julia H Indik. (2004) The evolution and revolution of the implantable cardioverter defibrillator. Expert Review of Cardiovascular Therapy 2:4, 461-464
CrossRef552
F. JAMES BRENNAN. (2004) Ethical Issues with Implantable Defibrillators. Pacing and Clinical Electrophysiology 27:7, 897-898
CrossRef553
ROSE M.F.L. SILVA, LLUIS MONT, SANTIAGO NAVA, ULISES ROJEL, MARIONA MATAS, JOSEP BRUGADA. (2004) Radiofrequency Catheter Ablation for Arrhythmic Storm in Patients with An Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:7, 971-975
CrossRef554
S.Adam Strickberger, George J Klein. (2004) Is defibrillation testing required for defibrillator implantation?. Journal of the American College of Cardiology 44:1, 88-91
CrossRef555
Nanette K. Wenger, Gabriel Gregoratos, Dalane W. Kitzman, Stephen Scheidt, Michael A. Weber, Joseph S. Alpert. (2004) Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: Commentary by Editorial Board Members of The American Journal of Geriatric Cardiology. CARDIAC ARRHYTHMIAS. HEART FAILURE. CORONARY ARTERY DISEASE (CHRONIC STABLE ANGINA, ACUTE CORONARY SYNDROME, ACUTE MI). SYSTEMIC ARTERIAL HYPERTENSION. VALVULOPATHIES. CARDIOVASCULAR RISK PREVENTION. The American Journal of Geriatric Cardiology 13:4, 209-209
CrossRef556
Peter A McCullough. (2004) Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease. Advances in Chronic Kidney Disease 11:3, 294-303
CrossRef557
Gerald V Naccarelli. (2004) Implantable cardioverter-defibrillators: expanding indications. Current Opinion in Cardiology 19:4, 317-322
CrossRef558
Frank Godemann, Christian Butter, Felix Lampe, Michael Linden, Michael Schlegl, Hans-Peter Schultheiss, Steffen Behrens. (2004) Panic disorders and agoraphobia: Side effects of treatment with an implantable cardioverter/defibrillator. Clinical Cardiology 27:6, 321-326
CrossRef559
MICHAEL GLIKSON, IGOR LIPCHENCA, SAMI VISKIN, KARLA V. BALLMAN, JANE M. TRUSTY, OSNAT T. GUREVITZ, DAVID M. LURIA, MICHAEL ELDAR, STEPHEN C. HAMMILL, PAUL A. FRIEDMAN. (2004) Long-Term Outcome of Patients Who Received Implantable Cardioverter Defibrillators for Stable Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology 15:6, 658-664
CrossRef560
ANIL-MARTIN SINHA, CHRISTOPH STELLBRINK, ANDREAS SCHUCHERT, BERNHARD MOX, LUC JORDAENS, DOMINIQUE LAMAISON, JASWINDER GILL, ANDREW KAPLAN, BELA MERKELY, . (2004) Clinical Experience with a New Detection Algorithm for Differentiation of Supraventricular from Ventricular Tachycardia in a Dual-Chamber Defibrillator. Journal of Cardiovascular Electrophysiology 15:6, 646-652
CrossRef561
Rachel Lampert, Craig A. McPherson, Jude F. Clancy, Teresa L. Caulin-Glaser, Lynda E. Rosenfeld, William P. Batsford. (2004) Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. Journal of the American College of Cardiology 43:12, 2293-2299
CrossRef562
MARK H. SCHOENFELD, STEVEN J. COMPTON, R. HARDWIN MEAD, DANIEL N. WEISS, LOU SHERFESEE, JENNIFER ENGLUND, LUC R. MONGEON. (2004) Remote Monitoring of Implantable Cardioverter Defibrillators:. A Prospective Analysis. Pacing and Clinical Electrophysiology 27:6p1, 757-763
CrossRef563
Kadish, Alan, Dyer, Alan, Daubert, James P., Quigg, Rebecca, Estes, N.A. Mark, Anderson, Kelley P., Calkins, Hugh, Hoch, David, Goldberger, Jeffrey, Shalaby, Alaa, Sanders, William E., Schaechter, Andi, Levine, Joseph H., . (2004) Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. New England Journal of Medicine 350:21, 2151-2158
Full Text564
Alida E Borger van der Burg, Jeroen J Bax, Eric Boersma, Lieselot van Erven, Marianne Bootsma, Ernst E van der Wall, Martin J Schalij. (2004) Standardized screening and treatment of patients with life-threatening arrhythmias: The leiden out-of-hospital cardiac arrest evaluation study. Heart Rhythm 1:1, 51-57
CrossRef565
Jenny Tagney. (2004) Can nurses in cardiology areas prepare patients for implantable cardioverter defibrillator implant and life at home?. Nursing in Critical Care 9:3, 104-114
CrossRef566
ANTONIS A. ARMOUNDAS, CHRISTINE M. ALBERT, RICHARD J COHEN, THEOFANIE MELA, . (2004) Utility of Implantable Cardioverter Defibrillator Electrograms to Estimate Repolarization Alternans Preceding a Tachyarrhythmic Event. Journal of Cardiovascular Electrophysiology 15:5, 594-597
CrossRef567
Dalip Singh, Lee A Biblo. (2004) The Leiden out-of-hospital cardiac arrest evaluation study (LOHCAT): a useful protocol: a critical process. Heart Rhythm 1:1, 58-59
CrossRef568
T. J. Bunch, R. D. White, B. J. Gersh, W.-K. Shen, S. C. Hammill, D. L. Packer. (2004) Outcomes and In-hospital Treatment of Out-of-Hospital Cardiac Arrest Patients Resuscitated From Ventricular Fibrillation by Early Defibrillation. Mayo Clinic Proceedings 79:5, 613-619
CrossRef569
Chandra Kunavarapu, Daniel M. Bloomfield. (2004) Role of noninvasive studies in risk stratification for sudden cardiac death. Clinical Cardiology 27:4, 192-197
CrossRef570
T. Jared Bunch, Roger D. White, Akbar H. Khan, Douglas L. Packer. (2004) Impact of age on long-term survival and quality of life following out-of-hospital cardiac arrest*. Critical Care Medicine 32:4, 963-967
CrossRef571
WILLIAM H. MAISEL. (2004) Physician Management of Pacemaker and Implantable Cardioverter Defibrillator Advisories. Pacing and Clinical Electrophysiology 27:4, 437-442
CrossRef572
G. G. Urizar. (2004) Psychosocial Intervention for a Geriatric Patient to Address Fears Related to Implantable Cardioverter Defibrillator Discharges. Psychosomatics 45:2, 140-144
CrossRef573
WILLIAM J. GROH, DEEPAK BHAKTA, MIRIAM R. LOWE, SUSAN J. BENNETT. (2004) Come See the Softer Side of Clinical Outcomes:. Journal of Cardiovascular Electrophysiology 15:3, 292-294
CrossRef574
PETER A. NOSEWORTHY, ILAN LASHEVSKY, PAUL DORIAN, MARY GREENE, SUZAN CVITKOVIC, DAVID NEWMAN. (2004) Feasibility of Implantable Cardioverter Defibrillator Use in Elderly Patients:. Pacing and Clinical Electrophysiology 27:3, 373-378
CrossRef575
Robert W. Peters, Michael R. Gold. (2004) The Influence of Gender on Arrhythmias. Cardiology in Review 12:2, 97-105
CrossRef576
RISHI ARORA, ANDREW KRUMMERMAN, PUGAZHENDIHI VIJAYARAMAN, MICHAEL ROSENGARTEN, VANA SURYADEVARA, THIERRY LEJEMTEL, KEVIN J. FERRICK. (2004) Heart Rate Variability and Diastolic Heart Failure. Pacing and Clinical Electrophysiology 27:3, 299-303
CrossRef577
DAVID S. CANNOM, ERIC N. PRYSTOWSKY. (2004) Evolution of the Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 15:3, 375-385
CrossRef578
DAVID S. CANNOM, ERIC N. PRYSTOWSKY. (2004) The Evolution of the Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:3, 419-431
CrossRef579
ERIC J. RASHBA, AHMED F. OSMAN, KAREN MACMURDY, MALCOLM M. KIRK, SAMANTHA E. SARANG, ROBERT W. PETERS, STEPHEN R. SHOROFSKY, MICHAEL R. GOLD. (2004) Enhanced Detection of Arrhythmia Vulnerability Using T Wave Alternans, Left Ventricular Ejection Fraction, and Programmed Ventricular Stimulation:. A Prospective Study in Subjects with Chronic Ischemic Heart Disease. Journal of Cardiovascular Electrophysiology 15:2, 170-176
CrossRef580
Glenys A. Hamilton, Diane L. Carroll. (2004) The effects of age on quality of life in implantable cardioverter defibrillator recipients. Journal of Clinical Nursing 13:2, 194-200
CrossRef581
SHALINI L. KULASINGAM, TOSHIO AKIYAMA, J. PAUL MOUNSEY, ROBERT LEDINGHAM, ALFRED P. HALLSTROM, . (2004) Lower Observed Versus Expected (Based on U.S. Age and Gender Specific Rates) Survival in Patients Treated for Near-Fatal Ventricular Arrhythmias. Pacing and Clinical Electrophysiology 27:2, 230-234
CrossRef582
J. Jason Sims, Michael R. Ujhelyi. (2004) Better Living Through Medical Device Technology. Pharmacotherapy 24:2, 298-306
CrossRef583
PATRICIO A. FRIAS. (2004) Implantable Cardioverter Defibrillators in Children:. Journal of Cardiovascular Electrophysiology 15:1, 77-78
CrossRef584
William S Weintraub, Hugh Kawabata, Michele Tran, Gilbert J L???italien, Roland S Chen. (2004) Cost of Heart Failure in Patients Receiving ??-Blockers and Angiotensin-Converting Enzyme Inhibitors. Clinical Drug Investigation 24:5, 255-264
CrossRef585
ARTHUR M. FELDMAN, HELMUT KLEIN, PATRICK TCHOU, SRINIVAS MURALI, W. JACKSON HALL, DONNA MANCINI, JOHN BOEHMER, MARK HARVEY, M. STEPHEN HEILMAN, STEVEN J. SZYMKIEWICZ, ARTHUR J. MOSS, . (2004) Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death:. Results of WEARIT/BIROAD. Pacing and Clinical Electrophysiology 27:1, 4-9
CrossRef586
Rosemary S. Bubien, Elizabeth A. Ching, G. Neal Kay. (2004) Cardiac Defibrillation and Resynchronization Therapies. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 340-361
CrossRef587
GUSTAVO LOPERA, WILLIAM G. STEVENSON, KYOKO SOEJIMA, WILLIAM H. MAISEL, BRUCE KOPLAN, JOHN L. SAPP, S. DINAKAR SATTI, LAURENCE M. EPSTEIN. (2004) Identification and Ablation of Three Types of Ventricular Tachycardia Involving the His-Purkinje System in Patients with Heart Disease. Journal of Cardiovascular Electrophysiology 15:1, 52-58
CrossRef588
Samuel F. Sears, Adrienne H. Kovacs, Lora Azzarello, Karin Larsen, Jamie B. Conti. (2004) Innovations in Health Psychology: The Psychosocial Care of Adults With Implantable Cardioverter Defibrillators.. Professional Psychology: Research and Practice 35:5, 520-526
CrossRef589
ANNIE DORE, PATRIZIA SANTAGATA, MARC DUBUC, LISE-ANDREE MERCIER. (2004) Implantable Cardioverter Defibrillators in Adults with Congenital Heart Disease:. A Single Center Experience. Pacing and Clinical Electrophysiology 27:1, 47-51
CrossRef590
Oseroff Oscar, Retyk Enrique, Bochoeyer Andres. (2004) Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH). Current Opinion in Cardiology 19:1, 26-30
CrossRef591
BORYS SURAWICZ. (2004) Brief History of Cardiac Arrhythmias Since the End of the Nineteenth Century:. Journal of Cardiovascular Electrophysiology 15:1, 101-111
CrossRef592
Grzegorz Raczak, Gian Domenico Pinna, Roberto Maestri, Ludmila Danilowicz-Szymanowicz, Malgorzta Szwoch, Andrzej Lubinski, Maciej Kempa, Maria Teresa La Rovere, Grazyna Swiatecka. (2004) Different Predictive Values of Electrophysiological Testing and Autonomic Assessment in Patients Surviving a Sustained Arrhythmic Episode. Circulation Journal 68:7, 634-638
CrossRef593
Anne B Curtis. (2004) Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. Journal of the American College of Cardiology 43:1, 44-46
CrossRef594
Samuel F. Sears, Adrienne H. Kovacs, Jamie B. Conti, Eileen Handberg. (2004) Expanding the Scope of Practice for Cardiac Rehabilitation. Journal of Cardiopulmonary Rehabilitation 24:4, 209-215
CrossRef595
Yoshifusa AIZAWA, Masaomi CHINUSHI, Takashi WASHIZUKA. (2004) Indications for an Implantable Cardioverter Defibrillator (ICD). Internal Medicine 43:5, 360-367
CrossRef596
XIAOHONG ZHOU, BRUCE D. GUNDERSON, WALTER H. OLSON, . (2004) Incidence of Nonsustained and Sustained Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 15:1, 14-20
CrossRef597
SUSHIL K. SINGH, MARK S. LINK, PAUL J. WANG, MUNTHER HOMOUD, N.A. MARK ESTES. (2004) Syncope in the Patient with Nonischemic Dilated Cardiomyopathy. Pacing and Clinical Electrophysiology 27:1, 97-100
CrossRef598
Zoran Cosic, Dragan Tavciovski, Aleksandra Jovelic, Radoslav Romanovic. (2004) Late ventricular potentials in risk assessment of the occurrence of complex ventricular arrhythmia in patients with myocardial infarction and heart failure. Vojnosanitetski pregled 61:6, 589-597
CrossRef599
RICHARD C. KLEIN, ELEANOR B. SCHRON, ELLEN GRAHAM RENFROE, AL HALLSTROM, JACK KRON, CELESTE OCAMPO, ANNA LEONEN, NICHOLAS TULLO, . (2003) Factors Determining ICD Implantation in Drug Therapy Patients After Termination of Antiarrythmics Versus Implantable Defibrillators Trial. Pacing and Clinical Electrophysiology 26:12, 2235-2240
CrossRef600
ANDREA M. RUSSO, HEMAL NAYAK, RALPH VERDINO, JAMIE SPRINGMAN, EDWARD GERSTENFELD, HENRY HSIA, FRANCIS E. MARCHLINSKI. (2003) Implantable Cardioverter Defibrillator Events in Patients with Asymptomatic Nonsustained Ventricular Tachycardia:. Pacing and Clinical Electrophysiology 26:12, 2289-2295
CrossRef601
DAN M. RODEN. (2003) Antiarrhythmic Drugs:. Pacing and Clinical Electrophysiology 26:12, 2340-2348
CrossRef602
DiMarco, John P., . (2003) Implantable Cardioverter–Defibrillators. New England Journal of Medicine 349:19, 1836-1847
Full Text603
Arthur E. Fass. (2003) Perspectives in the Management of Chronic Coronary Artery Disease. Heart Disease 5:6, 365-367
CrossRef604
Sheila A Doggrell. (2003) Are implantable cardioverter-defribrillators always superior to amiodarone?. Expert Opinion on Pharmacotherapy 4:11, 2111-2114
CrossRef605
CHIA-TI TSAI, SHOEI K. STEPHEN HUANG, JIUNN-LEE LIN, LING-PING LAI, . (2003) Distinct Clinical Features in the Recipients of the Implantable Cardioverter Defibrillator in Taiwan:. A Multicenter Registry Study. Pacing and Clinical Electrophysiology 26:11, 2083-2090
CrossRef606
SVEN REEK, J. CHRISTOPH GELLER, ULF MELTENDORF, ANKE WOLLBRUECK, STEVEN J. SZYMKIEWICZ, HELMUT U. KLEIN. (2003) Clinical Efficacy of a Wearable Defibrillator in Acutely Terminating Episodes of Ventricular Fibrillation Using Biphasic Shocks. Pacing and Clinical Electrophysiology 26:10, 2016-2022
CrossRef607
B. Hygriv Rao, Sanjeev Saksena. (2003) Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications. Current Opinion in Critical Care 9:5, 362-368
CrossRef608
ERIC J. RASHBA, MATT BONNER, JOHN WILSON, STEPHEN R. SHOROFSKY, ROBERT W. PETERS, MICHAEL R. GOLD. (2003) Distal Right Ventricular Coil Position Reduces Defibrillation Thresholds. Journal of Cardiovascular Electrophysiology 14:10, 1036-1040
CrossRef609
EDUARDO B. SAAD, WALID I. SALIBA, ROBERT A. SCHWEIKERT, AYMAN S. AL-KHADRA, AHMAD ABDUL-KARIM, MARK J. NIEBAUER, BRUCE L. WILKOFF. (2003) Nonthoracotomy Implantable Defibrillator Lead Extraction:. Results and Comparison with Extraction of Pacemaker Leads. Pacing and Clinical Electrophysiology 26:10, 1944-1950
CrossRef610
Michiel J. Janse. (2003) A brief history of sudden cardiac death and its therapy. Pharmacology & Therapeutics 100:1, 89-99
CrossRef611
RICHARD C. KLEIN, MERRITT H. RAITT, BRUCE L. WILKOFF, KAREN J. BECKMAN, JAMES COROMILAS, D. GEORGE WYSE, PETER L. FRIEDMAN, JAMES B. MARTINS, ANDREW E. EPSTEIN, ALFRED P. HALLSTROM, ROBERT B. LEDINGHAM, KAREN M. BELCO, H. LEON GREENE, . (2003) Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Journal of Cardiovascular Electrophysiology 14:9, 940-948
CrossRef612
Peter Cram, Sandeep Vijan, A. Mark Fendrick. (2003) Cost-effectiveness of Automated External Defibrillator Deployment in Selected Public Locations. Journal of General Internal Medicine 18:9, 745-754
CrossRef613
Béatrice Brembilla-Perrot, Hielko Miljoen, Pierre Houriez, Daniel Beurrier, Marc Nippert, Anne Claire Vançon, Arnaud Terrier de la Chaise, Pierre Louis, Laurent Mock, Nicolas Sadoul, Marius Andronache. (2003) Causes and prognosis of cardiac arrest in a population admitted to a general hospital; a diagnostic and therapeutic problem. Resuscitation 58:3, 319-327
CrossRef614
RUEDIGER BECKER, MICHAIL MELKUMOV, JULIA C. SENGES-BECKER, FREDERIK VOSS, ALEXANDER BAUER, JOCHEN MICHAELSEN, SLAWOMIR WERETKA, FERAYDOON NIROOMAND, HUGO A. KATUS, WOLFGANG SCHOELS. (2003) Are Electrophysiological Studies Needed Prior to Defibrillator Implantation?. Pacing and Clinical Electrophysiology 26:8, 1715-1721
CrossRef615
OSNAT GUREVITZ, RICHARD I. FOGEL, MARK E. HERNER, ROSS SAMPLE, ADAM S. STRICKBERGER, EMILE G. DAOUD, FRED MORADY, ERIC N. PRYSTOWSKY. (2003) Patients with an ICD Can Safely Resume Work in Industrial Facilities Following Simple Screening for Electromagnetic Interference. Pacing and Clinical Electrophysiology 26:8, 1675-1678
CrossRef616
Tomas Kara, Jiri Nykodym, Virend K. Somers. (2003) Heart Rate Variability:. Journal of Cardiovascular Electrophysiology 14:8, 800-802
CrossRef617
C. ALDO RINALDI, RON D.B. SIMON, PETER GEELEN, SVEN REEK, ARTUR BASZKO, MARTIN KUEHL, JASWINDER S. GILL. (2003) A Randomized Prospective Study of Single Coil Versus Dual Coil Defibrillation in Patients with Ventricular Arrhythmias Undergoing Implantable Cardioverter Defibrillator Therapy. Pacing and Clinical Electrophysiology 26:8, 1684-1690
CrossRef618
Peter Cram, Sandeep Vijan, Alex Wolbrink, A. Mark Fendrick. (2003) The Impact of Including Passive Benefits in Cost-Effectiveness Analysis: The Case of Automated External Defibrillators on Commercial Aircraft. Value in Health 6:4, 466-473
CrossRef619
Mohammad Saeed, Anna Jin, Gregory Pontone, Steve Higgins, Michael Gold, David Harari, Steven Nunley, Mark S. Link, Munther K. Homoud, N.A. Mark Estes, Paul J. Wang, . (2003) Prevalence of Sensing Abnormalities in Dual Chamber Implantable Cardioverter Defibrillators. Annals of Noninvasive Electrocardiology 8:3, 219-226
CrossRef620
L.Brent Mitchell, Judy L Powell, Anne M Gillis, Victoria Kehl, Alfred P Hallstrom. (2003) Are lipid-lowering drugs also antiarrhythmic drugs?. Journal of the American College of Cardiology 42:1, 81-87
CrossRef621
RAINER GRADAUS, MICHAEL BLOCK, JOHANNES BRACHMANN, GUNTER BREITHARDT, HANS G. HUBER, WERNER JUNG, WOLFGANG KRANIG, RALPH U. MLETZKO, WOLFGANG SCHOELS, KARLHEINZ SEIDL, JOCHEN SENGES, JURGEN SIEBELS, GERHARD STEINBECK, CHRISTOPH STELLBRINK, DIETRICH ANDRESEN, . (2003) Mortality, Morbidity, and Complications in 3,344 Patients with Implantable Cardioverter Defibrillators:. Results From the German ICD Registry EURID. Pacing and Clinical Electrophysiology 26:7p1, 1511-1518
CrossRef622
Kelley P Anderson. (2003) Lipid-lowering therapy for prevention of ventricular tachyarrhythmias. Journal of the American College of Cardiology 42:1, 88-92
CrossRef623
Thomas F. Oppelt, Rodel V. Bobadilla. (2003) Better Living Through Chemistry: Does It Still Apply to Patients After Myocardial Infarction?. Pharmacotherapy 23:6, 816-822
CrossRef624
Vivek Y Reddy, Petr Neuzil, Milos Taborsky, Jeremy N Ruskin. (2003) Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. Journal of the American College of Cardiology 41:12, 2228-2236
CrossRef625
Stefan H Hohnloser, Thomas Klingenheben, Daniel Bloomfield, Omar Dabbous, Richard J Cohen. (2003) Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. Journal of the American College of Cardiology 41:12, 2220-2224
CrossRef626
Douglas S Lee, Lawrence D Green, Peter P Liu, Paul Dorian, David M Newman, F.Curry Grant, Jack V Tu, David A Alter. (2003) Effectiveness of implantable defibrillators for preventing arrhythmic events and death. Journal of the American College of Cardiology 41:9, 1573-1582
CrossRef627
S.Adam Strickberger, John D Hummel, Thomas G Bartlett, Howard I Frumin, Claudio D Schuger, Scott L Beau, Cynthia Bitar, Fred Morady. (2003) Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT. Journal of the American College of Cardiology 41:10, 1707-1712
CrossRef628
Anne M. Gillis, Robert S. Sheldon, D. George Wyse, Henry J. Duff, Margaret R. Cassidy, L. Brent Mitchell. (2003) Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology 14:5, 492-498
CrossRef629
Steven E Lipshultz, Stacy D Fisher, Wyman W Lai, Tracie L Miller. (2003) Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS 17, S96-S122
CrossRef630
Samir Saba, Walter L Atiga, William Barrington, Leonard I Ganz, Robert L Kormos, Guy A MacGowan, Michael A Mathier, Dennis M McNamara, Ogundu Obioha-Ngwu, Srinivas Murali. (2003) Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. The Journal of Heart and Lung Transplantation 22:4, 411-418
CrossRef631
Kristin E. Ellison, William G. Stevenson, Michael O. Sweeney, Laurence M. Epstein, William H. Maisel. (2003) Management of Arrhythmias in Heart Failure. Congestive Heart Failure 9:2, 91-99
CrossRef632
Peter Lercher, Brigitte Rotman, Daniel Scherr, Wilfried Kraxner, Olef Luha, Werner Klein. (2003) Die Auswirkungen nach dem Multicenter Automatic Defibrillator Implantation Trial II in einem kardiologischen Schwerpunktzentrum — müssen alle Postinfarktpatienten mit reduzierter Linksventrikelfunktion einen implantierbaren Kardioverter-Defibrillator erhalten?. Wiener Klinische Wochenschrift 115:5-6, 167-174
CrossRef633
Jan Nemec, Win-Kuang Shen. (2003) Antiarrhythmic drugs: new agents and evolving concepts. Expert Opinion on Investigational Drugs 12:3, 435-453
CrossRef634
(2003) Public Use of Automated External Defibrillators. New England Journal of Medicine 348:8, 755-756
Full Text635
RAINER GRADAUS, GUNTER BREITHARDT, DIRK BOCKER. (2003) ICD Leads:. Design and Chronic Dysfunctions. Pacing and Clinical Electrophysiology 26:2p1, 649-657
CrossRef636
JOERG CARLSSON, BRITTA SCHULTE, ALI ERDOGAN, JOHANNES SPERZEL, NORBERT GUTTLER, TORSTEN SCHWARZ, HEINZ-F. PITSCHNER, JOERG NEUZNER. (2003) Prospective Randomized Comparison of Two Defibrillation Safety Margins in Unipolar, Active Pectoral Defibrillator Therapy. Pacing and Clinical Electrophysiology 26:2p1, 613-618
CrossRef637
PATRICK T. ELLINOR, MARY L. GUY, JEREMY N. RUSKIN, BRIAN A. MCGOVERN. (2003) Variability in Implantable Cardioverter Defibrillator Pulse Generator Longevity Between Manufacturers. Pacing and Clinical Electrophysiology 26:1p1, 71-75
CrossRef638
Jonathan B Shammash, William A Ghali. (2003) Preoperative assessment and perioperative management of the patient with nonischemic heart disease. Medical Clinics of North America 87:1, 137-152
CrossRef639
Kenneth A Ellenbogen, Mark A Wood, Richard K Shepard, Henry F Clemo, Tim Vaughn, Keith Holloman, Marlene Dow, Jeanne Leffler, Athula Abeyratne, Dave Verness. (2003) Detection and management of animplantable cardioverter defibrillator lead failure. Journal of the American College of Cardiology 41:1, 73-80
CrossRef640
DIRK VOLLMANN, LARS LUETHJE, DIETER ZENKER, SEBASTIAN DOMHOF, CHRISTINA UNTERBERG. (2003) Subthreshold Test Pulses Versus Low Energy Shock Delivery to Estimate High Energy Lead Impedance in Implanted Cardioverter Defibrillator Patients. Pacing and Clinical Electrophysiology 26:1p2, 457-460
CrossRef641
CHRISTOPHER J. PLUMMER, R. JOHN IRVING, JANET M. MCCOMB. (2003) Implications of National Guidance for Implantable Cardioverter Defibrillation Implantation in the United Kingdom. Pacing and Clinical Electrophysiology 26:1p2, 479-482
CrossRef642
Michael E. Bourke, Jeffrey S. Healey. (2002) Pacemakers, recent directions and developments. Current Opinion in Anaesthesiology 15:6, 681-686
CrossRef643
Paul A Gould, David M Kaye. (2002) Clinical treatment regimens for chronic heart failure: a review. Expert Opinion on Pharmacotherapy 3:11, 1569-1576
CrossRef644
Gabriel Gregoratos, Jonathan Abrams, Andrew E Epstein, Roger A Freedman, David L Hayes, Mark A Hlatky, Richard E Kerber, Gerald V Naccarelli, Mark H Schoenfeld, Michael J Silka, Stephen L Winters, Raymond J Gibbons, Elliott M Antman, Joseph S Alpert, Gabriel Gregoratos, Loren F Hiratzka, David P Faxon, Alice K Jacobs, Valentin Fuster, Sidney C Smith. (2002) ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article. Journal of the American College of Cardiology 40:9, 1703-1719
CrossRef645
John C. Somberg. (2002) Arrhythmia Therapy. American Journal of Therapeutics 9:6, 537-542
CrossRef646
Petri Korhonen, Ilkka Tierala, Kim Simelius, Heikki Väänänen, Markku Mäkijärvi, Jukka Nenonen, Toivo Katila, Lauri Toivonen. (2002) Late QRS Activity in Signal-Averaged Magnetocardiography, Body Surface Potential Mapping, and Orthogonal ECG in Postinfarction Ventricular Tachycardia Patients. Annals of Noninvasive Electrocardiology 7:4, 389-398
CrossRef647
Johan De Sutter, Vida Firsovaite, Rene Tavernier. (2002) Prevention of Sudden Death in Patients With Coronary Artery Disease: Do Lipid-Lowering Drugs Play a Role?. Preventive Cardiology 5:4, 177-182
CrossRef648
Robyn L. Wallace, Samuel F. Sears, Tara Saia Lewis, Jared T. Griffis, Anne Curtis, Jamie B. Conti. (2002) Predictors of Quality of Life in Long-term Recipients of Implantable Cardioverter Defibrillators. Journal of Cardiopulmonary Rehabilitation 22:4, 278-281
CrossRef649
Arthur J. Moss. (2002) MADIT-II and Implications for Noninvasive Electrophysiologic Testing. Annals of Noninvasive Electrocardiology 7:3, 179-180
CrossRef650
J.ürg Schläpfer, Fabrice Rapp, Lukas Kappenberger, Martin Fromer. (2002) Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction. Journal of the American College of Cardiology 39:11, 1813-1819
CrossRef651
Lambert A Wu, Thomas E Kottke, Paul A Friedman, David M Luria, Diane E Grill, Matthew J Maurer. (2002) Implantable cardioverter defibrillator implantation rates in the Olmsted County, Minnesota, Population. Journal of Clinical Epidemiology 55:5, 458-461
CrossRef652
Bhavesh Sachdev, Perry M Elliott, M Shoaib Hamid. (2002) The prevention of sudden death in hypertrophic cardiomyopathy. Expert Opinion on Pharmacotherapy 3:5, 499-504
CrossRef653
BARRY J. MARON. (2002) Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Cardiology in Review 10:3, 173-181
CrossRef654
Carmine A. Sorbera, Evelyn J. Cusack. (2002) Indications for Implantable Cardioverter Defibrillator Therapy. Heart Disease 4:3, 166-170
CrossRef655
L.Brent Mitchell, Edgar A Pineda, Jack L Titus, Paulette M Bartosch, David G Benditt. (2002) Sudden death in patients with implantable cardioverter defibrillators. Journal of the American College of Cardiology 39:8, 1323-1328
CrossRef656
Bigger, J. Thomas, . (2002) Expanding Indications for Implantable Cardiac Defibrillators. New England Journal of Medicine 346:12, 931-933
Full Text657
Moss, Arthur J., Zareba, Wojciech, Hall, W. Jackson, Klein, Helmut, Wilber, David J., Cannom, David S., Daubert, James P., Higgins, Steven L., Brown, Mary W., Andrews, Mark L., . (2002) Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction. New England Journal of Medicine 346:12, 877-883
Full Text658
Volker Kühlkamp. (2002) Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. Journal of the American College of Cardiology 39:5, 790-797
CrossRef659
Wolfram Grimm, J.ürgen Hoffmann, Hans-Helge Müller, Bernhard Maisch. (2002) Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. Journal of the American College of Cardiology 39:5, 780-787
CrossRef660
Alan Kadish. (2002) Primary prevention ofsudden death using ICD therapy: incremental steps. Journal of the American College of Cardiology 39:5, 788-789
CrossRef661
Michel Accad, Andrew D. Michaels. (2002) Management after myocardial infarction. Current Treatment Options in Cardiovascular Medicine 4:1, 41-54
CrossRef662
Marian A. Spath, Bernie J. O??Brien. (2002) Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death. PharmacoEconomics 20:11, 727-738
CrossRef663
Franco Naccarella, Gerald V Naccarelli, Stefano Sdringola Maranga, Giovannina Lepera, Maria Carmela Grippo, Francesco Melandri, Mauro Gatti, Stefano Pazzaglia, Giovanna Spinelli, Vittorio Angelini, Ettore Ambrosioni, Claudio Borghi, Maria Teresa Giovagnorio, Seah Nisam. (2002) Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials. Current Opinion in Cardiology 17:1, 6-18
CrossRef664
Bente Brendorp, Oledyg Pedersen, Christian Torp-Pedersen, Naji Sahebzadah, Lars K??ber. (2002) A Benefit-Risk Assessment of Class III Antiarrhythmic Agents. Drug Safety 25:12, 847-865
CrossRef665
WILLIAM G. STEVENSON, KRISTIN E. ELLISON, MICHAEL O. SWEENEY, LAURENCE M. EPSTEIN, WILLIAM H. MAISEL. (2002) Management of Arrhythmias in Heart Failure. Cardiology in Review 10:1, 8-14
CrossRef666
Hidetsuna Kitamura, Yoshio Ohnishi, Katsunori Okajima, Akihiko Ishida, ErdulfoJavier Galeano, Kazumasa Adachi, Mitsuhiro Yokoyama. (2002) Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. Journal of the American College of Cardiology 39:2, 295-300
CrossRef667
Karlheinz Seidl, Monika Rameken, Margit Vater, Jochen Senges. (2002) Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure. American Journal of Cardiovascular Drugs 2:4, 219-226
CrossRef668
Craig Swygman, Paul J. Wang, Mark S. Link, Munther K. Homoud, N.A. Mark Estes. (2002) Advances in implantable cardioverter defibrillators. Current Opinion in Cardiology 17:1, 24-28
CrossRef669
David S. Cannom. (2002) Implantable cardioverter defibrillator trials: what's new?. Current Opinion in Cardiology 17:1, 29-35
CrossRef670
Takeshi Aiba, Takashi Kurita, Atsushi Taguchi, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Shiro Kamakura. (2002) Long-Term Efficacy of Empirical Chronic Amiodarone Therapy in Patients With Sustained Ventricular Tachyarrhythmia and Structural Heart Disease. Circulation Journal 66:4, 367-367
CrossRef671
James J Bailey, Alan S Berson, Harry Handelsman, Morrison Hodges. (2001) Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. Journal of the American College of Cardiology 38:7, 1902-1911
CrossRef672
Huikuri, Heikki V., Castellanos, Agustin, Myerburg, Robert J., . (2001) Sudden Death Due to Cardiac Arrhythmias. New England Journal of Medicine 345:20, 1473-1482
Full Text673
Jeffrey J. Goldberger, Michele A. Parker, Alan H. Kadish. (2001) Over-AVID subgroup analysis. Journal of the American College of Cardiology 38:5, 1586
CrossRef674
STEVEN E. LIPSHULTZ, STACY D. FISHER, WYMAN W. LAI, TRACIE L. MILLER. (2001) Cardiovascular Monitoring and Therapy for HIV-Infected Patients. Annals of the New York Academy of Sciences 946:1, 236-273
CrossRef675
John L. Atlee, Alan D. Bernstein. (2001) Cardiac Rhythm Management Devices (Part I). Anesthesiology 95:5, 1265-1280
CrossRef676
D.George Wyse, Peter L Friedman, Michael A Brodsky, Karen J Beckman, Mark D Carlson, Anne B Curtis, Alfred P Hallstrom, Merritt H Raitt, Bruce L Wilkoff, H.Leon Greene. (2001) Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. Journal of the American College of Cardiology 38:6, 1718-1724
CrossRef677
Wilbert S. Aronow. (2001) Treatment of the Elderly Post-Myocardial Infarction Patient. The American Journal of Geriatric Cardiology 10:6, 316-323
CrossRef678
Sheila A Doggrell. (2001) Amiodarone - waxed and waned and waxed again. Expert Opinion on Pharmacotherapy 2:11, 1877-1890
CrossRef679
Sami Viskin, Amir Halkin, Jeffrey E. Olgin. (2001) Treatable causes of sudden death: not really “treatable” or not really the cause?. Journal of the American College of Cardiology 38:6, 1725-1727
CrossRef680
Gregory F. Michaud, S.Adam Strickberger. (2001) Should an abnormal serum potassium concentration be considered a correctable cause of cardiac arrest?. Journal of the American College of Cardiology 38:4, 1224-1225
CrossRef681
Nabil El-Sherif, Gioia Turitto, Ronald P. Pedalino, Dyonissios Robotis. (2001) T-Wave Alternans and Arrhythmia Risk Stratification. Annals of Noninvasive Electrocardiology 6:4, 323-332
CrossRef682
J.F. Leclercq. (2001) Les indications du défibrillateur automatique implantable ventriculaire. Implications pour la pratique quotidienne. Annales de Cardiologie et d'Angéiologie 50:6, 319-325
CrossRef683
P. Göudde, R. Agrawal, H.-P. Müuller, K. Czerski, P. Endt, U. Steinhoff, M. Oeff, H.-P. Schultheiss, S. Behrens. (2001) Magnetocardiographic mapping of QRS fragmentation in patients with a history of malignant tachyarrhythmias. Clinical Cardiology 24:10, 682-688
CrossRef684
Eric J Rashba, Mary R Olsovsky, Stephen R Shorofsky, Malcolm M Kirk, Robert W Peters, Michael R Gold. (2001) Temporal decline in defibrillation thresholds with an active pectoral lead system. Journal of the American College of Cardiology 38:4, 1150-1155
CrossRef685
Luis A. Pires, Lynette M. May, Srihari Ravi, Vinit R. Lal, Jaskamal P. S. Kahlon. (2001) Safety and potential cost savings of same-setting electrophysiologic testing and placement of transvenous implantable cardioverter-defibrillators. Clinical Cardiology 24:9, 592-596
CrossRef686
Smith, Timothy W., . (2001) Driving after Ventricular Arrhythmias. New England Journal of Medicine 345:6, 451-452
Full Text687
Akiyama, Toshio, Powell, Judy L., Mitchell, L. Brent, Ehlert, Frederick A., Baessler, Christina, . (2001) Resumption of Driving after Life-Threatening Ventricular Tachyarrhythmia. New England Journal of Medicine 345:6, 391-397
Full Text688
&NA;. (2001) ??-Blockers are best antiarrhythmics for reducing post-MI mortality. Drugs & Therapy Perspectives 17:13, 5-8
CrossRef689
George A. Stouffer, Richard G. Sheahan, Daniel J. Lenihan, Richard G. Sheahan. (2001) Syncope and Arrhythmias:. The American Journal of the Medical Sciences 322:1, 37-43
CrossRef690
Claus Schmitt, Petra Barthel, Gjin Ndrepepa, Jürgen Schreieck, Andreas Plewan, A Schömig, Georg Schmidt. (2001) Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. Journal of the American College of Cardiology 37:7, 1901-1907
CrossRef691
Mark A Hlatky, Thomas Bigger. (2001) Cost-effectiveness of the implantable cardioverter defibrillator?. The Lancet 357:9271, 1817-1818
CrossRef692
John P DiMarco. (2001) Is programmed stimulation in survivors of myocardial infarction helpful?. Journal of the American College of Cardiology 37:7, 1908-1909
CrossRef693
Nahum A Freedberg, John N Hill, Richard I Fogel, Eric N Prystowsky. (2001) Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy. Journal of the American College of Cardiology 37:7, 1910-1915
CrossRef694
Eugen C. Palma. (2001) Therapeutic options in patients with reduced ejection fraction and nonsustained ventricular tachycardia. Current Cardiology Reports 3:3, 219-223
CrossRef695
Gillian D. Sanders, Robert F. Nease, Douglas K. Owens. (2001) Publishing web-based guidelines using interactive decision models. Journal of Evaluation in Clinical Practice 7:2, 175-189
CrossRef696
Daniel E. Hilleman, Jerry L. Bauman. (2001) Role of Antiarrhythmic Therapy in Patients at Risk for Sudden Cardiac Death: An Evidence-Based Review. Pharmacotherapy 21:5, 556-575
CrossRef697
David Lewis, Qing Wang, Eric Topol. 2001. Ischaemic Heart Disease. .
CrossRef698
Michael Glikson, Paul A Friedman. (2001) The implantable cardioverter defibrillator. The Lancet 357:9262, 1107-1117
CrossRef699
L FEI, R TROHMAN. (2001) ADVANCES IN CARDIAC ELECTROPHYSIOLOGY AND PACING. Critical Care Clinics 17:2, 337-364
CrossRef700
David M. Luria, Win Kaung Shen. (2001) Syncope in the Elderly: New Trends in Diagnostic Approach and Nonpharmacologic Management. The American Journal of Geriatric Cardiology 10:2, 91-96
CrossRef701
Perry M. Elliott. (2001) The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era. Current Cardiology Reports 3:2, 167-172
CrossRef702
Robert W. Peters, Michael R. Gold. (2001) Implantable Cardiac Defibrillators. Medical Clinics of North America 85:2, 343-367
CrossRef703
Sue Ann Thomas, Erika Friedmann, Frances J. Kelley. (2001) Living With an Implantable Cardioverter-Defibrillator: A Review of the Current Literature Related to Psychosocial Factors. AACN Clinical Issues: Advanced Practice in Acute & Critical Care 12:1, 156-163
CrossRef704
Samuel F. Sears, Sheila Rauch, Eileen Handberg, Jamie B. Conti. (2001) Fear of Exertion Following ICD Storm: Considering ICD Shock and Learning History. Journal of Cardiopulmonary Rehabilitation 21:1, 47-49
CrossRef705
Massimo Santini, Renato Ricci, Carlo Pignalberi, Gerardo Ansalone. (2001) Electrotherapeutic Management of Patients with Heart Failure. American Journal of Cardiovascular Drugs 1:4, 227-231
CrossRef706
K.K. Talwar, N. Naik. (2001) Etiology and Management of Sustained Ventricular Tachycardia. American Journal of Cardiovascular Drugs 1:3, 179-192
CrossRef707
Mark S. Link, Paul J. Wang, N. A. Mark Estes. (2001) Ventricular arrhythmias in the athlete. Current Opinion in Cardiology 16:1, 30-39
CrossRef708
Jose L. Merino. (2001) Mechanisms Underlying Ventricular Arrhythmias in Idiopathic Dilated Cardiomyopathy. American Journal of Cardiovascular Drugs 1:2, 105-118
CrossRef709
Takashi Washizuka, Masaomi Chinushi, Hidehiro Kasai, Hiroshi Watanabe, Minoru Tagawa, Yukio Hosaka, Akira Abe, Yoshifusa Aizawa. (2001) Inappropriate Discharges From an Intravenous Implantable Cardioverter Defibrillator Due to T-Wave Oversensing. Japanese Circulation Journal 65:7, 685-687
CrossRef710
Mark S. Link, Munther K. Homoud, Paul J. Wang, N.A. Mark Estes. (2001) Cardiac Arrhythmias in the Athlete. Cardiology in Review 9:1, 21-30
CrossRef711
Taka-aki Matsuyama, Kaoru Tanno, Youichi Kobayashi, Chiaki Obara, Shunsho Ryu, Taro Adachi, Hitoshi Ezumi, Taku Asano, Akira Miyata, Shinji Koba, Takao Baba, Takashi Katagiri. (2001) T Wave Alternans for Predicting Adverse Effects of Amiodarone in a Patient With Dilated Cardiomyopathy. Japanese Circulation Journal 65:5, 468-468
CrossRef712
Takashi Washizuka, Masaomi Chinushi, Minoru Tagawa, Hidehiro Kasai, Hiroshi Watanabe, Yukio Hosaka, Fumio Yamashita, Hiroshi Furushima, Akira Abe, Hiroshi Watanabe, Junichi Hayashi, Yoshifusa Aizawa. (2001) Inappropriate Discharges by Fourth Generation Implantable Cardioverter Defibrillators in Patients With Ventricular Arrhythmias. Japanese Circulation Journal 65:11, 927-930
CrossRef713
Takao Katoh, Hiroyuki Iinuma, Hiroshi Inoue, Tohru Ohe, Satoshi Ogawa, Hiroshi Kasanuki, Teruhisa Tanabe, Hirokazu Hayakawa. (2001) Multicenter Prospective Nonrandomized Study of Long-Term Antiarrhythmic Drug Therapy in Patients With Tachyarrhythmias. Japanese Circulation Journal 65:4, 275-278
CrossRef714
Kazumasa Adachi, Yoshio Ohnishi, Mitsuhiro Yokoyama. (2001) Risk Stratification for Sudden Cardiac Death in Dilated Cardiomyopathy Using Microvolt-Level T-Wave Alternans. Japanese Circulation Journal 65:2, 76-80
CrossRef715
MARK H. SCHOENFELD. (2000) Deciding Against Defibrillator Replacement: Second-Guessing the Past?. Pacing and Clinical Electrophysiology 23:12, 2019-2021
CrossRef716
ROBERT N. GELDER, JOSEPH M. GALVIN, CHRISTINE M. ALBERT, DAVID KEANE, JEREMY N. RUSKIN. (2000) Lead Noise with an Active-Fixation Defibrillation Lead. Pacing and Clinical Electrophysiology 23:12, 2113-2116
CrossRef717
Rajjit Abrol, Richard L Page. (2000) Azimilide dihydrochloride: a new class III anti-arrhythmic agent. Expert Opinion on Investigational Drugs 9:11, 2705-2715
CrossRef718
Anthony W. C. Chow, Richard J. Schilling, Nicholas S. Peters, D. Wyn Davies. (2000) Catheter ablation of ventricular tachycardia related to coronary artery disease: The role of noncontact mapping. Current Cardiology Reports 2:6, 529-536
CrossRef719
Sami Viskin, Roman Fish. (2000) Prevention of ventricular arrhythmias in the congenital long QT syndrome. Current Cardiology Reports 2:6, 492-497
CrossRef720
Jeffrey J Goldberger, Suresh Neelagaru. (2000) Therapeutic developments in sudden cardiac death. Expert Opinion on Investigational Drugs 9:11, 2543-2554
CrossRef721
Davendra Mehta. (2000) Canadian implantable defibrillator study: What does it mean after the antiarrhythmics versus implantable defibrillators trial?. Current Cardiology Reports 2:6, 489-491
CrossRef722
Barry J. Maron. (2000) Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy. Current Cardiology Reports 2:6, 522-528
CrossRef723
Stefan H Hohnloser, Karl-Heinz Kuck, Jurgen Lilienthal. (2000) Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. The Lancet 356:9244, 1789-1794
CrossRef724
Mina K. Chung. (2000) Cardiac surgery: Postoperative arrhythmias. Critical Care Medicine 28:Supplement, N136-N144
CrossRef725
Sergio L. Pinski. (2000) Emergencies related to implantable cardioverter-defibrillators. Critical Care Medicine 28:Supplement, N174-N180
CrossRef726
BARBARA DIJKMAN, HEIN J.J. WELLENS. (2000) Dual Chamber Arrhythmia Detection in the Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 11:10, 1105-1115
CrossRef727
Karthik Ramaswamy, Mohamed H. Hamdan. (2000) Ischemia, metabolic disturbances, and arrhythmogenesis: Mechanisms and management. Critical Care Medicine 28:Supplement, N151-N157
CrossRef728
Richard I. Fogel, Eric N. Prystowsky. (2000) Management of malignant ventricular arrhythmias and cardiac arrest. Critical Care Medicine 28:Supplement, N165-N169
CrossRef729
Stefan H Hohnloser. (2000) Prevention of recurrent life-threatening arrhythmias: will lipid-lowering therapy make a difference?. Journal of the American College of Cardiology 36:3, 773-775
CrossRef730
Sanjeev Saksena. (2000) Implantable defibrillators in the third millennium: increasingly relegated to a standby role?. Journal of the American College of Cardiology 36:3, 828-831
CrossRef731
Johan De Sutter, Rene Tavernier, Marc De Buyzere, Luc Jordaens, Guy De Backer. (2000) Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. Journal of the American College of Cardiology 36:3, 766-772
CrossRef732
OTTO COSTANTINI, CAROLE DRABEK, DAVID S. ROSENBAUM. (2000) Can Sudden Cardiac Death Be Predicted from the T Wave of the ECG? A Critical Examination of T Wave Alternans and QT Interval Dispersion. Pacing and Clinical Electrophysiology 23:9, 1407-1416
CrossRef733
T Klingenheben, M Zabel, RB D'Agostino, RJ Cohen, SH Hohnloser. (2000) Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. The Lancet 356:9230, 651-652
CrossRef734
Peter Ott. (2000) Ventricular arrhythmias. Current Treatment Options in Cardiovascular Medicine 2:4, 323-327
CrossRef735
O.A. Obel. (2000) Revisiting established medical options — antiarrhythmic drugs and β-blocker combinations. Resuscitation 45:3, S7-S10
CrossRef736
Dietmar Bänsch, Marco Castrucci, Dirk Böcker, Günter Breithardt, Michael Block. (2000) Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators. Journal of the American College of Cardiology 36:2, 557-565
CrossRef737
Angelo Auricchio, Helmut Klein. (2000) Arrhythmias in heart failure. Current Treatment Options in Cardiovascular Medicine 2:4, 329-339
CrossRef738
IGOR R. EFIMOV, YUANNA CHENG, YOSHIO YAMANOUCHI, PATRICK J. TCHOU. (2000) Direct Evidence of the Role of Virtual Electrode-Induced Phase Singularity in Success and Failure of Defibrillation. Journal of Cardiovascular Electrophysiology 11:8, 861-868
CrossRef739
SUBRAMANIAM C. KRISHNAN, MARK E. JOSEPHSON. (2000) Surgery for Postinfarction Ventricular Tachycardia: Is it Obsolete?. Pacing and Clinical Electrophysiology 23:8, 1295-1301
CrossRef740
HEIKO SCHMITT, TANJA HURST, MICHAEL COCH, HOLGER KILLAT, BETTINA WUNN, BERND WALDECKER. (2000) Nonsustained, Asymptomatic Ventricular Tachycardia in Patients with Coronary Artery Disease: Prognosis and Incidence of Sudden Death of Patients Who Are Noninducible by Electrophysiological Testing. Pacing and Clinical Electrophysiology 23:8, 1220-1225
CrossRef741
(2000) Implantable Cardioverter–Defibrillators in Hypertrophic Cardiomyopathy. New England Journal of Medicine 343:1, 68-69
Full Text742
Ajay M. Naik, C. Thomas Peter. (2000) Are implantable cardioverter-defibrillators cost-effective?. Current Cardiology Reports 2:4, 341-345
CrossRef743
Dietrich Pfeiffer, Maika Mende, Andreas Hagendorff. (2000) Implantable dual-chamber cardioverter-defibrillator-pacemaker. Current Cardiology Reports 2:4, 335-340
CrossRef744
Seah Nisam, David J. Wilber. (2000) Survey of Prophylactic Defibrillator Implantation Following MADIT. Annals of Noninvasive Electrocardiology 5:3, 248-254
CrossRef745
Michael J. Domanski. (2000) Prevention of sudden cardiac death: management considerations. Current Opinion in Cardiology 15:4, 304-308
CrossRef746
PAUL A. FRIEDMAN, MICHAEL GLIKSON, MARSHALL S. STANTON. (2000) Defibrillator Challenges for the New Millennium:.. Journal of Cardiovascular Electrophysiology 11:6, 697-709
CrossRef747
XAVIER COPIE, OLIVIER PIOT, MINA AIT SAID, THOMAS LAVERGNE, JACKY OLLITRAULT, LOUIS GUIZE, JEAN-YVES HEUZEY, . (2000) Temporal and Geographical Trends in Indications for Implantation of Cardiac Defibrillators in Europe 1993-1998. Pacing and Clinical Electrophysiology 23:6, 979-984
CrossRef748
SAMUEL F. SEARS, JOHN F. TODARO, GUIDO URIZAR, TARA SAIA LEWIS, BRIAN SIROIS, ROBYN WALLACE, WAYNE SOTILE, ANNE B. CURTIS, JAMIE B. CONTI. (2000) Assessing the Psychosocial Impact of the ICD: A National Survey of Implantable Cardioverter Defibrillator Health Care Providers. Pacing and Clinical Electrophysiology 23:6, 939-945
CrossRef749
Allan S. Jaffe. (2000) The Costs of Inadequate Data. Academic Emergency Medicine 7:6, 687-688
CrossRef750
ALFRED P. HALLSTROM, JEFFREY L. ANDERSON, LEONARD A. COBB, PETER L. FRIEDMAN, JOHN M. HERRE, RICHARD C. KLEIN, JOHN MCANULTY, JONATHAN S. STEINBERG, . (2000) Advantages and Disadvantages of Trial Designs: A Review of Analysis Methods for ICD Studies. Pacing and Clinical Electrophysiology 23:6, 1029-1038
CrossRef751
H. Leon Greene. (2000) The implantable cardioverter-defibrillator. Clinical Cardiology 23:5, 315-326
CrossRef752
Kirkwood F. Adams, Kenneth L. Baughman, William G. Dec, Uri Elkayam, Alan D. Forker, Mihai Gheorghiade, Denise Hermann, Marvin A. Konstam, Peter Liu, Barry M. Massie, J. Herbert Patterson, Marc A. Silver, Lynne Warner Stevenson, Arthur M. Feldman, Jay N. Cohn, Gary S. Francis, Barry Greenberg, Marvin A. Konstam, Carl Leier, Beverly H. Lorell, Milton Packer, Bertram Pitt, Marc A. Silver, Edmund Sonnenblick, John Strobeck, Richard Walsh, Salim Yusuf. (2000) HFSA Guidelines for Management of Patients With Heart Failure Caused by Left Ventricular Systolic Dysfunction—Pharmacological Approaches. Pharmacotherapy 20:5, 495-522
CrossRef753
John H. McAnulty. (2000) Arrhythmia Therapy in the Elderly. The American Journal of Geriatric Cardiology 9:3, 151-158
CrossRef754
Jennifer A. Larsen, Alan H. Kadish, Janice B. Schwartz. (2000) Proper Use of Antiarrhythmic Therapy for Reduction of Mortality After Myocardial Infarction. Drugs & Aging 16:5, 341-350
CrossRef755
Hans Domanovits, Martin Schillinger, Peter Lercher, Gerhard Stark, Günther Stix, Fritz Sterz, Martin Mayrleitner, Anton N. Laggner. (2000) E 047/1: A New Class III Antiarrhythmic Agent. Journal of Cardiovascular Pharmacology 35:5, 716-722
CrossRef756
Douglas P. Zipes. (2000) A century of cardiac arrhythmias. Journal of the American College of Cardiology 35:5, 38B-44B
CrossRef757
CAROLYNN S. KOHN, RALPH J. PETRUCCI, CHRIS BAESSLER, DESIREE M. SOTO, COLIN MOVSOWITZ. (2000) The Effect of Psychological Intervention on Patients' Long-Term Adjustment to the ICD: A Prospective Study. Pacing and Clinical Electrophysiology 23:4, 450-456
CrossRef758
C. B. Singleton, B. D. Walker, T. J. Campbell. (2000) N-3 polyunsaturated fatty acids and cardiac mortality. Australian and New Zealand Journal of Medicine 30:2, 246-251
CrossRef759
Angela S. Eads, Samuel F. Sears, Wayne M. Sotile, Jamie B. Conti. (2000) Supportive Communication With Implantable Cardioverter Defibrillator Patients: Seven Principles to Facilitate Psychosocial Adjustment. Journal of Cardiopulmonary Rehabilitation 20:2, 109-114
CrossRef760
Vend Menon, Jonathan S. Steinberg, Luis Carillo, Toshio Akiyama, Karen Beckman, Steven Kutalek. (2000) Implantable cardioverter defibrillator discharge rates in patients with unexplained syncope, structural heart disease, and inducible ventricular tachycardia at electrophysiologic study. Clinical Cardiology 23:3, 195-200
CrossRef761
Maron, Barry J., Shen, Win-Kuang, Link, Mark S., Epstein, Andrew E., Almquist, Adrian K., Daubert, James P., Bardy, Gust H., Favale, Stefano, Rea, Robert F., Boriani, Giuseppe, Estes, N.A. Mark, Spirito, Paolo, Casey, Susan A., Stanton, Marshall S., Betocchi, Sandro, . (2000) Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy. New England Journal of Medicine 342:6, 365-373
Full Text762
Gerald V. Naccarelli, Deborah L. Wolbrette, Joseph T. Dell'Orfano, Hemantkumar M. Patel, Jerry C. Luck. (2000) Amiodarone: What have we learned from clinical trials?. Clinical Cardiology 23:2, 73-82
CrossRef763
Annette Peters, Emerson Liu, Richard L. Verrier, Joel Schwartz, Diane R. Gold, Murray Mittleman, Jeff Baliff, J. Annie Oh, George Allen, Kevin Monahan, Douglas W. Dockery. (2000) Air Pollution and Incidence of Cardiac Arrhythmia. Epidemiology 11:1, 11-17
CrossRef764
ANTONIS S. MANOLIS, THEMOS MAOUNIS, VASSILIS VASSILIKOS, JOHN CHILADAKIS, DENNIS V. COKKINOS. (2000) Electrophysiologist-Implanted Transvenous Cardioverter Defibrillators Using Local Versus General Anesthesia. Pacing and Clinical Electrophysiology 23:1, 96-105
CrossRef765
Toby C. Trujillo, Paul E. Nolan. (2000) Antiarrhythmic Agents. Drug Safety 23:6, 509-532
CrossRef766
FLORIN T. DEGERATU, KOROUSH KHALIGHI, ROBERT W. PETERS, STEPHEN R. SHOROFSKY, MICHAEL R. GOLD. (2000) Sensing Lead Failure in Implantable Defibrillators:.. Journal of Cardiovascular Electrophysiology 11:1, 21-24
CrossRef767
LARS ECKARDT, WILHELM HAVERKAMP, ROBERT JOHNA, DIRK BÖCKER, MARIO C. DENG, GÜNTER BREITHARDT, MARTIN BORGGREEE. (2000) Arrhythmias in Heart Failure:.. Journal of Cardiovascular Electrophysiology 11:1, 106-117
CrossRef768
Arthur J. Moss. (2000) Introductory Note. Annals of Noninvasive Electrocardiology 5:1, 92-93
CrossRef769
Gerald V. Naccarelli, Deborah L. Wolbrette, Hemantkumar M. Patel, Jerry C. Luck. (2000) Amiodarone: clinical trials. Current Opinion in Cardiology 15:1, 64-72
CrossRef770
Buxton, Alfred E., Lee, Kerry L., Fisher, John D., Josephson, Mark E., Prystowsky, Eric N., Hafley, Gail, . (1999) A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease. New England Journal of Medicine 341:25, 1882-1890
Full Text771
SAMUEL F. SEARS, JAMIE B CONTI, ANNE B CURTIS, TARA L SAIA, REBECCA FOOTE, FRANCIS WEN. (1999) Affective Distress and Implantable Cardioverter Defibrillators: Cases for Psychological and Behavioral Interventions. Pacing and Clinical Electrophysiology 22:12, 1831-1834
CrossRef772
CRAIG M. BRODSKY, FANG CHANG, STEPHEN C. VLAY, . (1999) Multicenter Evaluation of Implantable Cardioverter Defibrillator Testing after Implant: The Post Implant Testing Study (PITS). Pacing and Clinical Electrophysiology 22:12, 1769-1776
CrossRef773
Heart Failure Society Of America. (1999) HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches. Journal of Cardiac Failure 5:4, 357-382
CrossRef774
CRAIG M. PRATT, A. JOHN CAMM, J. THOMAS BIGGER, GÜNTER BREITHARDT, RONALD W.F. CAMPBELL, ANDREW E. EPSTEIN, LUKAS J. KAPPENBERGER, KARL-HEINZ KUCK, STUART POCOCK, SANJEEV SAKSENA, ALBERT L. WALDO. (1999) Evaluation of Antiarrhythmic Drug Efficacy in Patients with an ICD:.. Journal of Cardiovascular Electrophysiology 10:11, 1534-1549
CrossRef775
Ryan Cooley, Masood Akhtar, Jasbir Sra. (1999) Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?. Current Cardiology Reports 1:4, 268-273
CrossRef776
H. LEON GREENE. (1999) Testing Antiarrhythmic Drugs with the ICD:.. Journal of Cardiovascular Electrophysiology 10:11, 1550-1552
CrossRef777
(1999) Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trial. Journal of the American College of Cardiology 34:5, 1552-1559
CrossRef778
Michael J Domanski, Sanjeev Sakseena, Andrew E Epstein, Alfred P Hallstrom, Michael A Brodsky, Soo Kim, Scott Lancaster, Eleanor Schron. (1999) Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. Journal of the American College of Cardiology 34:4, 1090-1095
CrossRef779
Andrew E. Epstein, Judy Powell, Qing Yao, Celeste Ocampo, Scott Lancaster, Yves Rosenberg, David S. Cannom, John M. Herre, H.Leon Greene. (1999) In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival. Journal of the American College of Cardiology 34:4, 1111-1116
CrossRef780
G Altemose. (1999) Assessment of electrical devices for arrhythmia control and prevention: past and future. ACC Current Journal Review 8:5, 47-50
CrossRef781
Michael H Crawford, Steven J Bernstein, Prakash C Deedwania, John P DiMarco, Kevin J Ferrick, Arthur Garson, Lee A Green, H.Leon Greene, Michael J Silka, Peter H Stone, Cynthia M Tracy, Raymond J Gibbons, Joseph S Alpert, Kim A Eagle, Timothy J Gardner, Arthur Garson, Gabriel Gregoratos, Richard O Russell, Thomas J Ryan, Sidney C Smith. (1999) ACC/AHA guidelines for ambulatory electrocardiography. Journal of the American College of Cardiology 34:3, 912-948
CrossRef782
PEARILA B. NAMEROW, BEVERLY R. FIRTH, GEOFFREY M. HEYWOOD, JOHN R. WINDLE, MICHAEL K. PARIDES, . (1999) Quality-of-Life Six Months After CABG Surgery in Patients Randomized to ICD Versus No ICD Therapy: Findings from the CABG Patch Trial. Pacing and Clinical Electrophysiology 22:9, 1305-1313
CrossRef783
Patrick J Welch, Richard L Page, Mohamed H Hamdan. (1999) Management of ventricular arrhythmias. Journal of the American College of Cardiology 34:3, 621-630
CrossRef784
PAUL A. FRIEDMAN, MARY JANE RASMUSSEN, SUELLEN GRICE, JANE TRUSTY, MICHAEL GLIKSON, MARSHALL S. STANTON. (1999) Defibrillation Thresholds are Increased by Right-Sided Implantation of Totally Transvenous Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 22:8, 1186-1192
CrossRef785
GREGORY F. MICHAUD, QUAN LI, XENOPHON COSTEAS, ROBERT STEARNS, MARK ESTES III, PAUL J. WANG. (1999) Correlation Waveform Analysis to Discriminate Monomorphic Ventricular Tachycardia from Sinus Rhythm Using Stored Electrograms from Implantable Defibrillators. Pacing and Clinical Electrophysiology 22:8, 1146-1151
CrossRef786
LENNART BERGFELDT. (1999) CABG and ICD for All Patients with Hemodynamically Significant Ventricular Arrhythmia and Significant Coronary Artery Disease? Do We Know Enough to Decide-or to Design a Randomized Trial?. Pacing and Clinical Electrophysiology 22:8, 1129-1131
CrossRef787
Michael Cooklin, Mary R Olsovsky, Randall G Brockman, Stephen R Shorofsky, Michael R Gold. (1999) Atrial defibrillation with a transvenous lead. Journal of the American College of Cardiology 34:2, 358-362
CrossRef788
Ted C Braun, Neil A Hagen, Robert E Hatfield, D.George Wyse. (1999) Cardiac Pacemakers and Implantable Defibrillators in Terminal Care. Journal of Pain and Symptom Management 18:2, 126-131
CrossRef789
Jeffrey J. Goldberger. (1999) Sudden cardiac death. Current Treatment Options in Cardiovascular Medicine 1:2, 127-135
CrossRef790
LUIS A. PIRES, MICHAEL L. HULL, CHARLES L. NINO, LYNETTE M. MAY, JAGADEESH R. GANJI. (1999) Sudden Death in Recipients of Transvenous Implantable Cardioverter Defibrillator Systems:.. Journal of Cardiovascular Electrophysiology 10:8, 1049-1056
CrossRef791
Derek V. Exner, James A. Reiffel, Andrew E. Epstein, Robert Ledingham, Michael J. Reiter, Qing Yao, Henry J. Duff, Dean Follmann, Eleanor Schron, H.Leon Greene, Mark D. Carlson, Michael A. Brodsky, Toshio Akiyama, Christina Baessler, Jeffrey L. Anderson. (1999) Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial. Journal of the American College of Cardiology 34:2, 325-333
CrossRef792
Antonio Pacifico, Laura L Ferlic, Félix R Cedillo-Salazar, Nadim Nasir, Timothy K Doyle, Philip D Henry. (1999) Shocks as predictors of survival in patients with implantable cardioverter-defibrillators. Journal of the American College of Cardiology 34:1, 204-210
CrossRef793
Richard N. Fogoros. (1999) Evidence-based medicine and the implantable defibrillator. Current Cardiology Reports 1:2, 135-141
CrossRef794
A. John Camm, Samuel F. Sears, John F. Todaro, Tara Saia Lewis, Wayne Sotile, Jamie B. Conti. (1999) Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clinical Cardiology 22:7, 481-489
CrossRef795
VOLKER KÜHLKAMP, VOLKER DÖRNBERGER, CHRISTIAN MEWIS, RALF SUCHALLA, RALPH E. BOSCH, LUDGER SEIPEL. (1999) Clinical Experience with the New Detection Algorithms for Atrial Fibrillation of a Defibrillator with Dual Chamber Sensing and Pacing. Journal of Cardiovascular Electrophysiology 10:7, 905-915
CrossRef796
Podrid, Philip J., . (1999) Redefining the Role of Antiarrhythmic Drugs. New England Journal of Medicine 340:24, 1910-1912
Full Text797
Pacifico, Antonio, Hohnloser, Stefan H., Williams, John H., Tao, Ben, Saksena, Sanjeev, Henry, Philip D., Prystowsky, Eric N., . (1999) Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol. New England Journal of Medicine 340:24, 1855-1862
Full Text798
Christian Mewis, Volker Kühlkamp, Johann Mermi, Ralph F Bosch, Ludger Seipel. (1999) Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias. Journal of the American College of Cardiology 33:7, 1989-1995
CrossRef799
Stefan H Hohnloser, Thomas Klingenheben, Markus Zabel, Matthias Schöpperl, Oliver Mauß. (1999) Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. Journal of the American College of Cardiology 33:7, 1895-1902
CrossRef800
C. SEMSARIAN, D. R. RICHMOND. (1999) Sudden cardiac death in familial hypertrophic cardiomyopathy: an Australian experience. Australian and New Zealand Journal of Medicine 29:3, 368-370
CrossRef801
P. Kovoor, A. Yung, K. Byth, V. E. Eipper, J. B. Uther, M. J. Cooper, D. L. Ross. (1999) Comparison of the long-term efficacy of implantable defibrillators and sotalol for documented spontaneous sustained ventricular tachyarrhythmias secondary to coronary artery disease. Australian and New Zealand Journal of Medicine 29:3, 331-341
CrossRef802
Bradley P Knight, Rajiva Goyal, Frank Pelosi, Matthew Flemming, Laura Horwood, Fred Morady, S.Adam Strickberger. (1999) Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. Journal of the American College of Cardiology 33:7, 1964-1970
CrossRef803
JEFFREY H. HERBST, MARK GOODMAN, STANLEY FELDSTEIN, JOSEPH M. REILLY. (1999) Health-Related Quality-of-Life Assessment of Patients with Life-Threatening Ventricular Arrhythmias. Pacing and Clinical Electrophysiology 22:6, 915-926
CrossRef804
Audrey H. Wu, Sunil K. Das. (1999) Sudden death in dilated cardiomyopathy. Clinical Cardiology 22:4, 267-272
CrossRef805
Robert D. Lerman, David S. Cannom. (1999) Sudden electrical death. Current Treatment Options in Cardiovascular Medicine 1:1, 91-96
CrossRef806
Dawn G. Zarembski, Staci A. Fischer, Peter A. Santucci, Mary T. Porter, Maria Rosa Costanzo, Richard G. Trohman. (1999) Impact of Rifampin on Serum Amiodarone Concentrations in a Patient with Congenital Heart Disease. Pharmacotherapy 19:2, 249-251
CrossRef807
DOUGLAS P. ZIPES. (1999) An Overview of Arrhythmias and Antarrhythmic Approaches. Journal of Cardiovascular Electrophysiology 10:2, 267-271
CrossRef808
FELIPE AGUEL, JAMES C. EASON, NATALIA A. TRAYANOVA, GREG IEKAS, MATTHEW G. FISHLER. (1999) Impact of Transvenous Lead Position on Active-Can ICD Defibrillation: A Computer Simulation Study. Pacing and Clinical Electrophysiology 22:1, 158-164
CrossRef809
Volker Kühlkamp, Christian Mewis, Johannes Mermi, Ralph F Bosch, Ludger Seipel. (1999) Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. Journal of the American College of Cardiology 33:1, 46-52
CrossRef810
Peter Weismüller, Hans-Joachim Trappe. (1999) Update Kardiologie. Medizinische Klinik 94:1, 15-28
CrossRef811
Sandra B. Dunbar, Laura P. Kimble, Louise S. Jenkins, Mary Hawthorne, William Dudley, Marina Slemmons, Jonathan J. Langberg. (1999) Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depression and Anxiety 9:4, 163-168
CrossRef812
WOLFRAM GRIMM, VOLKER MENZ, JURGEN HOFFMANN, UWE TIMMANN, REINHARD FUNCK, RAINER MOOSDORF, BERNHARD MAISCH. (1999) Complications of Third-Generation Implantable Cardioverter Defibrillator Therapy. Pacing and Clinical Electrophysiology 22:1, 206-211
CrossRef813
Craig A. Swygman, Munther K. Homoud, Mark S. Link, Paul J. Wang, N. A. Mark Estes. (1999) Technologic advances in implantable cardioverter defibrillators. Current Opinion in Cardiology 14:1, 9
CrossRef814
Dan M Roden. (1999) An Overview of Contemporary Approaches to Antiarrhythmic Therapy. Japanese Circulation Journal 63:9, 655-658
CrossRef815
Masaomi Chinushi, Takashi Washizuka, Hidehiro Kasai, Kouji Ohhira, Masahito Satoh, Yoshifusa Aizawa. (1999) Development of Ventricular Fibrillations With Different Characteristics in the Local Electrocardiogram. Japanese Circulation Journal 63:12, 1007-1010
CrossRef816
YASUHIRO ENDOH, SATOSHI OHNISHI, HIROSHI KASANUKI. (1999) Clinical Significance of Consecutive Shocks in Patients with Left Ventricular Dysfunction Treated with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 22:1, 187-191
CrossRef817
PHILIP ZILO, DANIEL N. WEISS, RICHARD M. LUCERI. (1999) Late Retesting of System Performance in ICD Patients Without Spontaneous Shocks. Pacing and Clinical Electrophysiology 22:1, 197-201
CrossRef818
Eric J. Eichhorn, Mohamed H. Hamdan. (1998) β-Blockade and amiodarone therapy: Twin brothers from different parents. Journal of Cardiac Failure 4:4, 289-294
CrossRef819
STEFAN H. HOHNLOSER, THOMAS KLINGENHEBEN, YI-GANG LI, MARKUS ZABEL, JOY PEETERMANS, RICHARD J. COHEN. (1998) T Wave Alternans as a Predictor of Recurrent Ventricular Tachyarrhythmias in ICD Recipients: Prospective Comparison with Conventional Risk Markers. Journal of Cardiovascular Electrophysiology 9:12, 1258-1268
CrossRef820
Maron, Barry J., , Mitten, Matthew J., , Quandt, Eric F., , Zipes, Douglas P., . (1998) Competitive Athletes with Cardiovascular Disease — The Case of Nicholas Knapp. New England Journal of Medicine 339:22, 1632-1635
Full Text821
JENS JUNG, DANIEL STRAUSS, THOMAS SINNWELL, GREGOR HOHENBERG, ROLAND FRIES, HARALD WERN, HERMANN SCHIEFFER, ARMIN HEISEL. (1998) Assessment of Intersignal Variability for Discrimination of Atrial Fibrillation from Atrial Flutter. Pacing and Clinical Electrophysiology 21:11, 2426-2430
CrossRef822
Wolfgang Schoels. (1998) Gesicherte und nichtgesicherte Indikationen zur elektrophysiologischen Untersuchung. Herz 23:7, 463-465
CrossRef823
WOLFRAM GRIMM, CHRISTINA GLAVERIS, JURGEN HOFFMANN, VOLKER MENZ, NADJA MET, STEPHAN BORN, BERNHARD MAISCH. (1998) Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Design and First Results of the Marburg Cardiomyopathy Study. Pacing and Clinical Electrophysiology 21:11, 2551-2556
CrossRef824
CHARLES GOTTLIEB, DAVID J. CALLANS, FRANCIS MARCHLINSKI. (1998) Implantable Cardioverter Defibrillators in the United States: Understanding the Benefits and Limitations of Implantable Cardioverter Defibrillator Therapy Based on Clinical Trial Results. Pacing and Clinical Electrophysiology 21:11, 2016-2020
CrossRef825
Eric M Grubman, Behzad B Pavri, Tamara Shipman, Nancy Britton, Dusan Z Kocovic. (1998) Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators. Journal of the American College of Cardiology 32:4, 1056-1062
CrossRef826
JACQUES CLEMENTY. (1998) The ICD in FRANCE: Money Problem or Donkey Syndrome?. Pacing and Clinical Electrophysiology 21:9, 1683-1685
CrossRef827
Wolfram Grimm, Jürgen Hoffmann, Volker Menz, Kathrin Luck, Bernhard Maisch. (1998) Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. Journal of the American College of Cardiology 32:3, 739-745
CrossRef828
GERALD V. NACCARELLLI, DEBORAH L. WOLBRETTE, JOSEPH T. DELL'ORFANO, HEMANTKUMAR M. PATEL, JERRY C. LUCK. (1998) A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond. Journal of Cardiovascular Electrophysiology 9:8, 864-891
CrossRef829
Stuart J Connolly. (1998) Implantable cardioverter defibrillators—for whom?. The Lancet 352:9125, 338-340
CrossRef830
W Groh. (1998) The use of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. ACC Current Journal Review 7:4, 48-51
CrossRef831
Arthur J. Moss. (1998) Noninvasive Electrocardiological Identification of Patients Who Will Benefit from an Implantable Defibrillator. Annals of Noninvasive Electrocardiology 3:3, 181-182
CrossRef832
SEAH NISAM, MORTON MOWER. (1998) ICD Trials: An Extraordinary Means of Determining Patient Risk?. Pacing and Clinical Electrophysiology 21:7, 1341-1346
CrossRef833
PRAMOD DESHMUKH, KATHY ANDERSON. (1998) Myopotential Sensing by a Dual Chamber Implantable Cardioverter Defibrillator:.. Journal of Cardiovascular Electrophysiology 9:7, 767-772
CrossRef834
L. BRENT MITCHELL. (1998) Pharmacological Therapy for Ventricular Arrhythmias in the Era of the Implantable Cardioverter Defibrillator: Indispensable or Inadvisable?. Journal of Interventional Cardiology 11:3, 235-246
CrossRef835
DAVID S. CANNOM. (1998) AVID and Beyond: Lessons Learned. Journal of Interventional Cardiology 11:3, 217-226
CrossRef836
SEAH NISAM, IGOR SINGER. (1998) Prophylactic Trials With Implantable Cardioverter Defibrillators: MADIT and Beyond. Journal of Interventional Cardiology 11:3, 227-233
CrossRef837
SAMUEL LÉVY. (1998) The Role of Antiarrhythmic Drugs in Patients With Implanted Cardioverter Defibrillators. Journal of Interventional Cardiology 11:3, 213-216
CrossRef838
PENG-SHENG CHEN, CHARLES D. SWERDLOW, CHUN HWANG, HRAYR S. KARAGUEUZIAN. (1998) Current Concepts of Ventricular Defibrillation. Journal of Cardiovascular Electrophysiology 9:5, 553-562
CrossRef839
WERNER PETERS, PETER KOWALLIK, MANFRED REISBERG, MALTE MEESMANN. (1998) Body Surface Potentials During Discharge of the Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 9:5, 491-497
CrossRef840
Eleanor B Schron, Lawrence M Friedman, H Leon Greene, Chuke Nwachuku. (1998) Ongoing and planned clinical trials of anti-arrhythmic drugs: an update. Expert Opinion on Investigational Drugs 7:3, 427-435
CrossRef841
Hal V Barron, Sami Viskin. (1998) Autonomic markers and prediction of cardiac death after myocardial infarction. The Lancet 351:9101, 461-462
CrossRef842
Janice Pogue, Salim Yusuf. (1998) Overcoming the limitations of current meta-analysis of randomised controlled trials. The Lancet 351:9095, 47-52
CrossRef843
Members of the Sicilian Gambit. (1998) The Search for Novel Antiarrhythmic Strategies. Japanese Circulation Journal 62:9, 633-648
CrossRef844
Satsuki Yamada, Iwao Yamaguchi. (1998) Effect of Relatively Low Dose Amiodarone Therapy on Left Ventricular Function in Patients With Ventricular Tachyarrhythmias. Japanese Circulation Journal 62:9, 707-709
CrossRef845
Bigger, J. Thomas Jr., . (1997) Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery. New England Journal of Medicine 337:22, 1569-1575
Full Text846
Myerburg, Robert J., Castellanos, Agustin, . (1997) Clinical Trials of Implantable Defibrillators. New England Journal of Medicine 337:22, 1621-1623
Full Text
